Publications
LSP Bibliography
2576724
IXMHRBF6
LSP paper
1
apa-cv
50
date
desc
year
1
2179
https://labsyspharm.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A400%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%223S5WIB4Q%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Oskolas%20et%20al.%22%2C%22parsedDate%22%3A%222025-05-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EOskolas%2C%20H.%2C%20Nogueira%2C%20F.%20C.%20N.%2C%20Domont%2C%20G.%20B.%2C%20Yu%2C%20K.-H.%2C%20Semenov%2C%20Y.%20R.%2C%20Sorger%2C%20P.%2C%20Steinfelder%2C%20E.%2C%20Corps%2C%20L.%2C%20Schulz%2C%20L.%2C%20Wieslander%2C%20E.%2C%20Feny%26%23xF6%3B%2C%20D.%2C%20K%26%23xE1%3Brp%26%23xE1%3Bti%2C%20S.%2C%20Holl%26%23xF3%3B%2C%20P.%2C%20Kem%26%23xE9%3Bny%2C%20L.%20V.%2C%20D%26%23xF6%3Bme%2C%20B.%2C%20Megyesfalvi%2C%20Z.%2C%20Paw%26%23x142%3Bowski%2C%20K.%2C%20Nishimura%2C%20T.%2C%20Kwon%2C%20H.%2C%20%26%23x2026%3B%20Gil%2C%20J.%20%282025%29.%20Comprehensive%20biobanking%20strategy%20with%20clinical%20impact%20at%20the%20European%20Cancer%20Moonshot%20Lund%20Center.%20%3Ci%3EJournal%20of%20Proteomics%3C%5C%2Fi%3E%2C%20%3Ci%3E316%3C%5C%2Fi%3E%2C%20105442.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jprot.2025.105442%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jprot.2025.105442%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comprehensive%20biobanking%20strategy%20with%20clinical%20impact%20at%20the%20European%20Cancer%20Moonshot%20Lund%20Center%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henriett%22%2C%22lastName%22%3A%22Oskolas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%5Cu00e1bio%20C.%20N.%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilberto%20B.%22%2C%22lastName%22%3A%22Domont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kun-Hsing%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yevgeniy%20R.%22%2C%22lastName%22%3A%22Semenov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%22%2C%22lastName%22%3A%22Steinfelder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Les%22%2C%22lastName%22%3A%22Corps%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lesley%22%2C%22lastName%22%3A%22Schulz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabet%22%2C%22lastName%22%3A%22Wieslander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Feny%5Cu00f6%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarolta%22%2C%22lastName%22%3A%22K%5Cu00e1rp%5Cu00e1ti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%5Cu00e9ter%22%2C%22lastName%22%3A%22Holl%5Cu00f3%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lajos%20V.%22%2C%22lastName%22%3A%22Kem%5Cu00e9ny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Balazs%22%2C%22lastName%22%3A%22D%5Cu00f6me%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zsolt%22%2C%22lastName%22%3A%22Megyesfalvi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krzysztof%22%2C%22lastName%22%3A%22Paw%5Cu0142owski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toshihide%22%2C%22lastName%22%3A%22Nishimura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22HoJeong%22%2C%22lastName%22%3A%22Kwon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%22%2C%22lastName%22%3A%22Encarnaci%5Cu00f3n-Guevara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20Marcell%22%2C%22lastName%22%3A%22Szasz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zolt%5Cu00e1n%22%2C%22lastName%22%3A%22Ver%5Cu00e9b%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rolland%22%2C%22lastName%22%3A%22Gyulai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Istv%5Cu00e1n%20Bal%5Cu00e1zs%22%2C%22lastName%22%3A%22N%5Cu00e9meth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%22%2C%22lastName%22%3A%22Appelqvist%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melinda%22%2C%22lastName%22%3A%22Rezeli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo%22%2C%22lastName%22%3A%22Baldetorp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Horvatovich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Malmstr%5Cu00f6m%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Indira%22%2C%22lastName%22%3A%22Pla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniel%22%2C%22lastName%22%3A%22Sanchez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatrice%22%2C%22lastName%22%3A%22Knudsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e1s%22%2C%22lastName%22%3A%22Kiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Malm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gy%5Cu00f6rgy%22%2C%22lastName%22%3A%22Marko-Varga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeovanis%22%2C%22lastName%22%3A%22Gil%22%7D%5D%2C%22abstractNote%22%3A%22This%20white%20paper%20presents%20a%20comprehensive%20biobanking%20framework%20developed%20at%20the%20European%20Cancer%20Moonshot%20Lund%20Center%20that%20merges%20rigorous%20sample%20handling%2C%20advanced%20automation%2C%20and%20multi-omic%20analyses%20to%20accelerate%20precision%20oncology.%20Tumor%20and%20blood-based%20workflows%2C%20supported%20by%20automated%20fractionation%20systems%20and%20standardized%20protocols%2C%20ensure%20the%20collection%20of%20high-quality%20biospecimens%20suitable%20for%20proteomic%2C%20genomic%2C%20and%20metabolic%20studies.%20A%20robust%20informatics%20infrastructure%2C%20integrating%20LIMS%2C%20barcoding%2C%20and%20REDCap%2C%20supports%20end-to-end%20traceability%20and%20realtime%20data%20synchronization%2C%20thereby%20enriching%20each%20sample%20with%20critical%20clinical%20metadata.%20Proteogenomic%20integration%20lies%20at%20the%20core%20of%20this%20initiative%2C%20uncovering%20tumor-%20and%20blood-based%20molecular%20profiles%20that%20inform%20cancer%20heterogeneity%2C%20metastasis%2C%20and%20therapeutic%20resistance.%20Machine%20learning%20and%20AI-driven%20models%20further%20enhance%20these%20datasets%20by%20stratifying%20patient%20populations%2C%20predicting%20therapeutic%20responses%2C%20and%20expediting%20the%20discovery%20of%20actionable%20targets%20and%20companion%20biomarkers.%20This%20synergy%20between%20technology%2C%20automation%2C%20and%20high-dimensional%20data%20analytics%20enables%20individualized%20treatment%20strategies%20in%20melanoma%2C%20lung%2C%20and%20other%20cancer%20types.%20Aligned%20with%20international%20programs%20such%20as%20the%20Cancer%20Moonshot%20and%20the%20ICPC%2C%20the%20Lund%20Center%27s%20approach%20fosters%20open%20collaboration%20and%20data%20sharing%20on%20a%20global%20scale.%20This%20scalable%2C%20patient-centric%20biobanking%20paradigm%20provides%20an%20adaptable%20model%20for%20institutions%20aiming%20to%20unify%20clinical%2C%20molecular%2C%20and%20computational%20resources%20for%20transformative%20cancer%20research.%22%2C%22date%22%3A%222025-05-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jprot.2025.105442%22%2C%22ISSN%22%3A%221876-7737%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-19T13%3A37%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22R82UE74B%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jobin%20et%20al.%22%2C%22parsedDate%22%3A%222025-05-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJobin%2C%20B.%2C%20Zigrand%2C%20C.%2C%20Frasnelli%2C%20J.%2C%20Boller%2C%20B.%2C%20%26amp%3B%20Albers%2C%20M.%20W.%20%282025%29.%20Lower%20Odor%20Identification%20in%20Subjective%20Cognitive%20Decline%3A%20A%20Meta-analysis.%20%3Ci%3EMedRxiv%3A%20The%20Preprint%20Server%20for%20Health%20Sciences%3C%5C%2Fi%3E%2C%202025.04.15.25325887.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.04.15.25325887%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.04.15.25325887%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lower%20Odor%20Identification%20in%20Subjective%20Cognitive%20Decline%3A%20A%20Meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benoit%22%2C%22lastName%22%3A%22Jobin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Coline%22%2C%22lastName%22%3A%22Zigrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%22%2C%22lastName%22%3A%22Frasnelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Boller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Odor%20identification%20correlates%20with%20Alzheimer%27s%20disease%20%28AD%29%20biomarkers%2C%20and%20its%20decline%20may%20emerge%20before%20measurable%20cognitive%20deficits%20as%20early%20as%20the%20subjective%20cognitive%20decline%20%28SCD%29%20stage.%20We%20aimed%20to%20compare%20odor%20identification%20between%20SCD%20and%20cognitively%20normal%20%28CN%29%20stages%20and%20investigate%20whether%20cognitive%20differences%20moderate%20olfactory%20deficits.%5CnMETHODS%3A%20A%20systematic%20search%20of%20four%20databases%20identified%20studies%20assessing%20olfactory%20identification%20and%20cognitive%20screening%20in%20individuals%20aged%2050%2B.%20A%20random-effects%20meta-analysis%20was%20performed%20on%2011%20studies%20%28660%20SCD%2C%20574%20CN%29.%5CnRESULTS%3A%20Individuals%20with%20SCD%20exhibited%20lower%20olfactory%20identification%20scores%20compared%20to%20CN%20participants%20%28SMD%20%3D%20-0.67%2C%2095%25CI%20%5B-1.31%2C%20-0.03%5D%2C%20p%20%3D%20.04%29.%20Meta-regression%20revealed%20a%20negative%20association%20%28%5Cu03b2%20%3D%20-1.79%2C%20p%20%3D%20.02%29%20between%20cognitive%20and%20olfactory%20differences%2C%20indicating%20that%20greater%20cognitive%20decline%20was%20not%20consistently%20associated%20with%20greater%20olfactory%20deficits%2C%20lower%20odor%20identification%20scores%20in%20SCD%20occurred%20despite%20minimal%20cognitive%20differences%20across%20groups.%5CnDISCUSSION%3A%20Odor%20identification%20is%20lower%20in%20pre-MCI%20individuals%20reporting%20SCD.%20Olfactory%20decline%20may%20emerge%20independently%20prior%20to%20measurable%20cognitive%20decline%2C%20supporting%20the%20role%20of%20odor%20identification%20as%20a%20screen%20for%20AD.%22%2C%22date%22%3A%222025-05-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.04.15.25325887%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-13T12%3A54%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22MUXQKAHJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khoury%20et%20al.%22%2C%22parsedDate%22%3A%222025-05-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKhoury%2C%20R.%2C%20Longobardi%2C%20G.%2C%20Barnatan%2C%20T.%20T.%2C%20Venkert%2C%20D.%2C%20Garc%26%23xED%3Ba%20Alvarado%2C%20A.%2C%20Yona%2C%20A.%2C%20Green%20Buzhor%2C%20M.%2C%20Shahar%2C%20S.%2C%20Wang%2C%20Q.%2C%20Ac%26%23xFA%3Brcio%2C%20R.%20C.%2C%20Guedes%2C%20R.%20C.%2C%20Florindo%2C%20H.%20F.%2C%20Zhao%2C%20J.%20J.%2C%20%26amp%3B%20Satchi-Fainaro%2C%20R.%20%282025%29.%20Radiation-guided%20nanoparticles%20enhance%20the%20efficacy%20of%20PARP%20inhibitors%20in%20primary%20and%20metastatic%20BRCA1-deficient%20tumors%20via%20immunotherapy.%20%3Ci%3EJournal%20of%20Controlled%20Release%3A%20Official%20Journal%20of%20the%20Controlled%20Release%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E383%3C%5C%2Fi%3E%2C%20113812.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jconrel.2025.113812%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jconrel.2025.113812%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Radiation-guided%20nanoparticles%20enhance%20the%20efficacy%20of%20PARP%20inhibitors%20in%20primary%20and%20metastatic%20BRCA1-deficient%20tumors%20via%20immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rami%22%2C%22lastName%22%3A%22Khoury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giuseppe%22%2C%22lastName%22%3A%22Longobardi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tania%20T.%22%2C%22lastName%22%3A%22Barnatan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%22%2C%22lastName%22%3A%22Venkert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9rica%22%2C%22lastName%22%3A%22Garc%5Cu00eda%20Alvarado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adi%22%2C%22lastName%22%3A%22Yona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Green%20Buzhor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shir%22%2C%22lastName%22%3A%22Shahar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiwei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%20C.%22%2C%22lastName%22%3A%22Ac%5Cu00farcio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%20C.%22%2C%22lastName%22%3A%22Guedes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%20F.%22%2C%22lastName%22%3A%22Florindo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronit%22%2C%22lastName%22%3A%22Satchi-Fainaro%22%7D%5D%2C%22abstractNote%22%3A%22Poly%20%28ADP-ribose%29%20polymerase%20inhibitors%20%28PARPi%29%20have%20revolutionized%20the%20treatment%20landscape%20for%20patients%20suffering%20from%20BRCA1-mutated%20breast%20and%20ovarian%20cancers.%20However%2C%20responses%20are%20not%20durable.%20We%20demonstrate%20that%20treatment%20with%20PARPi%2C%20niraparib%2C%20increases%20programmed%20death-ligand%201%20%28PD-L1%29%20expression%20in%20BRCA1-deficient%20cancer%20cells%2C%20contributing%20to%20immune%20evasion.%20To%20circumvent%20this%2C%20we%20developed%20P-selectin-targeted%20poly%20%28lactic-co-glycolic%29%20acid%20%28PLGA%29-poly%20%28ethylene%20glycol%29%20%28PEG%29-based%20nanoparticles%20%28NPs%29%20encapsulating%20PARP%20and%20PD-L1%20inhibitors%20at%20a%20synergistic%20ratio.%20To%20further%20enhance%20tumor%20targeting%2C%20we%20leveraged%20radiation-induced%20P-selectin%20upregulation%20in%20BRCA1-deficient%20cancer%20cells%20and%20their%20associated%20angiogenic%20endothelial%20cells%2C%20improving%20NP%20accumulation%20in%20the%20primary%20tumors%20and%20hard-to-target%20metastatic%20sites%2C%20including%20brain%20metastasis.%20Using%20a%20combination%20of%20traditional%202-dimensional%20%282D%29%20cell%20cultures%2C%20advanced%203-dimensional%20%283D%29%20spheroids%2C%20tumor-on-a-chip%20platforms%2C%20and%20in%20vivo%20models%2C%20we%20demonstrate%20the%20enhanced%20accumulation%20and%20efficacy%20of%20the%20radiation-guided%20P-selectin-targeted%20NPs%20in%20primary%20and%20brain-metastatic%20BRCA1-deficient%20tumors.%22%2C%22date%22%3A%222025-05-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jconrel.2025.113812%22%2C%22ISSN%22%3A%221873-4995%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-13T12%3A56%3A21Z%22%7D%7D%2C%7B%22key%22%3A%224YKJ35QH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gui%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGui%2C%20F.%2C%20Jiang%2C%20B.%2C%20Jiang%2C%20J.%2C%20He%2C%20Z.%2C%20Tsujino%2C%20T.%2C%20Takai%2C%20T.%2C%20Arai%2C%20S.%2C%20Pana%2C%20C.%2C%20K%26%23xF6%3Bllermann%2C%20J.%2C%20Bradshaw%2C%20G.%20A.%2C%20Eisert%2C%20R.%2C%20Kalocsay%2C%20M.%2C%20Fassl%2C%20A.%2C%20Balk%2C%20S.%20P.%2C%20Kibel%2C%20A.%20S.%2C%20%26amp%3B%20Jia%2C%20L.%20%282025%29.%20Acute%20BRCAness%20induction%20and%20AR%20pathway%20blockage%20through%20CDK12%5C%2F7%5C%2F9%20degradation%20enhances%20PARP%20inhibitor%20sensitivity%20in%20prostate%20cancer.%20%3Ci%3EScience%20Advances%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%2817%29%2C%20eadu0847.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.adu0847%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.adu0847%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Acute%20BRCAness%20induction%20and%20AR%20pathway%20blockage%20through%20CDK12%5C%2F7%5C%2F9%20degradation%20enhances%20PARP%20inhibitor%20sensitivity%20in%20prostate%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fu%22%2C%22lastName%22%3A%22Gui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Baishan%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhixiang%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takuya%22%2C%22lastName%22%3A%22Tsujino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomoaki%22%2C%22lastName%22%3A%22Takai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seiji%22%2C%22lastName%22%3A%22Arai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celine%22%2C%22lastName%22%3A%22Pana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%22%2C%22lastName%22%3A%22K%5Cu00f6llermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20Andrew%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Fassl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20P.%22%2C%22lastName%22%3A%22Balk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20S.%22%2C%22lastName%22%3A%22Kibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Jia%22%7D%5D%2C%22abstractNote%22%3A%22Current%20treatments%20for%20advanced%20prostate%20cancer%20%28PCa%29%20primarily%20target%20the%20androgen%20receptor%20%28AR%29%20pathway.%20However%2C%20the%20emergence%20of%20castration-resistant%20prostate%20cancer%20%28CRPC%29%20and%20resistance%20to%20AR%20pathway%20inhibitors%20%28APPIs%29%20remains%20ongoing%20challenges.%20Here%2C%20we%20present%20BSJ-5-63%2C%20a%20proteolysis-targeting%20chimera%20%28PROTAC%29%20targeting%20cyclin-dependent%20kinases%20%28CDKs%29%20CDK12%2C%20CDK7%2C%20and%20CDK9%2C%20offering%20a%20multipronged%20approach%20to%20CRPC%20therapy.%20BSJ-5-63%20degrades%20CDK12%2C%20diminishing%20BRCA1%20and%20BRCA2%20expression%20and%20inducing%20a%20sustained%20%5C%22BRCAness%5C%22%20state.%20This%20sensitizes%20cancer%20cells%20to%20PARP%20inhibitors%20%28PARPis%29%20regardless%20of%20their%20homologous%20recombination%20repair%20%28HRR%29%20status.%20Furthermore%2C%20CDK7%20and%20CDK9%20degradation%20attenuates%20AR%20signaling%2C%20enhancing%20its%20therapeutic%20efficacy.%20Preclinical%20studies%2C%20including%20both%20in%20vitro%20and%20in%20vivo%20CRPC%20models%2C%20demonstrate%20that%20BSJ-5-63%20exerts%20potent%20antitumor%20activity%20in%20both%20AR-positive%20and%20AR-negative%20setting.%20This%20study%20introduces%20BSJ-5-63%20as%20a%20promising%20therapeutic%20agent%20that%20addresses%20both%20DNA%20repair%20and%20AR%20signaling%20mechanisms%2C%20with%20potential%20benefits%20for%20a%20board%20patient%20population.%22%2C%22date%22%3A%222025-04-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.adu0847%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-28T14%3A28%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22FMAVITQP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gevertz%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGevertz%2C%20J.%20L.%2C%20Greene%2C%20J.%20M.%2C%20Prosperi%2C%20S.%2C%20Comandante-Lou%2C%20N.%2C%20%26amp%3B%20Sontag%2C%20E.%20D.%20%282025%29.%20Understanding%20therapeutic%20tolerance%20through%20a%20mathematical%20model%20of%20drug-induced%20resistance.%20%3Ci%3ENPJ%20Systems%20Biology%20and%20Applications%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%281%29%2C%2030.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41540-025-00511-3%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41540-025-00511-3%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Understanding%20therapeutic%20tolerance%20through%20a%20mathematical%20model%20of%20drug-induced%20resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jana%20L.%22%2C%22lastName%22%3A%22Gevertz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20M.%22%2C%22lastName%22%3A%22Greene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%22%2C%22lastName%22%3A%22Prosperi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natacha%22%2C%22lastName%22%3A%22Comandante-Lou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20D.%22%2C%22lastName%22%3A%22Sontag%22%7D%5D%2C%22abstractNote%22%3A%22There%20is%20growing%20recognition%20that%20phenotypic%20plasticity%20enables%20cancer%20cells%20to%20adapt%20to%20various%20environmental%20conditions.%20An%20example%20of%20this%20adaptability%20is%20the%20ability%20of%20an%20initially%20sensitive%20population%20of%20cancer%20cells%20to%20acquire%20resistance%20and%20persist%20in%20the%20presence%20of%20therapeutic%20agents.%20Understanding%20the%20implications%20of%20this%20drug-induced%20resistance%20is%20essential%20for%20predicting%20transient%20and%20long-term%20tumor%20dynamics%20subject%20to%20treatment.%20This%20paper%20introduces%20a%20mathematical%20model%20of%20drug-induced%20resistance%20which%20provides%20excellent%20fits%20to%20time-resolved%20in%20vitro%20experimental%20data.%20From%20observational%20data%20of%20total%20numbers%20of%20cells%2C%20the%20model%20unravels%20the%20relative%20proportions%20of%20sensitive%20and%20resistance%20subpopulations%20and%20quantifies%20their%20dynamics%20as%20a%20function%20of%20drug%20dose.%20The%20predictions%20are%20then%20validated%20using%20data%20on%20drug%20doses%20that%20were%20not%20used%20when%20fitting%20parameters.%20Optimal%20control%20techniques%20are%20then%20utilized%20to%20discover%20dosing%20strategies%20that%20could%20lead%20to%20better%20outcomes%20as%20quantified%20by%20lower%20total%20cell%20volume.%22%2C%22date%22%3A%222025-04-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41540-025-00511-3%22%2C%22ISSN%22%3A%222056-7189%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-15T12%3A22%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22BZEF7GKE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ma%20and%20Clardy%22%2C%22parsedDate%22%3A%222025-04-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMa%2C%20X.%20C.%2C%20%26amp%3B%20Clardy%2C%20J.%20%282025%29.%20Spontaneous%20Generation%20of%20an%20Endogenous%20ROR%26%23x3B3%3Bt%20Agonist.%20%3Ci%3EJournal%20of%20the%20American%20Chemical%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E147%3C%5C%2Fi%3E%2814%29%2C%2011688%26%23x2013%3B11692.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fjacs.5c02724%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fjacs.5c02724%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Spontaneous%20Generation%20of%20an%20Endogenous%20ROR%5Cu03b3t%20Agonist%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%20Corey%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%22%2C%22lastName%22%3A%22Clardy%22%7D%5D%2C%22abstractNote%22%3A%22The%20transcription%20factor%20ROR%5Cu03b3t%20regulates%20the%20development%20of%20Th17%20cells%20and%20their%20inflammatory%20cytokine%20IL-17%5Cu2500a%20pathway%20that%20can%20both%20clear%20bacterial%20pathogens%20and%20drive%20autoimmune%20diseases.%20An%20endogenous%20ROR%5Cu03b3t%20agonist%20with%20a%20noncanonical%20structure%2C%20a%20lysophosphatidylethanolamine%20%281-18%3A1-LPE%20or%201%29%2C%20was%20recently%20identified%2C%20and%20its%20identity%20both%20increases%20our%20understanding%20of%20immune%20regulation%20and%20creates%20options%20for%20therapeutic%20intervention.%20Compound%201%20could%20be%20formed%20directly%20through%20enzymatic%20cleavage%20of%20a%20suitable%20phosphatidylethanolamine%20%28PE%29%20by%20a%20phospholipase%20A2%20%28PLA2%29%20or%20by%20%5C%22triggering%5C%22%20of%20a%20suitable%20plasmalogen%20with%20accompanying%201%2C2-acyl%20migration%20from%20the%20sn-2%20to%20sn-1%20positions%20of%20glycerol.%20This%20study%20illustrates%20the%20plausibility%20of%20a%20plasmalogen-based%20pathway%20through%20synthesis%20of%20the%20plasmalogen%20precursor%20%282%29%20and%20triggering%20the%20plasmalogen%27s%20electron-rich%20vinyl%20ether%20with%20small%20electrophiles%20characteristic%20of%20inflammatory%20and%20tumor%20environments%20to%20create%201-18%3A1-LPE%20%281%29.%20The%20plasmalogen-based%20pathway%20is%20consistent%20with%20previous%20studies%20on%20the%20formation%20of%201%2C%20and%20it%20also%20conforms%20to%20Lands%20rules%20for%20acyl%20chain%20distribution%20and%20provides%20a%20mechanism%20for%20immune%20signaling%20with%20both%20spatial%20and%20temporal%20control.%22%2C%22date%22%3A%222025-04-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Fjacs.5c02724%22%2C%22ISSN%22%3A%221520-5126%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A56%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22V88QVFZR%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kelley%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKelley%2C%20L.%20P.%2C%20Hu%2C%20S.-H.%2C%20Boswell%2C%20S.%20A.%2C%20Sorger%2C%20P.%20K.%2C%20Ringel%2C%20A.%20E.%2C%20%26amp%3B%20Haigis%2C%20M.%20C.%20%282025%29.%20Integrated%20analysis%20of%20transcriptional%20and%20metabolic%20responses%20to%20mitochondrial%20stress.%20%3Ci%3ECell%20Reports%20Methods%3C%5C%2Fi%3E%2C%20101027.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.crmeth.2025.101027%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.crmeth.2025.101027%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integrated%20analysis%20of%20transcriptional%20and%20metabolic%20responses%20to%20mitochondrial%20stress%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%20P.%22%2C%22lastName%22%3A%22Kelley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Song-Hua%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A.%22%2C%22lastName%22%3A%22Boswell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%20E.%22%2C%22lastName%22%3A%22Ringel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcia%20C.%22%2C%22lastName%22%3A%22Haigis%22%7D%5D%2C%22abstractNote%22%3A%22Mitochondrial%20stress%20arises%20from%20a%20variety%20of%20sources%2C%20including%20mutations%20to%20mitochondrial%20DNA%2C%20the%20generation%20of%20reactive%20oxygen%20species%2C%20and%20an%20insufficient%20supply%20of%20oxygen%20or%20fuel.%20Mitochondrial%20stress%20induces%20a%20range%20of%20dedicated%20responses%20that%20repair%20damage%20and%20restore%20mitochondrial%20health.%20However%2C%20a%20systematic%20characterization%20of%20transcriptional%20and%20metabolic%20signatures%20induced%20by%20distinct%20types%20of%20mitochondrial%20stress%20is%20lacking.%20Here%2C%20we%20defined%20how%20primary%20human%20fibroblasts%20respond%20to%20a%20panel%20of%20mitochondrial%20inhibitors%20to%5Cu00a0trigger%20adaptive%20stress%20responses.%20Using%20metabolomic%20and%20transcriptomic%20analyses%2C%20we%20established%20integrated%20signatures%20of%20mitochondrial%20stress.%20We%20developed%20a%20tool%2C%20stress%20quantification%20using%20integrated%20datasets%20%28SQUID%29%2C%20to%20deconvolute%20mitochondrial%20stress%20signatures%20from%20existing%20datasets.%20Using%20SQUID%2C%20we%20profiled%20mitochondrial%20stress%20in%20The%20Cancer%20Genome%20Atlas%20%28TCGA%29%20PanCancer%20Atlas%2C%20identifying%20a%20signature%20of%20pyruvate%20import%20deficiency%20in%20IDH1-mutant%20glioma.%20Thus%2C%20this%20study%20defines%20a%20tool%20to%20identify%20specific%20mitochondrial%20stress%20signatures%2C%20which%20may%20be%20applied%20to%20a%20range%20of%20systems.%22%2C%22date%22%3A%222025-04-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.crmeth.2025.101027%22%2C%22ISSN%22%3A%222667-2375%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-13T12%3A54%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22GWZ3DV7V%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22de%20Bruijn%20et%20al.%22%2C%22parsedDate%22%3A%222025-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3Ede%20Bruijn%2C%20I.%2C%20Nikolov%2C%20M.%2C%20Lau%2C%20C.%2C%20Clayton%2C%20A.%2C%20Gibbs%2C%20D.%20L.%2C%20Mitraka%2C%20E.%2C%20Pozhidayeva%2C%20D.%2C%20Lash%2C%20A.%2C%20Sumer%2C%20S.%20O.%2C%20Altreuter%2C%20J.%2C%20Anton%2C%20K.%2C%20DeFelice%2C%20M.%2C%20Li%2C%20X.%2C%20Lisman%2C%20A.%2C%20Longabaugh%2C%20W.%20J.%20R.%2C%20Muhlich%2C%20J.%2C%20Santagata%2C%20S.%2C%20Nandakumar%2C%20S.%2C%20Sorger%2C%20P.%20K.%2C%20%26%23x2026%3B%20Eddy%2C%20J.%20A.%20%282025%29.%20Sharing%20data%20from%20the%20Human%20Tumor%20Atlas%20Network%20through%20standards%2C%20infrastructure%20and%20community%20engagement.%20%3Ci%3ENature%20Methods%3C%5C%2Fi%3E%2C%20%3Ci%3E22%3C%5C%2Fi%3E%284%29%2C%20664%26%23x2013%3B671.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41592-025-02643-0%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41592-025-02643-0%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sharing%20data%20from%20the%20Human%20Tumor%20Atlas%20Network%20through%20standards%2C%20infrastructure%20and%20community%20engagement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ino%22%2C%22lastName%22%3A%22de%20Bruijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milen%22%2C%22lastName%22%3A%22Nikolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarisse%22%2C%22lastName%22%3A%22Lau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashley%22%2C%22lastName%22%3A%22Clayton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20L.%22%2C%22lastName%22%3A%22Gibbs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elvira%22%2C%22lastName%22%3A%22Mitraka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dar%27ya%22%2C%22lastName%22%3A%22Pozhidayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%22%2C%22lastName%22%3A%22Lash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Selcuk%20Onur%22%2C%22lastName%22%3A%22Sumer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Altreuter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristen%22%2C%22lastName%22%3A%22Anton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mialy%22%2C%22lastName%22%3A%22DeFelice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%22%2C%22lastName%22%3A%22Lisman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20J.%20R.%22%2C%22lastName%22%3A%22Longabaugh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Subhiksha%22%2C%22lastName%22%3A%22Nandakumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Suver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xengie%22%2C%22lastName%22%3A%22Doan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%22%2C%22lastName%22%3A%22Guinney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%5Cu00e9steinn%22%2C%22lastName%22%3A%22Thorsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%22%2C%22lastName%22%3A%22Cerami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A.%22%2C%22lastName%22%3A%22Eddy%22%7D%5D%2C%22abstractNote%22%3A%22Data%20from%20the%20first%20phase%20of%20the%20Human%20Tumor%20Atlas%20Network%20%28HTAN%29%20are%20now%20available%2C%20comprising%208%2C425%20biospecimens%20from%202%2C042%20research%20participants%20profiled%20with%20more%20than%2020%20molecular%20assays.%20The%20data%20were%20generated%20to%20study%20the%20evolution%20from%20precancerous%20to%20advanced%20disease.%20The%20HTAN%20Data%20Coordinating%20Center%20%28DCC%29%20has%20enabled%20their%20dissemination%20and%20effective%20reuse.%20We%20describe%20the%20diverse%20datasets%2C%20how%20to%20access%20them%2C%20data%20standards%2C%20underlying%20infrastructure%20and%20governance%20approaches%2C%20and%20our%20methods%20to%20sustain%20community%20engagement.%20HTAN%20data%20can%20be%20accessed%20through%20the%20HTAN%20Portal%2C%20explored%20in%20visualization%20tools-including%20CellxGene%2C%20Minerva%20and%20cBioPortal-and%20analyzed%20in%20the%20cloud%20through%20the%20NCI%20Cancer%20Research%20Data%20Commons.%20Infrastructure%20was%20developed%20to%20enable%20data%20ingestion%20and%20dissemination%20through%20the%20Synapse%20platform.%20The%20HTAN%20DCC%27s%20flexible%20and%20modular%20approach%20to%20sharing%20complex%20cancer%20research%20data%20offers%20valuable%20insights%20to%20other%20data-coordination%20efforts%20and%20researchers%20looking%20to%20leverage%20HTAN%20data.%22%2C%22date%22%3A%222025-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-025-02643-0%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-28T14%3A36%3A06Z%22%7D%7D%2C%7B%22key%22%3A%2268YY4JGV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22B%5Cu0159inda%20et%20al.%22%2C%22parsedDate%22%3A%222025-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EB%26%23x159%3Binda%2C%20K.%2C%20Lima%2C%20L.%2C%20Pignotti%2C%20S.%2C%20Quinones-Olvera%2C%20N.%2C%20Salikhov%2C%20K.%2C%20Chikhi%2C%20R.%2C%20Kucherov%2C%20G.%2C%20Iqbal%2C%20Z.%2C%20%26amp%3B%20Baym%2C%20M.%20%282025%29.%20Efficient%20and%20robust%20search%20of%20microbial%20genomes%20via%20phylogenetic%20compression.%20%3Ci%3ENature%20Methods%3C%5C%2Fi%3E%2C%20%3Ci%3E22%3C%5C%2Fi%3E%284%29%2C%20692%26%23x2013%3B697.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41592-025-02625-2%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41592-025-02625-2%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficient%20and%20robust%20search%20of%20microbial%20genomes%20via%20phylogenetic%20compression%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karel%22%2C%22lastName%22%3A%22B%5Cu0159inda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leandro%22%2C%22lastName%22%3A%22Lima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Pignotti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Quinones-Olvera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamil%22%2C%22lastName%22%3A%22Salikhov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rayan%22%2C%22lastName%22%3A%22Chikhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Kucherov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zamin%22%2C%22lastName%22%3A%22Iqbal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Comprehensive%20collections%20approaching%20millions%20of%20sequenced%20genomes%20have%20become%20central%20information%20sources%20in%20the%20life%20sciences.%20However%2C%20the%20rapid%20growth%20of%20these%20collections%20has%20made%20it%20effectively%20impossible%20to%20search%20these%20data%20using%20tools%20such%20as%20the%20Basic%20Local%20Alignment%20Search%20Tool%20%28BLAST%29%20and%20its%20successors.%20Here%2C%20we%20present%20a%20technique%20called%20phylogenetic%20compression%2C%20which%20uses%20evolutionary%20history%20to%20guide%20compression%20and%20efficiently%20search%20large%20collections%20of%20microbial%20genomes%20using%20existing%20algorithms%20and%20data%20structures.%20We%20show%20that%2C%20when%20applied%20to%20modern%20diverse%20collections%20approaching%20millions%20of%20genomes%2C%20lossless%20phylogenetic%20compression%20improves%20the%20compression%20ratios%20of%20assemblies%2C%20de%20Bruijn%20graphs%20and%20k-mer%20indexes%20by%20one%20to%20two%20orders%20of%20magnitude.%20Additionally%2C%20we%20develop%20a%20pipeline%20for%20a%20BLAST-like%20search%20over%20these%20phylogeny-compressed%20reference%20data%2C%20and%20demonstrate%20it%20can%20align%20genes%2C%20plasmids%20or%20entire%20sequencing%20experiments%20against%20all%20sequenced%20bacteria%20until%202019%20on%20ordinary%20desktop%20computers%20within%20a%20few%20hours.%20Phylogenetic%20compression%20has%20broad%20applications%20in%20computational%20biology%20and%20may%20provide%20a%20fundamental%20design%20principle%20for%20future%20genomics%20infrastructure.%22%2C%22date%22%3A%222025-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-025-02625-2%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-15T12%3A25%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22T42QZJIE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mukhija%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMukhija%2C%20S.%2C%20Sunog%2C%20M.%2C%20Magdamo%2C%20C.%2C%20%26amp%3B%20Albers%2C%20M.%20W.%20%282025%29.%20%3Ci%3EImpact%20of%20Severe%20COVID-19%20on%20Accelerating%20Dementia%20Onset%3A%20Clinical%20and%20Epidemiological%20Insights%3C%5C%2Fi%3E.%20medRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.03.26.25324688%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.03.26.25324688%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Impact%20of%20Severe%20COVID-19%20on%20Accelerating%20Dementia%20Onset%3A%20Clinical%20and%20Epidemiological%20Insights%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasha%22%2C%22lastName%22%3A%22Mukhija%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Max%22%2C%22lastName%22%3A%22Sunog%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Magdamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22IMPORTANCE%3A%20Severe%20COVID-19%20infection%20has%20been%20associated%20with%20neurological%20complications%2C%20but%20its%20role%20in%20accelerating%20cognitive%20decline%20remains%20unclear.%5CnOBJECTIVE%3A%20To%20determine%20whether%20individuals%20hospitalized%20for%20severe%20COVID-19%20exhibit%20a%20higher%20incidence%20of%20new%20onset%20cognitive%20impairment%20compared%20to%20those%20hospitalized%20for%20other%20conditions.%5CnDESIGN%3A%20A%20retrospective%20study%20emulating%20a%20target%20trial%20using%20Mass%20General%20Brigham%20electronic%20health%20records%20%28March%202020-August%202024%29.%20The%20causal%20effect%20of%20COVID-19%20hospitalization%20was%20estimated%20via%20cumulative%20incidence%20functions%20accounting%20for%20the%20competing%20risk%20of%20death.%5CnSETTING%3A%20Multicenter%20hospital-based%20study%20across%20the%20Mass%20General%20Brigham%20healthcare%20system.%5CnPARTICIPANTS%3A%20A%20total%20of%20221613%20hospitalized%20patients%20met%20the%20eligibility%20criteria%2C%20including%206454%20%282.0%25%29%20admitted%20due%20to%20COVID-19%20and%20215159%20%2898.0%25%29%20for%20all%20other%20conditions.%20Patients%20were%20excluded%20if%20they%20had%20less%20than%20three%20months%20of%20follow-up%20%28due%20to%20censoring%2C%20cognitive%20impairment%2C%20or%20death%29%2C%20were%20younger%20than%2055%20years%20at%20baseline%2C%20or%20had%20no%20prior%20visit%20to%20Mass%20General%20Brigham%20in%20the%20year%20before%20baseline.%5CnMAIN%20OUTCOMES%20AND%20MEASURES%3A%20The%20primary%20outcome%20was%20new-onset%20cognitive%20impairment%2C%20identified%20via%20ICD%20codes%20and%20dementia%20medication%20prescriptions.%20The%20primary%20analysis%20estimated%20the%20hazard%20ratio%20for%20cognitive%20impairment%20with%20COVID-19%20hospitalization%20relative%20to%20other%20hospitalizations%2C%20along%20with%20the%20risk%20difference%20at%204.5%20years%20estimated%20via%20cumulative%20incidence%20functions.%20Inverse%20propensity%20score%20weighting%20was%20used%20to%20balance%20covariates%20%28age%2C%20sex%2C%20comorbidities%2C%20hospitalization%20period%29.%5CnRESULTS%3A%20Among%20eligible%20patients%20%28mean%20%5BSD%5D%20age%2C%2069.55%20%5B9.42%5D%20years%2C%2055%25%20female%29%2C%20those%20hospitalized%20for%20COVID-19%20were%20significantly%20older%20and%20had%20more%20comorbidities%20%28p%20%3C%200.05%29.%20COVID-19%20hospitalization%20was%20associated%20with%20a%20higher%20risk%20of%20developing%20cognitive%20impairment%20%28Hazard%20Ratio%3A%201.14%20%5B95%25%20CI%3A%201.02-1.30%5D%2C%20P%20%3D%200.018%29.%20At%204.5%20years%2C%20the%20cumulative%20incidence%20of%20cognitive%20impairment%20was%2012.5%25%20%5B95%25%20CI%3A%2011.3-13.5%5D%20in%20the%20COVID-19%20group%2C%20compared%20to%2011.6%25%20%5B95%25%20CI%3A%2011.1-12.1%5D%20in%20the%20non-COVID-19%20group.%5CnCONCLUSIONS%20AND%20RELEVANCE%3A%20Severe%20COVID-19%20infection%20was%20associated%20with%20an%20elevated%20risk%20of%20developing%20clinically%20recognized%20cognitive%20impairment.%20Future%20studies%20are%20needed%20to%20validate%20findings%20in%20other%20health%20care%20settings.%20Early%20screening%20and%20intervention%20for%20cognitive%20decline%20may%20help%20optimize%20long-term%20outcomes%20for%20COVID-19%20patients.%5CnKEY%20POINTS%3A%20Question%3A%20Do%20individuals%20hospitalized%20for%20severe%20COVID-19%20have%20a%20higher%20incidence%20of%20new-onset%20cognitive%20impairment%20compared%20to%20those%20hospitalized%20for%20other%20conditions%3FFindings%3A%20In%20this%20retrospective%20study%20of%20221613%20hospitalized%20patients%2C%20including%206454%20hospitalized%20due%20to%20COVID-19%2C%20a%20higher%20incidence%20of%20new-onset%20cognitive%20impairment%20was%20observed%20among%20COVID-19%20patients.Meaning%3A%20Early%20recognition%20and%20diagnosis%20of%20dementia%20in%20individuals%20with%20severe%20COVID-19%20are%20crucial%20for%20optimizing%20long-term%20patient%20outcomes.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22medRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-03-28%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.03.26.25324688%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-15T12%3A26%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22NVP7V9RV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jobin%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJobin%2C%20B.%2C%20Magdamo%2C%20C.%2C%20Delphus%2C%20D.%2C%20Runde%2C%20A.%2C%20Reineke%2C%20S.%2C%20Soto%2C%20A.%20A.%2C%20Ergun%2C%20B.%2C%20Mukhija%2C%20S.%2C%20Albers%2C%20A.%20D.%2C%20%26amp%3B%20Albers%2C%20M.%20W.%20%282025%29.%20The%20AROMHA%20brain%20health%20test%20is%20a%20remote%20olfactory%20assessment%20to%20screen%20for%20cognitive%20impairment.%20%3Ci%3EScientific%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%281%29%2C%209290.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-025-92826-8%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-025-92826-8%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20AROMHA%20brain%20health%20test%20is%20a%20remote%20olfactory%20assessment%20to%20screen%20for%20cognitive%20impairment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beno%5Cu00eet%22%2C%22lastName%22%3A%22Jobin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Magdamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Delphus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Runde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Reineke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alysa%20Alejandro%22%2C%22lastName%22%3A%22Soto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beyzanur%22%2C%22lastName%22%3A%22Ergun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sasha%22%2C%22lastName%22%3A%22Mukhija%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alefiya%20Dhilla%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22Cost-effective%2C%20noninvasive%20screening%20methods%20for%20preclinical%20Alzheimer%27s%20disease%20%28AD%29%20and%20other%20neurocognitive%20disorders%20remain%20an%20unmet%20need.%20The%20olfactory%20neural%20circuits%20develop%20AD%20pathological%20changes%20prior%20to%20symptom%20onset.%20To%20probe%20these%20vulnerable%20circuits%2C%20we%20developed%20the%20digital%20remote%20AROMHA%20Brain%20Health%20Test%20%28ABHT%29%2C%20an%20at-home%20odor%20identification%2C%20discrimination%2C%20memory%2C%20and%20intensity%20assessment.%20The%20ABHT%20was%20self-administered%20among%20cognitively%20normal%20%28CN%29%20English%20and%20Spanish%20speakers%20%28n%5Cu2009%3D%5Cu2009127%29%2C%20participants%20with%20subjective%20cognitive%20complaints%20%28SCC%3B%20n%5Cu2009%3D%5Cu200934%29%2C%20and%20mild%20cognitive%20impairment%20%28MCI%3B%20n%5Cu2009%3D%5Cu200919%29.%20Self-administered%20tests%20took%20place%20remotely%20at%20home%20under%20unobserved%20%28among%20interested%20CN%20participants%29%20and%20observed%20modalities%20%28CN%2C%20SCC%2C%20and%20MCI%29%2C%20as%20well%20as%20in-person%20with%20a%20research%20assistant%20present%20%28CN%2C%20SCC%2C%20and%20MCI%29.%20Olfactory%20performance%20was%20similar%20across%20observed%20and%20unobserved%20remote%20self-administration%20and%20between%20English%20and%20Spanish%20speakers.%20Odor%20memory%2C%20identification%2C%20and%20discrimination%20scores%20decreased%20with%20age%2C%20and%20olfactory%20identification%20and%20discrimination%20were%20lower%20in%20the%20MCI%20group%20compared%20to%20CN%20and%20SCC%20groups%2C%20independent%20of%20age%2C%20sex%2C%20and%20education.%20The%20ABHT%20revealed%20age-related%20olfactory%20decline%2C%20and%20discriminated%20CN%20older%20adults%20from%20those%20with%20cognitive%20impairment.%20Replication%20of%20our%20results%20in%20other%20populations%20would%20support%20the%20use%20of%20the%20ABHT%20to%20identify%20and%20monitor%20individuals%20at%20risk%20for%20developing%20dementia.%22%2C%22date%22%3A%222025-03-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-025-92826-8%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-04T14%3A07%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22TNLT2IXS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mon-Wei%20Yu%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-22%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMon-Wei%20Yu%2C%20S.%2C%20Choi%2C%20J.%20Y.%2C%20Kady%2C%20J.%2C%20De%20Cos%2C%20M.%2C%20Wong%2C%20J.%20S.%2C%20King%2C%20E.%2C%20Younis%2C%20N.%2C%20Al%20Rahy%2C%20N.%2C%20Al%20Chaar%2C%20S.%2C%20Djebli%2C%20H.%2C%20Eskandari%2C%20S.%2C%20Samuel%2C%20S.%2C%20Merhej%2C%20T.%2C%20Sukumar%2C%20N.%2C%20Lin%2C%20J.-R.%2C%20Chen%2C%20J.-Y.%2C%20Xu%2C%20Y.%2C%20Santagata%2C%20S.%2C%20Weins%2C%20A.%2C%20%26%23x2026%3B%20Azzi%2C%20J.%20%282025%29.%20Transplantation%20of%20human%20kidney%20organoids%20elicited%20a%20robust%20allogeneic%20response%20in%20a%20humanized%20mouse%20model.%20%3Ci%3EKidney%20International%3C%5C%2Fi%3E%2C%20S0085-2538%2825%2900255-8.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.kint.2025.02.027%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.kint.2025.02.027%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transplantation%20of%20human%20kidney%20organoids%20elicited%20a%20robust%20allogeneic%20response%20in%20a%20humanized%20mouse%20model%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Mon-Wei%20Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20Yongjoon%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamie%22%2C%22lastName%22%3A%22Kady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22De%20Cos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenny%20S.%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22King%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nour%22%2C%22lastName%22%3A%22Younis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadim%22%2C%22lastName%22%3A%22Al%20Rahy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soltan%22%2C%22lastName%22%3A%22Al%20Chaar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Houda%22%2C%22lastName%22%3A%22Djebli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siawosh%22%2C%22lastName%22%3A%22Eskandari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%22%2C%22lastName%22%3A%22Samuel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamara%22%2C%22lastName%22%3A%22Merhej%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nivedha%22%2C%22lastName%22%3A%22Sukumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Astrid%22%2C%22lastName%22%3A%22Weins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Yeung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paolo%22%2C%22lastName%22%3A%22Cravedi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kirk%20N.%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dario%22%2C%22lastName%22%3A%22Lemos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20V.%22%2C%22lastName%22%3A%22Bonventre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Brehm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamil%22%2C%22lastName%22%3A%22Azzi%22%7D%5D%2C%22abstractNote%22%3A%22Human%20kidney%20organoids%20derived%20from%20embryonic%20stem%20cells%20%28ESCs%29%20or%20induced%20pluripotent%20stem%20cells%20%28iPSCs%29%20have%20become%20novel%20tools%20for%20studying%20various%20kidney%20pathologies.%20Here%2C%20we%20transplanted%20ESC-derived%20kidney%20organoids%20into%20humanized%20mice%20with%20a%20mature%20human%20adaptive%20immune%20system%20developed%20through%20thymic%20education.%20As%20judged%20by%20histology%20and%20immunophenotyping%2C%20the%20transplanted%20HLA-mismatched%20kidney%20organoids%20trigged%20a%20robust%20alloimmune%20response%2C%20characterized%20by%20a%20dense%20immune%20cell%20infiltrate%20and%20enhanced%20memory%20T%20cell%20phenotype%20in%20the%20allograft%2030%20days%20post-transplantation.%20Multiplexed%20immunofluorescence%20revealed%20expression%20of%20functional%20markers%20of%20various%20immune%20cell%20infiltrates%20in%20response%20to%20organoid%20allografts%2C%20mimicking%20the%20T%20cell-mediated%20rejection%20process%20in%20humans.%20This%20validated%20our%20model%20as%20a%20novel%20platform%20to%20study%20various%20therapeutic%20strategies%20to%20control%20alloimmunity.%20Splenocytes%20isolated%20from%20organoid-transplanted%20hosts%20showed%20an%20alloantigen-specific%20memory%20response%20against%202D%20kidney%20organoids%20ex%20vivo.%20Overall%2C%20our%20study%20indicates%20that%20transplanting%20kidney%20organoids%20in%20humanized%20mice%20may%20be%20a%20valuable%20tool%20for%20studying%20human%20allogeneic%20immunity.%22%2C%22date%22%3A%222025-03-22%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.kint.2025.02.027%22%2C%22ISSN%22%3A%221523-1755%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-03-31T14%3A00%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22V6RP4DEZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Zhou%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZhou%2C%20F.%20Y.%2C%20Marin%2C%20Z.%2C%20Yapp%2C%20C.%2C%20Zou%2C%20Q.%2C%20Nanes%2C%20B.%20A.%2C%20Daetwyler%2C%20S.%2C%20Jamieson%2C%20A.%2C%20Islam%2C%20M.%20T.%2C%20Jenkins%2C%20E.%2C%20Gihana%2C%20G.%20M.%2C%20Lin%2C%20J.%2C%20Borges%2C%20H.%20M.%2C%20Chang%2C%20B.-J.%2C%20Weems%2C%20A.%2C%20Morrison%2C%20S.%20J.%2C%20Sorger%2C%20P.%20K.%2C%20Fiolka%2C%20R.%20P.%2C%20Dean%2C%20K.%20M.%2C%20%26amp%3B%20Danuser%2C%20G.%20%282025%29.%20%3Ci%3EUniversal%20consensus%203D%20segmentation%20of%20cells%20from%202D%20segmented%20stacks%3C%5C%2Fi%3E%20%5BPreprint%5D.%20bioRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.05.03.592249%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.05.03.592249%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Universal%20consensus%203D%20segmentation%20of%20cells%20from%202D%20segmented%20stacks%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%20Yuran%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zach%22%2C%22lastName%22%3A%22Marin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiongjing%22%2C%22lastName%22%3A%22Zou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20A.%22%2C%22lastName%22%3A%22Nanes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%22%2C%22lastName%22%3A%22Daetwyler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Jamieson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Torikul%22%2C%22lastName%22%3A%22Islam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%20M.%22%2C%22lastName%22%3A%22Gihana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinlong%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hazel%20M.%22%2C%22lastName%22%3A%22Borges%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo-Jui%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Weems%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20J.%22%2C%22lastName%22%3A%22Morrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Karl%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reto%20Paul%22%2C%22lastName%22%3A%22Fiolka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20M.%22%2C%22lastName%22%3A%22Dean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaudenz%22%2C%22lastName%22%3A%22Danuser%22%7D%5D%2C%22abstractNote%22%3A%22Cell%20segmentation%20is%20the%20foundation%20of%20a%20wide%20range%20of%20microscopy-based%20biological%20studies.%20Deep%20learning%20has%20revolutionized%202D%20cell%20segmentation%2C%20enabling%20generalized%20solutions%20across%20cell%20types%20and%20imaging%20modalities.%20This%20has%20been%20driven%20by%20the%20ease%20of%20scaling%20up%20image%20acquisition%2C%20annotation%2C%20and%20computation.%20However%2C%203D%20cell%20segmentation%2C%20requiring%20dense%20annotation%20of%202D%20slices%20still%20poses%20significant%20challenges.%20Manual%20labeling%20of%203D%20cells%20to%20train%20broadly%20applicable%20segmentation%20models%20is%20prohibitive.%20Even%20in%20high-contrast%20images%20annotation%20is%20ambiguous%20and%20time-consuming.%20Here%20we%20develop%20a%20theory%20and%20toolbox%2C%20u-Segment3D%2C%20for%202D-to-3D%20segmentation%2C%20compatible%20with%20any%202D%20method%20generating%20pixel-based%20instance%20cell%20masks.%20u-Segment3D%20translates%20and%20enhances%202D%20instance%20segmentations%20to%20a%203D%20consensus%20instance%20segmentation%20without%20training%20data%2C%20as%20demonstrated%20on%2011%20real-life%20datasets%2C%20%3E70%2C000%20cells%2C%20spanning%20single%20cells%2C%20cell%20aggregates%2C%20and%20tissue.%20Moreover%2C%20u-Segment3D%20is%20competitive%20with%20native%203D%20segmentation%2C%20even%20exceeding%20when%20cells%20are%20crowded%20and%20have%20complex%20morphologies.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-03-20%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.05.03.592249%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T22%3A48%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22JEYN6F3I%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vidovi%5Cu0107%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-13%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVidovi%26%23x107%3B%2C%20D.%2C%20Shamsaei%2C%20B.%2C%20Sch%26%23xFC%3Brer%2C%20S.%20C.%2C%20Kogan%2C%20P.%2C%20Chojnacki%2C%20S.%2C%20Kouril%2C%20M.%2C%20Medvedovic%2C%20M.%2C%20Niu%2C%20W.%2C%20Azeloglu%2C%20E.%20U.%2C%20Birtwistle%2C%20M.%20R.%2C%20Chen%2C%20Y.%2C%20Chen%2C%20T.%2C%20Hansen%2C%20J.%2C%20Hu%2C%20B.%2C%20Iyengar%2C%20R.%2C%20Jayaraman%2C%20G.%2C%20Li%2C%20H.%2C%20Liu%2C%20T.%2C%20Sobie%2C%20E.%20A.%2C%20%26%23x2026%3B%20MacCoss%2C%20M.%20J.%20%282025%29.%20Comprehensive%20proteomics%20metadata%20and%20integrative%20web%20portals%20facilitate%20sharing%20and%20integration%20of%20LINCS%20multiomics%20data.%20%3Ci%3EMolecular%20%26amp%3B%20Cellular%20Proteomics%3A%20MCP%3C%5C%2Fi%3E%2C%20100947.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mcpro.2025.100947%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mcpro.2025.100947%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comprehensive%20proteomics%20metadata%20and%20integrative%20web%20portals%20facilitate%20sharing%20and%20integration%20of%20LINCS%20multiomics%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Du%5Cu0161ica%22%2C%22lastName%22%3A%22Vidovi%5Cu0107%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Behrouz%22%2C%22lastName%22%3A%22Shamsaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%20C.%22%2C%22lastName%22%3A%22Sch%5Cu00fcrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phillip%22%2C%22lastName%22%3A%22Kogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Szymon%22%2C%22lastName%22%3A%22Chojnacki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michal%22%2C%22lastName%22%3A%22Kouril%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Medvedovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen%22%2C%22lastName%22%3A%22Niu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evren%20U.%22%2C%22lastName%22%3A%22Azeloglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20R.%22%2C%22lastName%22%3A%22Birtwistle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yibang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tong%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%22%2C%22lastName%22%3A%22Hansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bin%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%22%2C%22lastName%22%3A%22Iyengar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gomathi%22%2C%22lastName%22%3A%22Jayaraman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tong%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20A.%22%2C%22lastName%22%3A%22Sobie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuguang%22%2C%22lastName%22%3A%22Xiong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20J.%22%2C%22lastName%22%3A%22Berberich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20A.%22%2C%22lastName%22%3A%22Everley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ben%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Hafner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maulik%20K.%22%2C%22lastName%22%3A%22Nariya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kartik%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Victor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Banuelos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victoria%22%2C%22lastName%22%3A%22Dardov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%22%2C%22lastName%22%3A%22Holewinski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danica-Mae%22%2C%22lastName%22%3A%22Manalo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berhan%22%2C%22lastName%22%3A%22Mandefro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20D.%22%2C%22lastName%22%3A%22Matlock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loren%22%2C%22lastName%22%3A%22Ornelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhruv%22%2C%22lastName%22%3A%22Sareen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clive%20N.%22%2C%22lastName%22%3A%22Svendsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vineet%22%2C%22lastName%22%3A%22Vaibhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20E.%22%2C%22lastName%22%3A%22Van%20Eyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vidya%22%2C%22lastName%22%3A%22Venkatraman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%22%2C%22lastName%22%3A%22Finkbiener%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernest%22%2C%22lastName%22%3A%22Fraenkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Rothstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22Asiedu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20A.%22%2C%22lastName%22%3A%22Carr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%20E.%22%2C%22lastName%22%3A%22Christianson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Desiree%22%2C%22lastName%22%3A%22Davison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20O.%22%2C%22lastName%22%3A%22Dele-Oni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20C.%22%2C%22lastName%22%3A%22DeRuff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20B.%22%2C%22lastName%22%3A%22Egri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alvaro%20Sebastian%20Vaca%22%2C%22lastName%22%3A%22Jacome%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%20D.%22%2C%22lastName%22%3A%22Jaffe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lev%22%2C%22lastName%22%3A%22Litichevskiy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaodong%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Mullahoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Officer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malvina%22%2C%22lastName%22%3A%22Papanastasiou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Peckner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caidin%22%2C%22lastName%22%3A%22Toder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joel%22%2C%22lastName%22%3A%22Blanchard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Bula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tak%22%2C%22lastName%22%3A%22Ko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li-Huei%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennie%20Z.%22%2C%22lastName%22%3A%22Young%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vagisha%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Pillai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jarek%22%2C%22lastName%22%3A%22Meller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22MacCoss%22%7D%5D%2C%22abstractNote%22%3A%22The%20Library%20of%20Integrated%20Network-based%20Cellular%20Signatures%20%28LINCS%29%2C%20an%20NIH%20Common%20Fund%20program%2C%20has%20cataloged%20and%20analyzed%20cellular%20function%20and%20molecular%20activity%20profiles%20in%20response%20to%20%3E80%2C000%20perturbing%20agents%20that%20are%20potentially%20disruptive%20to%20cells.%20Because%20of%20the%20importance%20of%20proteins%20and%20their%20modifications%20to%20the%20response%20of%20specific%20cellular%20perturbations%2C%20four%20of%20the%20six%20LINCS%20centers%20have%20included%20significant%20proteomics%20efforts%20in%20the%20characterization%20of%20the%20resulting%20phenotype.%20This%20manuscript%20aims%20to%20describe%20this%20effort%20and%20the%20data%20harmonization%20and%20integration%20of%20the%20LINCS%20proteomics%20data%20discussed%20in%20recent%20LINCS%20papers.%22%2C%22date%22%3A%222025-03-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.mcpro.2025.100947%22%2C%22ISSN%22%3A%221535-9484%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-03-19T20%3A48%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22X9P7NYQA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Deng%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDeng%2C%20X.%2C%20Bradshaw%2C%20G.%2C%20Kalocsay%2C%20M.%2C%20%26amp%3B%20Mitchison%2C%20T.%20%282025%29.%20%3Ci%3ETubulin%20Regulates%20the%20Stability%20and%20Localization%20of%20STMN2%20by%20Binding%20Preferentially%20to%20Its%20Soluble%20Form%3C%5C%2Fi%3E%20%5BPreprint%5D.%20bioRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.27.640326%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.27.640326%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Tubulin%20Regulates%20the%20Stability%20and%20Localization%20of%20STMN2%20by%20Binding%20Preferentially%20to%20Its%20Soluble%20Form%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Mitchison%22%7D%5D%2C%22abstractNote%22%3A%22Loss%20of%20the%20tubulin-binding%20protein%20STMN2%20is%20implicated%20in%20amyotrophic%20lateral%20sclerosis%20%28ALS%29%20but%20how%20it%20protects%20neurons%20is%20not%20known.%20STMN2%20is%20known%20to%20turn%20over%20rapidly%20and%20accumulate%20at%20axotomy%20sites.%20We%20confirmed%20fast%20turnover%20of%20STMN2%20in%20U2OS%20cells%20and%20iPSC-derived%20neurons%20and%20showed%20that%20degradation%20occurs%20mainly%20by%20the%20ubiquitin-proteasome%20system.%20The%20membrane%20targeting%20N-terminal%20domain%20of%20STMN2%20promoted%20fast%20turnover%2C%20whereas%20its%20tubulin%20binding%20stathmin-like%20domain%20%28SLD%29%20promoted%20stabilization.%20Proximity%20labeling%20and%20imaging%20showed%20that%20STMN2%20localizes%20to%20trans-Golgi%20network%20membranes%20and%20that%20tubulin%20binding%20reduces%20this%20localization.%20Pull-down%20assays%20showed%20that%20tubulin%20prefers%20to%20bind%20to%20soluble%20over%20membrane-bound%20STMN2.%20Our%20data%20suggest%20that%20STMN2%20interconverts%20between%20a%20soluble%20form%20that%20is%20rapidly%20degraded%20unless%20bound%20to%20tubulin%20and%20a%20membrane-bound%20form%20that%20does%20not%20bind%20tubulin.%20We%20propose%20that%20STMN2%20is%20sequestered%20and%20stabilized%20by%20tubulin%20binding%2C%20while%20its%20neuroprotective%20function%20depends%20on%20an%20unknown%20molecular%20activity%20of%20its%20membrane-bound%20form.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-02-28%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.02.27.640326%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T23%3A12%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22I8KVERLL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Fang%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-28%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFang%2C%20R.%2C%20Vallius%2C%20T.%2C%20Zhang%2C%20A.%2C%20Van%20Cura%2C%20D.%2C%20Alicandri%2C%20F.%2C%20Fischer%2C%20G.%2C%20Draper%2C%20E.%2C%20Xu%2C%20S.%2C%20Pelletier%2C%20R.%2C%20Wang%2C%20J.%2C%20Mandinova%2C%20A.%2C%20Katsyv%2C%20I.%2C%20Sorger%2C%20P.%20K.%2C%20Murphy%2C%20G.%20F.%2C%20%26amp%3B%20Lian%2C%20C.%20G.%20%282025%29.%20PRAME%20expression%20in%20melanoma%20is%20negatively%20regulated%20by%20TET2-mediated%20DNA%20hydroxymethylation.%20%3Ci%3ELaboratory%20Investigation%3B%20a%20Journal%20of%20Technical%20Methods%20and%20Pathology%3C%5C%2Fi%3E%2C%20104123.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.labinv.2025.104123%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.labinv.2025.104123%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22PRAME%20expression%20in%20melanoma%20is%20negatively%20regulated%20by%20TET2-mediated%20DNA%20hydroxymethylation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rui%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arianna%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Devon%22%2C%22lastName%22%3A%22Van%20Cura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%22%2C%22lastName%22%3A%22Alicandri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grant%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Draper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuyun%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justina%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Mandinova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%22%2C%22lastName%22%3A%22Katsyv%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%5D%2C%22abstractNote%22%3A%22Preferentially%20Expressed%20Antigen%20in%20Melanoma%20%28PRAME%29%20and%20Ten-Eleven%20Translocation%20%28TET%29%20dioxygenase-mediated%205-hydroxymethylcytosine%20%285hmC%29%20are%20emerging%20melanoma%20biomarkers.%20We%20observed%20an%20inverse%20correlation%20between%20PRAME%20expression%20and%205hmC%20levels%20in%20benign%20nevi%2C%20melanoma%20in%20situ%2C%20primary%20invasive%20melanoma%2C%20and%20metastatic%20melanomas%20via%20immunohistochemistry%20and%20multiplex%20immunofluorescence%3A%20nevi%20exhibited%20high%205hmC%20and%20low%20PRAME%2C%20whereas%20melanomas%20showed%20the%20opposite%20pattern.%20Single-cell%20multiplex%20imaging%20of%20melanoma%20precursors%20revealed%20that%20diminished%205hmC%20coincides%20with%20PRAME%20upregulation%20in%20premalignant%20cells.%20Analysis%20of%20TCGA%20and%20GTEx%20databases%20confirmed%20a%20negative%20relationship%20between%20TET2%20and%20PRAME%20mRNA%20expression%20in%20melanoma.%20Additionally%2C%205hmC%20levels%20were%20reduced%20at%20the%20PRAME%205%27%20promoter%20in%20melanoma%20compared%20to%20nevi%2C%20suggesting%20a%20role%20for%205hmC%20in%20PRAME%20transcription.%20Restoring%205hmC%20levels%20via%20TET2%20overexpression%20notably%20reduced%20PRAME%20expression%20in%20melanoma%20cell%20lines.%20These%20findings%20establish%20a%20function%20of%20TET2-mediated%20DNA%20hydroxymethylation%20in%20regulating%20PRAME%20expression%20and%20demonstrate%20epigenetic%20reprogramming%20as%20pivotal%20in%20melanoma%20tumorigenesis.%22%2C%22date%22%3A%222025-02-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.labinv.2025.104123%22%2C%22ISSN%22%3A%221530-0307%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T22%3A28%3A18Z%22%7D%7D%2C%7B%22key%22%3A%225XEB5J9U%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22He%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHe%2C%20X.%2C%20Wang%2C%20Q.%2C%20Cheng%2C%20X.%2C%20Wang%2C%20W.%2C%20Li%2C%20Y.%2C%20Nan%2C%20Y.%2C%20Wu%2C%20J.%2C%20Xiu%2C%20B.%2C%20Jiang%2C%20T.%2C%20Bergholz%2C%20J.%20S.%2C%20Gu%2C%20H.%2C%20Chen%2C%20F.%2C%20Fan%2C%20G.%2C%20Sun%2C%20L.%2C%20Xie%2C%20S.%2C%20Zou%2C%20J.%2C%20Lin%2C%20S.%2C%20Wei%2C%20Y.%2C%20Lee%2C%20J.%2C%20%26%23x2026%3B%20Zhao%2C%20J.%20J.%20%282025%29.%20Lysine%20vitcylation%20is%20a%20vitamin%20C-derived%20protein%20modification%20that%20enhances%20STAT1-mediated%20immune%20response.%20%3Ci%3ECell%3C%5C%2Fi%3E%2C%20S0092-8674%2825%2900145-X.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cell.2025.01.043%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cell.2025.01.043%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lysine%20vitcylation%20is%20a%20vitamin%20C-derived%20protein%20modification%20that%20enhances%20STAT1-mediated%20immune%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiadi%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiwei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weihua%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yutong%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yabing%22%2C%22lastName%22%3A%22Nan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiang%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bingqiu%22%2C%22lastName%22%3A%22Xiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tao%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johann%20S.%22%2C%22lastName%22%3A%22Bergholz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hao%22%2C%22lastName%22%3A%22Gu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fuhui%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangjian%22%2C%22lastName%22%3A%22Fan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lianhui%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaozhen%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junjie%22%2C%22lastName%22%3A%22Zou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yun%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Asara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ke%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lewis%20C.%22%2C%22lastName%22%3A%22Cantley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%5D%2C%22abstractNote%22%3A%22Vitamin%20C%20%28vitC%29%20is%20essential%20for%20health%20and%20shows%20promise%20in%20treating%20diseases%20like%20cancer%2C%20yet%20its%20mechanisms%20remain%20elusive.%20Here%2C%20we%20report%20that%20vitC%20directly%20modifies%20lysine%20residues%20to%20form%20%5C%22vitcyl-lysine%5C%22-a%20process%20termed%20vitcylation.%20Vitcylation%20occurs%20in%20a%20dose-%2C%20pH-%2C%20and%20sequence-dependent%20manner%20in%20both%20cell-free%20systems%20and%20living%20cells.%20Mechanistically%2C%20vitC%20vitcylates%20signal%20transducer%20and%20activator%20of%20transcription-1%20%28STAT1%29-%20lysine-298%20%28K298%29%2C%20impairing%20its%20interaction%20with%20T%5Cu00a0cell%20protein-tyrosine%20phosphatase%20%28TCPTP%29%20and%20preventing%20STAT1-Y701%20dephosphorylation.%20This%20leads%20to%20enhanced%20STAT1-mediated%20interferon%20%28IFN%29%20signaling%20in%20tumor%20cells%2C%20increased%20major%20histocompatibility%20complex%20%28MHC%29%5C%2Fhuman%20leukocyte%20antigen%20%28HLA%29%20class%20I%20expression%2C%20and%20activation%20of%20anti-tumor%20immunity%20in%5Cu00a0vitro%20and%20in%5Cu00a0vivo.%20The%20discovery%20of%20vitcylation%20as%20a%20distinctive%20post-translational%20modification%20provides%20significant%20insights%20into%20vitC%27s%20cellular%20function%20and%20therapeutic%20potential%2C%20opening%20avenues%20for%20understanding%20its%20biological%20effects%20and%20applications%20in%20disease%20treatment.%22%2C%22date%22%3A%222025-02-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2025.01.043%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-03-03T20%3A22%3A02Z%22%7D%7D%2C%7B%22key%22%3A%2299PPM8K2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Cort%5Cu00e9s-R%5Cu00edos%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECort%26%23xE9%3Bs-R%26%23xED%3Bos%2C%20J.%2C%20Rodriguez-Fernandez%2C%20M.%2C%20Sorger%2C%20P.%20K.%2C%20%26amp%3B%20Fr%26%23xF6%3Bhlich%2C%20F.%20%282025%29.%20%3Ci%3EDynamic%20Modeling%20of%20Cell%20Cycle%20Arrest%20Through%20Integrated%20Single-Cell%20and%20Mathematical%20Modelling%20Approaches%3C%5C%2Fi%3E%20%5BPreprint%5D.%20bioRxiv.%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.20.639240%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.20.639240%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Dynamic%20Modeling%20of%20Cell%20Cycle%20Arrest%20Through%20Integrated%20Single-Cell%20and%20Mathematical%20Modelling%20Approaches%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javiera%22%2C%22lastName%22%3A%22Cort%5Cu00e9s-R%5Cu00edos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Rodriguez-Fernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%5D%2C%22abstractNote%22%3A%22Highly%20multiplexed%20imaging%20assays%20allow%20simultaneous%20quantification%20of%20multiple%20protein%20and%20phosphorylation%20markers%2C%20providing%20a%20static%20snapshots%20of%20cell%20types%20and%20states.%20Pseudo-time%20techniques%20can%20transform%20these%20static%20snapshots%20of%20unsynchronized%20cells%20into%20dynamic%20trajectories%2C%20enabling%20the%20study%20of%20dynamic%20processes%20such%20as%20development%20trajectories%20and%20the%20cell%20cycle.%20Such%20ordering%20also%20enables%20training%20of%20mathematical%20models%20on%20these%20data%2C%20but%20technical%20challenges%20have%20hitherto%20made%20it%20difficult%20to%20integrate%20multiple%20experimental%20conditions%2C%20limiting%20the%20predictive%20power%20and%20insights%20these%20models%20can%20generate.%20In%20this%20work%2C%20we%20propose%20data%20processing%20and%20model%20training%20approaches%20for%20integrating%20multiplexed%2C%20multi-condition%20immunofluorescence%20data%20with%20mathematical%20modelling.%20We%20devise%20training%20strategies%20that%20are%20applicable%20to%20datasets%20where%20cells%20exhibit%20oscillatory%20as%20well%20as%20arrested%20dynamics%20and%20use%20them%20to%20train%20a%20cell%20cycle%20model%20on%20a%20dataset%20of%20MCF-10A%20mammary%20epithelial%20exposed%20to%20cell-cycle%20arresting%20small%20molecules.%20We%20validate%20the%20model%20by%20investigating%20predicted%20growth%20factor%20sensitivities%20and%20responses%20to%20inhibitors%20of%20cells%20at%20different%20initial%20conditions.%20We%20anticipate%20that%20our%20framework%20will%20generalise%20to%20other%20highly%20multiplexed%20measurement%20techniques%20such%20as%20mass-cytometry%2C%20rendering%20larger%20bodies%20of%20data%20accessible%20to%20dynamic%20modelling%20and%20paving%20the%20way%20to%20deeper%20biological%20insights.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-02-26%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.02.20.639240%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.20.639240%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T23%3A02%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22TFES5DM3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Mears%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-21%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMears%2C%20K.%20S.%2C%20Rossine%2C%20F.%20W.%2C%20Quinones-Olvera%2C%20N.%2C%20Souque%2C%20C.%2C%20%26amp%3B%20Baym%2C%20M.%20%282025%29.%20%3Ci%3ERNA-guided%20nucleases%20enable%20a%20gene%20drive%20of%20insertion%20sequences%20in%20plasmids%3C%5C%2Fi%3E%20%5BPreprint%5D.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.20.638934%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.20.638934%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22RNA-guided%20nucleases%20enable%20a%20gene%20drive%20of%20insertion%20sequences%20in%20plasmids%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kepler%20S.%22%2C%22lastName%22%3A%22Mears%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%20W.%22%2C%22lastName%22%3A%22Rossine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Quinones-Olvera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9lia%22%2C%22lastName%22%3A%22Souque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Mobile%20genetic%20elements%20%28MGEs%29%20and%20the%20interactions%20between%20them%20are%20a%20major%20source%20of%20evolutionary%20innovation.%20Insertion%20sequences%2C%20the%20simplest%20MGEs%20usually%20encoding%20only%20the%20necessary%20genes%20for%20transposition%20and%20maintenance%2C%20are%20widespread%20in%20bacterial%20genomes%2C%20and%20are%20particularly%20common%20in%20plasmids.%20Plasmids%2C%20self-replicating%20extrachromosomal%20DNA%20elements%2C%20often%20exist%20in%20multiple%20copies%20imparting%20a%20stochastic%20barrier%20to%20the%20fixation%20of%20an%20insertion%20sequence%20by%20limiting%20the%20proportion%20of%20the%20plasmid%20population%20harboring%20the%20IS.%20In%20this%20work%20we%20demonstrate%20that%20to%20overcome%20this%2C%20the%20IS200%5C%2F605%20family%20of%20insertion%20sequences%20utilizes%20programmable%20RNA%20guided%20nucleases%20as%20gene%20drive%20to%20spread%20the%20IS%20through%20the%20plasmid%20population.%20TnpB%2C%20the%20likely%20ancestor%20of%20Cas12%2C%20records%20the%20specific%20insertion%20site%20of%20the%20IS%20in%20its%20RNA%20guide%20to%20prevent%20loss%20of%20the%20IS%20during%20transposition.%20When%20introduced%20to%20a%20plasmid%20TnpB%20will%20be%20reprogrammed%20to%20target%20and%20cleave%20IS-%20plasmids%2C%20resulting%20in%20biased%20replication%20of%20IS%2B%20plasmids.%20Furthermore%2C%20the%20gene%20drive%20activity%20is%20critical%20for%20the%20IS%20to%20invade%20high%20copy%20plasmid%20populations.%20Because%20TnpB%20can%20only%20be%20mobilized%20between%20microbes%20on%20other%20mobile%20genetic%20elements%2C%20this%20advantage%20to%20fixing%20in%20plasmids%20may%20help%20explain%20the%20prevalence%20of%20TnpB%20across%20the%20tree%20of%20life.%20More%20generally%2C%20the%20unique%20pressures%20arising%20from%20movement%20between%20genetic%20contexts%20with%20different%20multiplicities%20shapes%20the%20evolution%20of%20strategies%20for%20MGE%20spread.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-02-21%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.02.20.638934%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.02.20.638934%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A48%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22T3UGPZB9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Rossine%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-21%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERossine%2C%20F.%2C%20Sanchez%2C%20C.%2C%20Eaton%2C%20D.%2C%20Paulsson%2C%20J.%2C%20%26amp%3B%20Baym%2C%20M.%20%282025%29.%20%3Ci%3EIntracellular%20competition%20shapes%20plasmid%20population%20dynamics%3C%5C%2Fi%3E%20%5BPreprint%5D.%20bioRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.19.639193%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.02.19.639193%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Intracellular%20competition%20shapes%20plasmid%20population%20dynamics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Rossine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Sanchez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Eaton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Paulsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Conflicts%20between%20levels%20of%20biological%20organization%20are%20central%20to%20evolution%2C%20from%20populations%20of%20multicellular%20organisms%20to%20selfish%20genetic%20elements%20in%20microbes.%20Plasmids%20are%20extrachromosomal%2C%20self-replicating%20genetic%20elements%20that%20underlie%20much%20of%20the%20evolutionary%20flexibility%20of%20bacteria.%20Evolving%20plasmids%20face%20selective%20pressures%20on%20their%20hosts%2C%20but%20also%20compete%20within%20the%20cell%20for%20replication%2C%20making%20them%20an%20ideal%20system%20for%20studying%20the%20joint%20dynamics%20of%20multilevel%20selection.%20While%20theory%20indicates%20that%20within-cell%20selection%20should%20matter%20for%20plasmid%20evolution%2C%20experimental%20measurement%20of%20within-cell%20plasmid%20fitness%20and%20its%20consequences%20has%20remained%20elusive.%20Here%20we%20measure%20the%20within-cell%20fitness%20of%20competing%20plasmids%20and%20characterize%20drift%20and%20selective%20dynamics.%20We%20achieve%20this%20by%20the%20controlled%20splitting%20of%20synthetic%20plasmid%20dimers%20to%20create%20balanced%20competition%20experiments.%20We%20find%20that%20incompatible%20plasmids%20co-occur%20for%20longer%20than%20expected%20due%20to%20methylation-based%20plasmid%20eclipsing.%20During%20this%20period%20of%20co-occurrence%2C%20less%20transcriptionally%20active%20plasmids%20display%20a%20within-cell%20selective%20advantage%20over%20their%20competing%20plasmids%2C%20leading%20to%20preferential%20fixation%20of%20silent%20plasmids.%20When%20the%20transcribed%20gene%20is%20beneficial%20to%20the%20cell%2C%20for%20example%20an%20antibiotic%20resistance%20gene%2C%20there%20is%20a%20cell-plasmid%20fitness%20tradeoff%20mediated%20by%20the%20dominance%20of%20the%20beneficial%20trait.%20Surprisingly%2C%20more%20dominant%20plasmid-encoded%20traits%20are%20less%20likely%20to%20fix%20but%20more%20likely%20to%20initially%20invade%20than%20less%20dominant%20traits.%20Taken%20together%2C%20our%20results%20show%20that%20plasmid%20evolution%20is%20driven%20by%20dynamics%20at%20two%20levels%2C%20with%20a%20transient%2C%20but%20critical%2C%20contribution%20of%20within-cell%20fitness.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-02-21%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.02.19.639193%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.02.19.639193%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A48%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22DFLGSH39%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rendo%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERendo%2C%20V.%2C%20Lee%2C%20E.%20Q.%2C%20Bossi%2C%20C.%2C%20Khuu%2C%20N.%2C%20Rudek%2C%20M.%20A.%2C%20Pal%2C%20S.%2C%20Azazmeh%2C%20N.%2C%20Rashid%2C%20R.%2C%20Lin%2C%20J.-R.%2C%20Cusick%2C%20M.%2C%20Reynolds%2C%20A.%20R.%20N.%2C%20Fassinou%2C%20A.%20C.%20R.%2C%20Ayoub%2C%20G.%2C%20Malinowski%2C%20S.%2C%20Lapinskas%2C%20E.%2C%20Pisano%2C%20W.%2C%20Jeang%2C%20J.%2C%20Stopka%2C%20S.%20A.%2C%20Regan%2C%20M.%20S.%2C%20%26%23x2026%3B%20Beroukhim%2C%20R.%20%282025%29.%20A%20window-of-opportunity%20trial%20reveals%20mechanisms%20of%20response%20and%20resistance%20to%20navtemadlin%20in%20patients%20with%20recurrent%20glioblastoma.%20%3Ci%3EScience%20Translational%20Medicine%3C%5C%2Fi%3E%2C%20%3Ci%3E17%3C%5C%2Fi%3E%28786%29%2C%20eadn6274.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscitranslmed.adn6274%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscitranslmed.adn6274%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20window-of-opportunity%20trial%20reveals%20mechanisms%20of%20response%20and%20resistance%20to%20navtemadlin%20in%20patients%20with%20recurrent%20glioblastoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronica%22%2C%22lastName%22%3A%22Rendo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eudocia%20Q.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%22%2C%22lastName%22%3A%22Bossi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Khuu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%20A.%22%2C%22lastName%22%3A%22Rudek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sangita%22%2C%22lastName%22%3A%22Pal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Narmen%22%2C%22lastName%22%3A%22Azazmeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rumana%22%2C%22lastName%22%3A%22Rashid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%22%2C%22lastName%22%3A%22Cusick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abigail%20R.%20N.%22%2C%22lastName%22%3A%22Reynolds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Auriole%20C.%20R.%22%2C%22lastName%22%3A%22Fassinou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georges%22%2C%22lastName%22%3A%22Ayoub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seth%22%2C%22lastName%22%3A%22Malinowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Lapinskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Pisano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Jeang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%20A.%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Spetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arati%22%2C%22lastName%22%3A%22Desai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Lieberman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamalakannan%22%2C%22lastName%22%3A%22Palanichamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joy%20D.%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristine%22%2C%22lastName%22%3A%22Pelton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20Y.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20B.%22%2C%22lastName%22%3A%22Nabors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Holdhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neeraja%22%2C%22lastName%22%3A%22Danda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%22%2C%22lastName%22%3A%22Strowd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%22%2C%22lastName%22%3A%22Desideri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tobias%22%2C%22lastName%22%3A%22Walbert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaobu%22%2C%22lastName%22%3A%22Ye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnab%22%2C%22lastName%22%3A%22Chakravarti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20A.%22%2C%22lastName%22%3A%22Grossman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20M.%22%2C%22lastName%22%3A%22Alexander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%5D%2C%22abstractNote%22%3A%22Inhibitors%20of%20murine%20double%20minute%20homolog%202%20%28MDM2%29%20represent%20a%20promising%20therapeutic%20approach%20for%20the%20treatment%20of%20TP53%20wild-type%20glioblastomas%20%28GBMs%29%2C%20reactivating%20p53%20signaling%20to%20induce%20cancer%20cell%20death.%20We%20conducted%20a%20surgical%20window-of-opportunity%20trial%20%28NCT03107780%29%20of%20the%20MDM2%20inhibitor%20navtemadlin%20%28KRT-232%29%20in%2021%20patients%20with%20TP53%20wild-type%20recurrent%20GBM%20to%20determine%20achievable%20drug%20concentrations%20within%20tumor%20tissues%20and%20biological%20mechanisms%20of%20response%20and%20resistance.%20Participants%20received%20navtemadlin%20at%20120%20mg%20%28n%20%3D%2010%29%20or%20240%20mg%20%28n%20%3D%2011%29%20for%202%20days%20before%20surgical%20resection%20and%20after%20surgery%20until%20progression%20or%20unacceptable%20toxicity.%20Both%20120%20and%20240%20mg%20daily%20dosing%20achieved%20a%20pharmacodynamic%20impact%2C%20but%20median%20progression-free%20survival%20was%203.1%20months.%20DNA%20sequencing%20of%20three%20recurrent%20tumors%20revealed%20an%20absence%20of%20TP53-inactivating%20mutations%2C%20indicating%20alternative%20mechanisms%20of%20resistance.%20To%20understand%20the%20mechanisms%20of%20response%20and%20resistance%20associated%20with%20navtemadlin%2C%20we%20conducted%20functional%20and%20spatial%20analyses%20of%20human%20tissue%20and%20patient-derived%20GBM%20neurosphere%20models.%20Navtemadlin%20induced%20partial%20tumor%20cell%20death%20as%20monotherapy%2C%20and%20combination%20with%20temozolomide%20enhanced%20apoptosis%20in%20GBM%20neurospheres%20while%20sparing%20normal%20bone%20marrow%20cells%20in%20vitro.%20We%20also%20observed%20up-regulation%20of%20oligodendrocyte%20differentiation%20genes%20with%20navtemadlin%20treatment%20and%20enrichment%20of%20oligodendrocyte%20transcription%20factor%202%20%28OLIG2%29-positive%20cells%20at%20relapse%2C%20suggesting%20an%20unexplored%20mechanism%20of%20navtemadlin%20tolerance%20in%20GBM.%20Overall%2C%20these%20results%20indicated%20that%20clinically%20achievable%20doses%20of%20navtemadlin%20exert%20pharmacodynamic%20effects%20on%20GBM%20and%20suggest%20that%20combined%20treatment%20with%20temozolomide%20may%20be%20a%20route%20to%20more%20durable%20survival%20benefits.%22%2C%22date%22%3A%222025-02-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fscitranslmed.adn6274%22%2C%22ISSN%22%3A%221946-6242%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-28T14%3A37%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22GMERRCR2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Prabhakaran%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPrabhakaran%2C%20S.%2C%20Yapp%2C%20C.%2C%20Baker%2C%20G.%20J.%2C%20Beyer%2C%20J.%2C%20Chang%2C%20Y.%20H.%2C%20Creason%2C%20A.%20L.%2C%20Krueger%2C%20R.%2C%20Muhlich%2C%20J.%2C%20Patterson%2C%20N.%20H.%2C%20Sidak%2C%20K.%2C%20Sudar%2C%20D.%2C%20Taylor%2C%20A.%20J.%2C%20Ternes%2C%20L.%2C%20Troidl%2C%20J.%2C%20Yubin%2C%20X.%2C%20Sokolov%2C%20A.%2C%20%26amp%3B%20Tyson%2C%20D.%20R.%20%282025%29.%20Addressing%20persistent%20challenges%20in%20digital%20image%20analysis%20of%20cancer%20tissue%3A%20resources%20developed%20from%20a%20hackathon.%20%3Ci%3EMolecular%20Oncology%3C%5C%2Fi%3E.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F1878-0261.13783%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F1878-0261.13783%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Addressing%20persistent%20challenges%20in%20digital%20image%20analysis%20of%20cancer%20tissue%3A%20resources%20developed%20from%20a%20hackathon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandhya%22%2C%22lastName%22%3A%22Prabhakaran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Beyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young%20Hwan%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%20L.%22%2C%22lastName%22%3A%22Creason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20Heath%22%2C%22lastName%22%3A%22Patterson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Sidak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damir%22%2C%22lastName%22%3A%22Sudar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%22%2C%22lastName%22%3A%22Ternes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakob%22%2C%22lastName%22%3A%22Troidl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xie%22%2C%22lastName%22%3A%22Yubin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20R.%22%2C%22lastName%22%3A%22Tyson%22%7D%5D%2C%22abstractNote%22%3A%22The%20National%20Cancer%20Institute%20%28NCI%29%20supports%20numerous%20research%20consortia%20that%20rely%20on%20imaging%20technologies%20to%20study%20cancerous%20tissues.%20To%20foster%20collaboration%20and%20innovation%20in%20this%20field%2C%20the%20Image%20Analysis%20Working%20Group%20%28IAWG%29%20was%20created%20in%202019.%20As%20multiplexed%20imaging%20techniques%20grow%20in%20scale%20and%20complexity%2C%20more%20advanced%20computational%20methods%20are%20required%20beyond%20traditional%20approaches%20like%20segmentation%20and%20pixel%20intensity%20quantification.%20In%202022%2C%20the%20IAWG%20held%20a%20virtual%20hackathon%20focused%20on%20addressing%20challenges%20in%20analyzing%20complex%2C%20high-dimensional%20datasets%20from%20fixed%20cancer%20tissues.%20The%20hackathon%20addressed%20key%20challenges%20in%20three%20areas%3A%20%281%29%20cell%20type%20classification%20and%20assessment%2C%20%282%29%20spatial%20data%20visualization%20and%20translation%2C%20and%20%283%29%20scaling%20image%20analysis%20for%20large%2C%20multi-terabyte%20datasets.%20Participants%20explored%20the%20limitations%20of%20current%20automated%20analysis%20tools%2C%20developed%20potential%20solutions%2C%20and%20made%20significant%20progress%20during%20the%20hackathon.%20Here%20we%20provide%20a%20summary%20of%20the%20efforts%20and%20resultant%20resources%20and%20highlight%20remaining%20challenges%20facing%20the%20research%20community%20as%20emerging%20technologies%20are%20integrated%20into%20diverse%20imaging%20modalities%20and%20data%20analysis%20platforms.%22%2C%22date%22%3A%222025-02-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2F1878-0261.13783%22%2C%22ISSN%22%3A%221878-0261%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-08T04%3A11%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22QBVFHE9K%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sun%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESun%2C%20Y.%2C%20Maggs%2C%20L.%2C%20Panda%2C%20A.%2C%20Wright%2C%20S.%20J.%2C%20Cicerchia%2C%20A.%20M.%2C%20Jenney%2C%20A.%2C%20Perricone%2C%20M.%20D.%2C%20Mills%2C%20C.%20E.%2C%20Cattaneo%2C%20G.%2C%20Ventin%2C%20M.%2C%20Chen%2C%20F.%2C%20Rasmussen%2C%20M.%20Q.%2C%20Miranda%2C%20A.%2C%20Revach%2C%20O.-Y.%2C%20Fang%2C%20J.%2C%20Fu%2C%20A.%2C%20Bowling%2C%20P.%20J.%2C%20Sharova%2C%20T.%2C%20Lawless%2C%20A.%2C%20%26%23x2026%3B%20Jenkins%2C%20R.%20W.%20%282025%29.%20TBK1%20Targeting%20Is%20Identified%20as%20a%20Therapeutic%20Strategy%20to%20Enhance%20CAR%20T-Cell%20Efficacy%20Using%20Patient-Derived%20Organotypic%20Tumor%20Spheroids.%20%3Ci%3ECancer%20Immunology%20Research%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%282%29%2C%20210%26%23x2013%3B228.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2326-6066.CIR-23-1011%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2326-6066.CIR-23-1011%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22TBK1%20Targeting%20Is%20Identified%20as%20a%20Therapeutic%20Strategy%20to%20Enhance%20CAR%20T-Cell%20Efficacy%20Using%20Patient-Derived%20Organotypic%20Tumor%20Spheroids%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%22%2C%22lastName%22%3A%22Maggs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Apekshya%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20J.%22%2C%22lastName%22%3A%22Wright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelina%20M.%22%2C%22lastName%22%3A%22Cicerchia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Jenney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20D.%22%2C%22lastName%22%3A%22Perricone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22Cattaneo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marco%22%2C%22lastName%22%3A%22Ventin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20Q.%22%2C%22lastName%22%3A%22Rasmussen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%22%2C%22lastName%22%3A%22Miranda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Or-Yam%22%2C%22lastName%22%3A%22Revach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacy%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amina%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20J.%22%2C%22lastName%22%3A%22Bowling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatyana%22%2C%22lastName%22%3A%22Sharova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleigha%22%2C%22lastName%22%3A%22Lawless%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabeel%22%2C%22lastName%22%3A%22Bardeesy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinhui%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20T.%22%2C%22lastName%22%3A%22Flaherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevieve%20M.%22%2C%22lastName%22%3A%22Boland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnav%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moshe%22%2C%22lastName%22%3A%22Sade-Feldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%20R.%22%2C%22lastName%22%3A%22Ferrone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%20W.%22%2C%22lastName%22%3A%22Jenkins%22%7D%5D%2C%22abstractNote%22%3A%22Novel%20therapeutic%20strategies%20are%20needed%20to%20improve%20the%20efficacy%20of%20chimeric%20antigen%20receptor%20%28CAR%29%20T%20cells%20as%20a%20treatment%20of%20solid%20tumors.%20Multiple%20tumor%20microenvironmental%20factors%20are%20thought%20to%20contribute%20to%20resistance%20to%20CAR%20T-cell%20therapy%20in%20solid%20tumors%2C%20and%20appropriate%20model%20systems%20to%20identify%20and%20examine%20these%20factors%20using%20clinically%20relevant%20biospecimens%20are%20limited.%20In%20this%20study%2C%20we%20examined%20the%20activity%20of%20B7-H3-directed%20CAR%20T%20cells%20%28B7-H3.CAR-T%29%20using%203D%20microfluidic%20cultures%20of%20patient-derived%20organotypic%20tumor%20spheroids%20%28PDOTS%29%20and%20then%20confirmed%20the%20activity%20of%20B7-H3.CAR%20T%20cells%20in%20PDOTS.%20Although%20B7-H3%20expression%20in%20PDOTS%20was%20associated%20with%20B7-H3.CAR-T%20sensitivity%2C%20mechanistic%20studies%20revealed%20dynamic%20upregulation%20of%20co-inhibitory%20receptors%20on%20CAR%20T-cells%20following%20target%20cell%20encounter%20that%20led%20to%20CAR%20T-cell%20dysfunction%20and%20limited%20efficacy%20against%20B7-H3-expressing%20tumors.%20PD-1%20blockade%20restored%20CAR%20T-cell%20activity%20in%20monotypic%20and%20organotypic%20tumor%20spheroids%20with%20improved%20tumor%20control%20and%20upregulation%20of%20effector%20cytokines.%20Given%20the%20emerging%20role%20of%20TANK-binding%20kinase%201%20%28TBK1%29%20as%20an%20immune%20evasion%20gene%2C%20we%20examined%20the%20effect%20of%20TBK1%20inhibition%20on%20CAR%20T-cell%20efficacy.%20Similar%20to%20PD-1%20blockade%2C%20TBK1%20inhibition%20restored%20CAR%20T-cell%20activity%20in%20monotypic%20and%20organotypic%20tumor%20spheroids%2C%20prevented%20CAR%20T-cell%20dysfunction%2C%20and%20enhanced%20CAR%20T-cell%20proliferation.%20Inhibition%20or%20deletion%20of%20TBK1%20also%20enhanced%20the%20sensitivity%20of%20cancer%20cells%20to%20immune-mediated%20killing.%20Taken%20together%2C%20our%20results%20demonstrate%20the%20feasibility%20and%20utility%20of%20ex%20vivo%20profiling%20of%20CAR%20T%20cells%20using%20PDOTS%20and%20suggest%20that%20targeting%20TBK1%20could%20be%20used%20to%20enhance%20CAR%20T-cell%20efficacy%20by%20overcoming%20tumor-intrinsic%20and%20-extrinsic%20resistance%20mechanisms.%22%2C%22date%22%3A%222025-02-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2326-6066.CIR-23-1011%22%2C%22ISSN%22%3A%222326-6074%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-02-11T14%3A04%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22CAINBEII%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Spellberg%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESpellberg%2C%20B.%2C%20Gilbert%2C%20D.%20N.%2C%20Baym%2C%20M.%2C%20Bearman%2C%20G.%2C%20Boyles%2C%20T.%2C%20Casadevall%2C%20A.%2C%20Forrest%2C%20G.%20N.%2C%20Freling%2C%20S.%2C%20Ghanem%2C%20B.%2C%20Hamilton%2C%20F.%2C%20Luna%2C%20B.%2C%20Moore%2C%20J.%2C%20Musher%2C%20D.%20M.%2C%20Nielsen%2C%20T.%20B.%2C%20Nori%2C%20P.%2C%20Phillips%2C%20M.%20C.%2C%20Pirofski%2C%20L.-A.%2C%20Shorr%2C%20A.%20F.%2C%20Tong%2C%20S.%20Y.%20C.%2C%20%26%23x2026%3B%20McDonald%2C%20E.%20G.%20%282025%29.%20Sustainable%20solutions%20to%20the%20continuous%20threat%20of%20antimicrobial%20resistance.%20%3Ci%3EHealth%20Affairs%20Scholar%3C%5C%2Fi%3E%2C%20%3Ci%3E3%3C%5C%2Fi%3E%282%29%2C%20qxaf012.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fhaschl%5C%2Fqxaf012%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fhaschl%5C%2Fqxaf012%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sustainable%20solutions%20to%20the%20continuous%20threat%20of%20antimicrobial%20resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brad%22%2C%22lastName%22%3A%22Spellberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20N.%22%2C%22lastName%22%3A%22Gilbert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gonzalo%22%2C%22lastName%22%3A%22Bearman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%22%2C%22lastName%22%3A%22Boyles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arturo%22%2C%22lastName%22%3A%22Casadevall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Graeme%20N.%22%2C%22lastName%22%3A%22Forrest%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Freling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bassam%22%2C%22lastName%22%3A%22Ghanem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fergus%22%2C%22lastName%22%3A%22Hamilton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Luna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20M.%22%2C%22lastName%22%3A%22Musher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Travis%20B.%22%2C%22lastName%22%3A%22Nielsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Nori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20C.%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liise-Anne%22%2C%22lastName%22%3A%22Pirofski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20F.%22%2C%22lastName%22%3A%22Shorr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20Y.%20C.%22%2C%22lastName%22%3A%22Tong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Todd%20C.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20G.%22%2C%22lastName%22%3A%22McDonald%22%7D%5D%2C%22abstractNote%22%3A%22To%20combat%20antimicrobial%20resistance%20%28AMR%29%2C%20advocates%20have%20called%20for%20passage%20of%20the%20Pioneering%20Antimicrobial%20Subscriptions%20To%20End%20Upsurging%20Resistance%20%28PASTEUR%29%20Act%20in%20the%20United%20States%2C%20which%20would%20appropriate%20%246%20billion%20in%20new%20taxpayer-funded%20subsidies%20for%20antibiotic%20development.%20However%2C%20the%20number%20of%20antibiotics%20in%20clinical%20development%2C%20and%20US%20Food%20and%20Drug%20Administration%20approvals%20of%20new%20antibiotics%2C%20have%20already%20markedly%20increased%20in%20the%20last%2015%20years.%20Thus%2C%20instead%20of%20focusing%20on%20more%20economic%20subsidies%2C%20we%20recommend%20reducing%20selective%20pressure%20driving%20AMR%20by%20%281%29%20establishing%20pay-for-performance%20mechanisms%20that%20disincentivize%20overprescribing%20of%20antibiotics%2C%20%282%29%20focusing%20existing%20research%20and%20development%20funding%20on%20strategies%20that%20decrease%20reliance%20on%20antibiotics%2C%20and%20%283%29%20changing%20regulation%20or%20law%20to%20require%20specialized%20training%20in%20antibiotic%20stewardship%20for%20a%20clinician%20to%20be%20able%20to%20prescribe%20new%20antibiotics%20that%20target%20unmet%20AMR%20need.%20To%20stabilize%20the%20antibiotic%20market%2C%20we%20recommend%20%281%29%20establishment%20of%20an%20advisory%20board%20of%20clinical%20practitioners%20to%20more%20accurately%20target%20existing%20antibiotic%20incentives%20and%20%282%29%20endowment%20of%20nonprofit%20companies%20that%20sustainably%20self-fund%20antibiotic%20discovery%2C%20creating%20a%20bench%20of%20molecules%20that%20can%20be%20partnered%20with%20industry%20at%20later%20stages%20of%20development.%22%2C%22date%22%3A%222025-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fhaschl%5C%2Fqxaf012%22%2C%22ISSN%22%3A%222976-5390%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A49%3A25Z%22%7D%7D%2C%7B%22key%22%3A%2289B3ISJF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Lee%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELee%2C%20E.%20Q.%2C%20Alexander%2C%20B.%20M.%2C%20Romo%2C%20C.%20G.%2C%20Supko%2C%20J.%20G.%2C%20Agar%2C%20N.%20Y.%20R.%2C%20Talebi%2C%20Z.%2C%20Ahluwalia%2C%20M.%20S.%2C%20Desai%2C%20A.%20S.%2C%20Dietrich%2C%20J.%2C%20Kaley%2C%20T.%20J.%2C%20Peereboom%2C%20D.%20M.%2C%20Gantchev%2C%20J.%2C%20Baquer%2C%20G.%2C%20Santagata%2C%20S.%2C%20Takebe%2C%20N.%2C%20Desideri%2C%20S.%2C%20Fisher%2C%20J.%20D.%2C%20Sims%2C%20M.%2C%20Ye%2C%20X.%2C%20%26%23x2026%3B%20Wen%2C%20P.%20Y.%20%282025%29.%20Phase%20I%20study%20of%20adavosertib%20with%20radiation%20therapy%20and%20temozolomide%20in%20newly%20diagnosed%20glioblastoma%20and%20intratumoral%20drug%20levels%20in%20recurrent%20glioblastoma.%20%3Ci%3EClinical%20Cancer%20Research%3A%20An%20Official%20Journal%20of%20the%20American%20Association%20for%20Cancer%20Research%3C%5C%2Fi%3E.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-24-2311%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-24-2311%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Phase%20I%20study%20of%20adavosertib%20with%20radiation%20therapy%20and%20temozolomide%20in%20newly%20diagnosed%20glioblastoma%20and%20intratumoral%20drug%20levels%20in%20recurrent%20glioblastoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eudocia%20Q.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20M.%22%2C%22lastName%22%3A%22Alexander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20G.%22%2C%22lastName%22%3A%22Romo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20G.%22%2C%22lastName%22%3A%22Supko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zahra%22%2C%22lastName%22%3A%22Talebi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manmeet%20S.%22%2C%22lastName%22%3A%22Ahluwalia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arati%20S.%22%2C%22lastName%22%3A%22Desai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorg%22%2C%22lastName%22%3A%22Dietrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Kaley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Peereboom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Gantchev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22Baquer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naoko%22%2C%22lastName%22%3A%22Takebe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%22%2C%22lastName%22%3A%22Desideri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joy%20D.%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Sims%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaobu%22%2C%22lastName%22%3A%22Ye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20B.%22%2C%22lastName%22%3A%22Nabors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20A.%22%2C%22lastName%22%3A%22Grossman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Adavosertib%20is%20an%20oral%20small%20molecular%20inhibitor%20of%20Wee1.%20The%20Adult%20Brain%20Tumor%20Consortium%20performed%20a%20phase%20I%20study%20of%20adavosertib%2C%20radiation%20%28RT%29%20and%20temozolomide%20%28TMZ%29%20in%20newly%20diagnosed%20glioblastoma%20%28GBM%29%20as%20well%20as%20a%20surgical%20window%20of%20opportunity%20study%20in%20recurrent%20GBM.%5CnPATIENTS%20AND%20METHODS%3A%20The%20maximum%20tolerated%20dose%20%28MTD%29%20of%20adavosertib%20was%20determined%20in%20adult%20patients%20with%20newly%20diagnosed%20GBM%20using%20a%20standard%203%2B3%20design%20in%202%20separate%20cohorts%3A%20with%20concurrent%20RT%5C%2FTMZ%20or%20with%20adjuvant%20TMZ.%20A%20combination%20cohort%20with%20both%20concurrent%20and%20adjuvant%20adavosertib%20at%20MTD%20followed.%20We%20also%20performed%20intratumoral%20drug%20distribution%20studies%20in%20recurrent%20GBM%20patients%20undergoing%20surgery.%5CnRESULTS%3A%20As%20separate%20cohorts%2C%20MTD%20for%20concurrent%20adavosertib%20with%20RT%5C%2FTMZ%20was%20200%20mg%20daily%20M-F%20x%206%20weeks%20during%20RT%20and%20for%20adjuvant%20adavosertib%20with%20TMZ%20was%20425%20mg%20daily%20for%205%20days%20of%20each%2028-day%20cycle.%20However%2C%206%5C%2F12%20patients%20experienced%20DLTs%20in%20the%20combination%20cohort.%20The%20mean%20ratio%20of%20the%20intratumoral-to-plasma%20concentration%20of%20adavosertib%20was%204.18%20%5Cu00b1%203.36%20for%20contrast-enhancing%20tissue%20and%200.74%20%5Cu00b1%200.63%20in%20non-enhancing%20tissue.%5CnCONCLUSIONS%3A%20Adavosertib%20200%20mg%20daily%20M-F%20x%206%20weeks%20with%20RT%5C%2FTMZ%20and%20425%20mg%20daily%20on%20a%205d%5C%2F28d%20cycle%20with%20TMZ%20had%20an%20unacceptable%20DLT%20rate.%20Additional%20dose%20levels%20in%20combination%20cohorts%20resulted%20in%20DLTs%20and%20we%20deemed%20concurrent%20adavosertib%20too%20toxic%20for%20further%20examination.%20Adavosertib%20425%20mg%20daily%20on%20a%205d%5C%2F28d%20cycle%20with%20adjuvant%20TMZ%20is%20the%20recommended%20phase%20II%20dose.%20Tissue%20PK%20in%20tissue%20homogenates%20and%20by%20microdialysis%20provided%20complementary%20information%20about%20drug%20penetration.%22%2C%22date%22%3A%222025-01-17%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F1078-0432.CCR-24-2311%22%2C%22ISSN%22%3A%221557-3265%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-21T17%3A14%3A59Z%22%7D%7D%2C%7B%22key%22%3A%227K42JVGV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Kaul%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-16%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKaul%2C%20A.%2C%20Souque%2C%20C.%2C%20Holland%2C%20M.%2C%20%26amp%3B%20Baym%2C%20M.%20%282025%29.%20%3Ci%3EGenomic%20resistance%20in%20historical%20clinical%20isolates%20increased%20in%20frequency%20and%20mobility%20after%20the%20age%20of%20antibiotics%3C%5C%2Fi%3E.%20bioRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.01.16.633422%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2025.01.16.633422%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Genomic%20resistance%20in%20historical%20clinical%20isolates%20increased%20in%20frequency%20and%20mobility%20after%20the%20age%20of%20antibiotics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arya%22%2C%22lastName%22%3A%22Kaul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9lia%22%2C%22lastName%22%3A%22Souque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mische%22%2C%22lastName%22%3A%22Holland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Antibiotic%20resistance%20is%20frequently%20observed%20shortly%20after%20the%20clinical%20introduction%20of%20an%20antibiotic.%20Whether%20and%20how%20frequently%20that%20resistance%20occurred%20before%20the%20introduction%20is%20harder%20to%20determine%2C%20as%20isolates%20could%20not%20have%20been%20tested%20for%20resistance%20before%20an%20antibiotic%20was%20discovered.%20Historical%20collections%2C%20like%20the%20British%20National%20Collection%20of%20Type%20Cultures%20%28NCTC%29%2C%20stretching%20back%20to%201885%2C%20provide%20a%20window%20into%20this%20history.%20Here%20we%20match%201%2C817%20sequenced%20high-quality%20genomes%20from%20the%20NCTC%20collection%20to%20their%20respective%20year%20of%20isolation%20to%20study%20resistance%20genes%20before%20and%20concurrent%20with%20the%20age%20of%20antibiotics.%20Concordant%20with%20previous%20work%2C%20we%20find%20resistance%20genes%20in%20both%20pathogens%20and%20environmental%20samples%20before%20the%20age%20of%20antibiotics.%20While%20generally%20rare%20before%20the%20introduction%20of%20an%20antibiotic%2C%20we%20find%20an%20associated%20increase%20in%20frequency%20with%20antibiotic%20introduction.%20Finally%2C%20we%20observe%20a%20trend%20of%20resistance%20elements%20becoming%20both%20increasingly%20mobile%20and%20nested%20within%20multiple%20mobile%20elements%20as%20time%20goes%20on.%20More%20broadly%2C%20our%20findings%20suggest%20that%20likely-functional%20antibiotic%20resistance%20genes%20were%20circulating%20in%20clinically%20relevant%20isolates%20before%20the%20age%20of%20antibiotics%2C%20but%20human%20usage%20is%20associated%20with%20increasing%20both%20their%20overall%20prevalence%20and%20mobility.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-01-16%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.01.16.633422%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.01.16.633422%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A48%3A31Z%22%7D%7D%2C%7B%22key%22%3A%2265R2VCTF%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stojanovic%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EStojanovic%2C%20L.%2C%20Abbotts%2C%20R.%2C%20Tripathi%2C%20K.%2C%20Coon%2C%20C.%20M.%2C%20Rajendran%2C%20S.%2C%20Abbasi%20Farid%2C%20E.%2C%20Hostetter%2C%20G.%2C%20Guarnieri%2C%20J.%20W.%2C%20Wallace%2C%20D.%20C.%2C%20Liu%2C%20S.%2C%20Wan%2C%20J.%2C%20Calendo%2C%20G.%2C%20Marker%2C%20R.%2C%20Gohari%2C%20Z.%2C%20Inayatullah%2C%20M.%20M.%20A.%2C%20Tiwari%2C%20V.%20K.%2C%20Kader%2C%20T.%2C%20Santagata%2C%20S.%2C%20Drapkin%2C%20R.%2C%20%26%23x2026%3B%20Rassool%2C%20F.%20V.%20%282025%29.%20ZNFX1%20functions%20as%20a%20master%20regulator%20of%20epigenetically%20induced%20pathogen%20mimicry%20and%20inflammasome%20signaling%20in%20cancer.%20%3Ci%3ECancer%20Research%3C%5C%2Fi%3E.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F0008-5472.CAN-24-1286%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F0008-5472.CAN-24-1286%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ZNFX1%20functions%20as%20a%20master%20regulator%20of%20epigenetically%20induced%20pathogen%20mimicry%20and%20inflammasome%20signaling%20in%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lora%22%2C%22lastName%22%3A%22Stojanovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Abbotts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaushelendra%22%2C%22lastName%22%3A%22Tripathi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Collin%20M.%22%2C%22lastName%22%3A%22Coon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saranya%22%2C%22lastName%22%3A%22Rajendran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elnaz%22%2C%22lastName%22%3A%22Abbasi%20Farid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galen%22%2C%22lastName%22%3A%22Hostetter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20W.%22%2C%22lastName%22%3A%22Guarnieri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20C.%22%2C%22lastName%22%3A%22Wallace%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gennaro%22%2C%22lastName%22%3A%22Calendo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22Marker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zahra%22%2C%22lastName%22%3A%22Gohari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%20M.%20A.%22%2C%22lastName%22%3A%22Inayatullah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%20K.%22%2C%22lastName%22%3A%22Tiwari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanjina%22%2C%22lastName%22%3A%22Kader%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronny%22%2C%22lastName%22%3A%22Drapkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Kommoss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacobus%22%2C%22lastName%22%3A%22Pfisterer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gottfried%20E.%22%2C%22lastName%22%3A%22Konecny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Coopergard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%20J.%22%2C%22lastName%22%3A%22Issa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Boris%20J.%20N.%22%2C%22lastName%22%3A%22Winterhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Topper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20E.%22%2C%22lastName%22%3A%22Sandusky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%20D.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20B.%22%2C%22lastName%22%3A%22Baylin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20P.%22%2C%22lastName%22%3A%22Nephew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feyruz%20V.%22%2C%22lastName%22%3A%22Rassool%22%7D%5D%2C%22abstractNote%22%3A%22DNA%20methyltransferase%20and%20poly%20%28ADP-ribose%29%20polymerase%20inhibitors%20%28DNMTis%2C%20PARPis%29%20induce%20a%20stimulator%20of%20interferon%20genes%20%28STING%29-dependent%20pathogen%20mimicry%20response%20%28PMR%29%20in%20ovarian%20and%20other%20cancers.%20Here%2C%20we%20showed%20that%20combining%20DNMTis%20and%20PARPis%20upregulates%20expression%20of%20the%20nucleic-acid%20sensor%20NFX1-type%20zinc%20finger-containing%201%20protein%20%28ZNFX1%29.%20ZNFX1%20mediated%20induction%20of%20PMR%20in%20mitochondria%2C%20serving%20as%20a%20gateway%20for%20STING-dependent%20interferon%5C%2Finflammasome%20signaling.%20Loss%20of%20ZNFX1%20in%20ovarian%20cancer%20cells%20promoted%20proliferation%20and%20spheroid%20formation%20in%20vitro%20and%20tumor%20growth%20in%20vivo.%20In%20patient%20ovarian%20cancer%20databases%2C%20expression%20of%20ZNFX1%20was%20elevated%20in%20advanced%20stage%20disease%2C%20and%20ZNFX1%20expression%20alone%20significantly%20correlated%20with%20an%20increase%20in%20overall%20survival%20in%20a%20phase%203%20trial%20for%20therapy-resistant%20ovarian%20cancer%20patients%20receiving%20bevacizumab%20in%20combination%20with%20chemotherapy.%20RNA-sequencing%20revealed%20an%20association%20between%20inflammasome%20signaling%20through%20ZNFX1%20and%20abnormal%20vasculogenesis.%20Together%2C%20this%20study%20identified%20that%20ZNFX1%20as%20a%20tumor%20suppressor%20that%20controls%20PMR%20signaling%20through%20mitochondria%20and%20may%20serve%20as%20a%20biomarker%20to%20facilitate%20personalized%20therapy%20in%20ovarian%20cancer%20patients.%22%2C%22date%22%3A%222025-01-13%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-24-1286%22%2C%22ISSN%22%3A%221538-7445%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-21T18%3A39%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22N7YHBVBQ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22MacDonald%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMacDonald%2C%20J.%20A.%2C%20Bradshaw%2C%20G.%20A.%2C%20Jochems%2C%20F.%2C%20Bernards%2C%20R.%2C%20%26amp%3B%20Letai%2C%20A.%20%282025%29.%20Apoptotic%20priming%20in%20senescence%20predicts%20specific%20senolysis%20by%20quantitative%20analysis%20of%20mitochondrial%20dependencies.%20%3Ci%3ECell%20Death%20and%20Differentiation%3C%5C%2Fi%3E.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41418-024-01431-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41418-024-01431-1%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Apoptotic%20priming%20in%20senescence%20predicts%20specific%20senolysis%20by%20quantitative%20analysis%20of%20mitochondrial%20dependencies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20A.%22%2C%22lastName%22%3A%22MacDonald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fleur%22%2C%22lastName%22%3A%22Jochems%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ren%5Cu00e9%22%2C%22lastName%22%3A%22Bernards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%5D%2C%22abstractNote%22%3A%22Cellular%20senescence%20contributes%20to%20a%20variety%20of%20pathologies%20associated%20with%20aging%20and%20is%20implicated%20as%20a%20cellular%20state%20in%20which%20cancer%20cells%20can%20survive%20treatment.%20Reported%20senolytic%20drug%20treatments%20act%20through%20varying%20molecular%20mechanisms%2C%20but%20heterogeneous%20efficacy%20across%20the%20diverse%20contexts%20of%20cellular%20senescence%20indicates%20a%20need%20for%20predictive%20biomarkers%20of%20senolytic%20activity.%20Using%20multi-parametric%20analyses%20of%20commonly%20reported%20molecular%20features%20of%20the%20senescent%20phenotype%2C%20we%20assayed%20a%20variety%20of%20models%2C%20including%20malignant%20and%20nonmalignant%20cells%2C%20using%20several%20triggers%20of%20senescence%20induction%20and%20found%20little%20univariate%20predictive%20power%20of%20these%20traditional%20senescence%20markers%20to%20identify%20senolytic%20drug%20sensitivity.%20We%20sought%20to%20identify%20novel%20drug%20targets%20in%20senescent%20cells%20that%20were%20insensitive%20to%20frequently%20implemented%20senolytic%20therapies%2C%20such%20as%20Navitoclax%20%28ABT-263%29%2C%20using%20quantitative%20mass%20spectrometry%20to%20measure%20changes%20in%20the%20senescent%20proteome%2C%20compared%20to%20cells%20which%20acquire%20an%20acute%20sensitivity%20to%20ABT-263%20with%20senescence%20induction.%20Inhibition%20of%20the%20antioxidant%20GPX4%20or%20the%20Bcl-2%20family%20member%20MCL-1%20using%20small%20molecule%20compounds%20in%20combination%20with%20ABT-263%20significantly%20increased%20the%20induction%20of%20apoptosis%20in%20some%2C%20but%20not%20all%2C%20previously%20insensitive%20senescent%20cells.%20We%20then%20asked%20if%20we%20could%20use%20BH3%20profiling%20to%20measure%20differences%20in%20mitochondrial%20apoptotic%20priming%20in%20these%20models%20of%20cellular%20senescence%20and%20predict%20sensitivity%20to%20the%20senolytics%20ABT-263%20or%20the%20combination%20of%20dasatinib%20and%20quercetin%20%28D%5Cu2009%2B%5Cu2009Q%29.%20We%20found%2C%20despite%20being%20significantly%20less%20primed%20for%20apoptosis%20overall%2C%20the%20dependence%20of%20senescent%20mitochondria%20on%20BCL-XL%20was%20significantly%20correlated%20to%20senescent%20cell%20killing%20by%20both%20ABT-263%20and%20D%5Cu2009%2B%5Cu2009Q%2C%20despite%20no%20significant%20changes%20in%20the%20gene%20or%20protein%20expression%20of%20BCL-XL.%20However%2C%20our%20data%20caution%20against%20broad%20classification%20of%20drugs%20as%20globally%20senolytic%20and%20instead%20provide%20impetus%20for%20context-specific%20senolytic%20targets%20and%20propose%20BH3%20profiling%20as%20an%20effective%20predictive%20biomarker.%22%2C%22date%22%3A%222025-01-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41418-024-01431-1%22%2C%22ISSN%22%3A%221476-5403%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-15T16%3A00%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22ABEBHA3S%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Morth%20et%20al.%22%2C%22parsedDate%22%3A%222025-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMorth%2C%20E.%2C%20Sidak%2C%20K.%2C%20Maliga%2C%20Z.%2C%20Moller%2C%20T.%2C%20Gehlenborg%2C%20N.%2C%20Sorger%2C%20P.%2C%20Pfister%2C%20H.%2C%20Beyer%2C%20J.%2C%20%26amp%3B%20Kruger%2C%20R.%20%282025%29.%20Cell2Cell%3A%20Explorative%20Cell%20Interaction%20Analysis%20in%20Multi-Volumetric%20Tissue%20Data.%20%3Ci%3EIEEE%20Transactions%20on%20Visualization%20and%20Computer%20Graphics%3C%5C%2Fi%3E%2C%20%3Ci%3E31%3C%5C%2Fi%3E%281%29%2C%20569%26%23x2013%3B579.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1109%5C%2FTVCG.2024.3456406%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1109%5C%2FTVCG.2024.3456406%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cell2Cell%3A%20Explorative%20Cell%20Interaction%20Analysis%20in%20Multi-Volumetric%20Tissue%20Data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Morth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Sidak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Torsten%22%2C%22lastName%22%3A%22Moller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nils%22%2C%22lastName%22%3A%22Gehlenborg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Beyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Kruger%22%7D%5D%2C%22abstractNote%22%3A%22We%20present%20Cell2Cell%2C%20a%20novel%20visual%20analytics%20approach%20for%20quantifying%20and%20visualizing%20networks%20of%20cell-cell%20interactions%20in%20three-dimensional%20%283D%29%20multi-channel%20cancerous%20tissue%20data.%20By%20analyzing%20cellular%20interactions%2C%20biomedical%20experts%20can%20gain%20a%20more%20accurate%20understanding%20of%20the%20intricate%20relationships%20between%20cancer%20and%20immune%20cells.%20Recent%20methods%20have%20focused%20on%20inferring%20interaction%20based%20on%20the%20proximity%20of%20cells%20in%20low-resolution%202D%20multi-channel%20imaging%20data.%20By%20contrast%2C%20we%20analyze%20cell%20interactions%20by%20quantifying%20the%20presence%20and%20levels%20of%20specific%20proteins%20within%20a%20tissue%20sample%20%28protein%20expressions%29%20extracted%20from%20high-resolution%203D%20multi-channel%20volume%20data.%20Such%20analyses%20have%20a%20strong%20exploratory%20nature%20and%20require%20a%20tight%20integration%20of%20domain%20experts%20in%20the%20analysis%20loop%20to%20leverage%20their%20deep%20knowledge.%20We%20propose%20two%20complementary%20semi-automated%20approaches%20to%20cope%20with%20the%20increasing%20size%20and%20complexity%20of%20the%20data%20interactively%3A%20On%20the%20one%20hand%2C%20we%20interpret%20cell-to-cell%20interactions%20as%20edges%20in%20a%20cell%20graph%20and%20analyze%20the%20image%20signal%20%28protein%20expressions%29%20along%20those%20edges%2C%20using%20spatial%20as%20well%20as%20abstract%20visualizations.%20Complementary%2C%20we%20propose%20a%20cell-centered%20approach%2C%20enabling%20scientists%20to%20visually%20analyze%20polarized%20distributions%20of%20proteins%20in%20three%20dimensions%2C%20which%20also%20captures%20neighboring%20cells%20with%20biochemical%20and%20cell%20biological%20consequences.%20We%20evaluate%20our%20application%20in%20three%20case%20studies%2C%20where%20biologists%20and%20medical%20experts%20use%20Cell2Cell%20to%20investigate%20tumor%20micro-environments%20to%20identify%20and%20quantify%20T-cell%20activation%20in%20human%20tissue%20data.%20We%20confirmed%20that%20our%20tool%20can%20fully%20solve%20the%20use%20cases%20and%20enables%20a%20streamlined%20and%20detailed%20analysis%20of%20cell-cell%20interactions.%22%2C%22date%22%3A%222025-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1109%5C%2FTVCG.2024.3456406%22%2C%22ISSN%22%3A%221941-0506%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T22%3A43%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22QLUV5UXC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Oka%20et%20al.%22%2C%22parsedDate%22%3A%222025-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EOka%2C%20T.%2C%20Hasegawa%2C%20T.%2C%20Lee%2C%20T.%2C%20Oliver-Garcia%2C%20V.%20S.%2C%20Mortaja%2C%20M.%2C%20Azin%2C%20M.%2C%20Horiba%2C%20S.%2C%20Smith%2C%20S.%20S.%2C%20Khattab%2C%20S.%2C%20Trerice%2C%20K.%20E.%2C%20Chen%2C%20S.%20T.%2C%20Semenov%2C%20Y.%20R.%2C%20%26amp%3B%20Demehri%2C%20S.%20%282025%29.%20Langerhans%20Cells%20Directly%20Interact%20with%20Resident%20T%20Cells%20in%20the%20Human%20Epidermis.%20%3Ci%3EJID%20Innovations%3A%20Skin%20Science%20from%20Molecules%20to%20Population%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E5%3C%5C%2Fi%3E%281%29%2C%20100324.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjidi.2024.100324%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjidi.2024.100324%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Langerhans%20Cells%20Directly%20Interact%20with%20Resident%20T%20Cells%20in%20the%20Human%20Epidermis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomonori%22%2C%22lastName%22%3A%22Oka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatsuya%22%2C%22lastName%22%3A%22Hasegawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Truelian%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%20S.%22%2C%22lastName%22%3A%22Oliver-Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahsa%22%2C%22lastName%22%3A%22Mortaja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marjan%22%2C%22lastName%22%3A%22Azin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satoshi%22%2C%22lastName%22%3A%22Horiba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%20S.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Khattab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20E.%22%2C%22lastName%22%3A%22Trerice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20T.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yevgeniy%20R.%22%2C%22lastName%22%3A%22Semenov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shadmehr%22%2C%22lastName%22%3A%22Demehri%22%7D%5D%2C%22abstractNote%22%3A%22Adult%20human%20skin%20contains%20nearly%20twice%20as%20many%20T%20cells%20as%20the%20peripheral%20blood%2C%20which%20include%20tissue-resident%20memory%20T%20cells.%20However%2C%20the%20precise%20mechanisms%20maintaining%20tissue-resident%20memory%20T%20cells%20in%20the%20healthy%20skin%20remain%20unclear.%20Using%20normal%20human%20skin%20samples%2C%20we%20find%20that%20Langerhans%20cells%20%28LCs%29%20contact%20T%20cells%20in%20the%20epidermis%20of%20the%20elderly.%20LCs%20with%20high%20HLA-II%2C%20CD86%2C%20and%20PD-L2%20expression%20directly%20contacted%20PD-1%2B%20tissue-resident%20memory%20T%20cells%20and%20CTLA-4%2B%20regulatory%20T%20cells%20in%20the%20epidermis%2C%20indicating%20an%20axis%20of%20peripheral%20tolerance%20in%20a%20steady%20state.%20Environmental%20insults%2C%20UVB%20radiation%2C%20and%20hapten%20downregulated%20HLA-II%20and%20CD86%20on%20LCs%20in%20the%20epidermis%2C%20suggesting%20that%20disruption%20of%20LC-T%20cell%20tolerogenic%20axis%20contributes%20to%20skin%20inflammation.%20Interestingly%2C%20immune%20checkpoint%20blockade%20therapy%20was%20associated%20with%20decreased%20epidermal%20LC-T%20cell%20contact%20in%20the%20normal%20skin%20of%20patients%20with%20cancer%20affected%20by%20cutaneous%20immune-related%20adverse%20events.%20Collectively%2C%20our%20findings%20indicate%20that%20LCs%20may%20contribute%20to%20T%20cell%20tolerance%20in%20the%20epidermis.%22%2C%22date%22%3A%222025-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xjidi.2024.100324%22%2C%22ISSN%22%3A%222667-0267%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-02-11T14%3A04%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22K27QX57C%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mollaoglu%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-26%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMollaoglu%2C%20G.%2C%20Tepper%2C%20A.%2C%20Falcomat%26%23xE0%3B%2C%20C.%2C%20Potak%2C%20H.%20T.%2C%20Pia%2C%20L.%2C%20Amabile%2C%20A.%2C%20Mateus-Tique%2C%20J.%2C%20Rabinovich%2C%20N.%2C%20Park%2C%20M.%20D.%2C%20LaMarche%2C%20N.%20M.%2C%20Brody%2C%20R.%2C%20Browning%2C%20L.%2C%20Lin%2C%20J.-R.%2C%20Zamarin%2C%20D.%2C%20Sorger%2C%20P.%20K.%2C%20Santagata%2C%20S.%2C%20Merad%2C%20M.%2C%20Baccarini%2C%20A.%2C%20%26amp%3B%20Brown%2C%20B.%20D.%20%282024%29.%20Ovarian%20cancer-derived%20IL-4%20promotes%20immunotherapy%20resistance.%20%3Ci%3ECell%3C%5C%2Fi%3E%2C%20%3Ci%3E187%3C%5C%2Fi%3E%2826%29%2C%207492-7510.e22.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cell.2024.10.006%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cell.2024.10.006%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ovarian%20cancer-derived%20IL-4%20promotes%20immunotherapy%20resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gurkan%22%2C%22lastName%22%3A%22Mollaoglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Tepper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Falcomat%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hunter%20T.%22%2C%22lastName%22%3A%22Potak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisanna%22%2C%22lastName%22%3A%22Pia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelo%22%2C%22lastName%22%3A%22Amabile%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaime%22%2C%22lastName%22%3A%22Mateus-Tique%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noam%22%2C%22lastName%22%3A%22Rabinovich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20D.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nelson%20M.%22%2C%22lastName%22%3A%22LaMarche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Brody%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22Browning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dmitriy%22%2C%22lastName%22%3A%22Zamarin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Merad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessia%22%2C%22lastName%22%3A%22Baccarini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20D.%22%2C%22lastName%22%3A%22Brown%22%7D%5D%2C%22abstractNote%22%3A%22Ovarian%20cancer%20is%20resistant%20to%20immunotherapy%2C%20and%20this%20is%20influenced%20by%20the%20immunosuppressed%20tumor%20microenvironment%20%28TME%29%20dominated%20by%20macrophages.%20Resistance%20is%20also%20affected%20by%20intratumoral%20heterogeneity%2C%20whose%20development%20is%20poorly%20understood.%20To%20identify%20regulators%20of%20ovarian%20cancer%20immunity%2C%20we%20employed%20a%20spatial%20functional%20genomics%20screen%20%28Perturb-map%29%2C%20focused%20on%20receptor%5C%2Fligands%20hypothesized%20to%20be%20involved%20in%20tumor-macrophage%20communication.%20Perturb-map%20recapitulated%20tumor%20heterogeneity%20and%20revealed%20that%20interleukin-4%20%28IL-4%29%20promotes%20resistance%20to%20anti-PD-1.%20We%20find%20ovarian%20cancer%20cells%20are%20the%20key%20source%20of%20IL-4%2C%20which%20directs%20the%20formation%20of%20an%20immunosuppressive%20TME%20via%20macrophage%20control.%20IL-4%20loss%20was%20not%20compensated%20by%20nearby%20IL-4-expressing%20clones%2C%20revealing%20short-range%20regulation%20of%20TME%20composition%20dictating%20tumor%20evolution.%20Our%20studies%20show%20heterogeneous%20TMEs%20can%20emerge%20from%20localized%20altered%20expression%20of%20cancer-derived%20cytokines%5C%2Fchemokines%20that%20establish%20immune-rich%20and%20immune-excluded%20neighborhoods%2C%20which%20drive%20clone%20selection%20and%20immunotherapy%20resistance.%20They%20also%20demonstrate%20the%20potential%20of%20targeting%20IL-4%20signaling%20to%20enhance%20ovarian%20cancer%20response%20to%20immunotherapy.%22%2C%22date%22%3A%222024-12-26%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2024.10.006%22%2C%22ISSN%22%3A%221097-4172%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-15T17%3A18%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22AJSV43N4%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kader%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKader%2C%20T.%2C%20Lin%2C%20J.-R.%2C%20Hug%2C%20C.%20B.%2C%20Coy%2C%20S.%2C%20Chen%2C%20Y.-A.%2C%20de%20Bruijn%2C%20I.%2C%20Shih%2C%20N.%2C%20Jung%2C%20E.%2C%20Pelletier%2C%20R.%20J.%2C%20Lopez%20Leon%2C%20M.%2C%20Mingo%2C%20G.%2C%20Omran%2C%20D.%20K.%2C%20Lee%2C%20J.%20S.%2C%20Yapp%2C%20C.%2C%20Satravada%2C%20B.%20A.%2C%20Kundra%2C%20R.%2C%20Xu%2C%20Y.%2C%20Chan%2C%20S.%2C%20Tefft%2C%20J.%20B.%2C%20%26%23x2026%3B%20Santagata%2C%20S.%20%282024%29.%20Multimodal%20Spatial%20Profiling%20Reveals%20Immune%20Suppression%20and%20Microenvironment%20Remodeling%20in%20Fallopian%20Tube%20Precursors%20to%20High-Grade%20Serous%20Ovarian%20Carcinoma.%20%3Ci%3ECancer%20Discovery%3C%5C%2Fi%3E.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2159-8290.CD-24-1366%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2159-8290.CD-24-1366%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multimodal%20Spatial%20Profiling%20Reveals%20Immune%20Suppression%20and%20Microenvironment%20Remodeling%20in%20Fallopian%20Tube%20Precursors%20to%20High-Grade%20Serous%20Ovarian%20Carcinoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanjina%22%2C%22lastName%22%3A%22Kader%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%20B.%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ino%22%2C%22lastName%22%3A%22de%20Bruijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Euihye%22%2C%22lastName%22%3A%22Jung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%20J.%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Lopez%20Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Mingo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalia%20K.%22%2C%22lastName%22%3A%22Omran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Suk%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Baby%20A.%22%2C%22lastName%22%3A%22Satravada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ritika%22%2C%22lastName%22%3A%22Kundra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliann%20B.%22%2C%22lastName%22%3A%22Tefft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20H.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%20M.%22%2C%22lastName%22%3A%22Gysler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Agudo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Heath%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20W.%22%2C%22lastName%22%3A%22Drescher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronny%22%2C%22lastName%22%3A%22Drapkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22High-Grade%20Serous%20Ovarian%20Cancer%20%28HGSOC%29%20originates%20from%20fallopian%20tube%20%28FT%29%20precursors.%20However%2C%20the%20molecular%20changes%20that%20occur%20as%20precancerous%20lesions%20progress%20to%20HGSOC%20are%20not%20well%20understood.%20To%20address%20this%2C%20we%20integrated%20high-plex%20imaging%20and%20spatial%20transcriptomics%20to%20analyze%20human%20tissue%20samples%20at%20different%20stages%20of%20HGSOC%20development%2C%20including%20p53%20signatures%2C%20serous%20tubal%20intraepithelial%20carcinomas%20%28STIC%29%2C%20and%20invasive%20HGSOC.%20Our%20findings%20reveal%20immune%20modulating%20mechanisms%20within%20precursor%20epithelium%2C%20characterized%20by%20chromosomal%20instability%2C%20persistent%20interferon%20%28IFN%29%20signaling%2C%20and%20dysregulated%20innate%20and%20adaptive%20immunity.%20FT%20precursors%20display%20elevated%20expression%20of%20MHC-class%20I%2C%20including%20HLA-E%2C%20and%20IFN-stimulated%20genes%2C%20typically%20linked%20to%20later-stage%20tumorigenesis.%20These%20molecular%20alterations%20coincide%20with%20progressive%20shifts%20in%20the%20tumor%20microenvironment%2C%20transitioning%20from%20immune%20surveillance%20in%20early%20STICs%20to%20immune%20suppression%20in%20advanced%20STICs%20and%20cancer.%20These%20insights%20identify%20potential%20biomarkers%20and%20therapeutic%20targets%20for%20HGSOC%20interception%20and%20clarify%20the%20molecular%20transitions%20from%20precancer%20to%20cancer.%22%2C%22date%22%3A%222024-12-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-24-1366%22%2C%22ISSN%22%3A%222159-8290%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-28T21%3A21%3A09Z%22%7D%7D%2C%7B%22key%22%3A%2272XL4YQK%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Girnius%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGirnius%2C%20N.%2C%20Henstridge%2C%20A.%20Z.%2C%20Marks%2C%20B.%2C%20Yu%2C%20J.%20K.%2C%20Gray%2C%20G.%20K.%2C%20Sander%2C%20C.%2C%20Zervantonakis%2C%20I.%20K.%2C%20%26amp%3B%20Luna%2C%20A.%20%282024%29.%20Cilengitide%20sensitivity%20is%20predicted%20by%20overall%20integrin%20expression%20in%20breast%20cancer.%20%3Ci%3EBreast%20Cancer%20Research%3A%20BCR%3C%5C%2Fi%3E%2C%20%3Ci%3E26%3C%5C%2Fi%3E%281%29%2C%20187.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13058-024-01942-2%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13058-024-01942-2%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cilengitide%20sensitivity%20is%20predicted%20by%20overall%20integrin%20expression%20in%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nomeda%22%2C%22lastName%22%3A%22Girnius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aylin%20Z.%22%2C%22lastName%22%3A%22Henstridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Marks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20K.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Kenneth%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Sander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioannis%20K.%22%2C%22lastName%22%3A%22Zervantonakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Augustin%22%2C%22lastName%22%3A%22Luna%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Treatment%20options%20for%20triple-negative%20breast%20cancer%20%28TNBC%29%20are%20limited%20and%20patients%20face%20a%20poor%20prognosis.%20Here%2C%20we%20sought%20to%20identify%20drugs%20that%20target%20TNBC%20vulnerabilities%20and%20understand%20the%20biology%20underlying%20these%20responses.%20We%20analyzed%20the%20Broad%20Institute%20DepMap%20to%20identify%20recurrent%20TNBC%20vulnerabilities%20and%20performed%20a%2045-compound%20screen%20on%20vulnerability-related%20pathways%20on%20a%20set%20of%20up%20to%208%20TNBC%20cell%20lines.%20We%20identified%20a%20subset%20of%20cell%20lines%20with%20an%20ITGAV%20vulnerability%20and%20a%20differential%20sensitivity%20to%20cilengitide%2C%20an%20integrin%20inhibitor%20targeting%20ITGAV%3AITGB3%20and%20ITGAV%3AITGB5.%20Next%2C%20we%20sought%20to%20understand%20cilengitide%20resistance%20and%20response%20biomarkers.%20Clinical%20trials%20targeting%20integrins%20continue%20enrolling%20patients%2C%20necessitating%20an%20understanding%20of%20how%20these%20drugs%20affect%20tumors.%5CnMETHODS%3A%20We%20combined%20in%20vitro%20assays%20with%20computational%20approaches%20to%20systematically%20explore%20the%20differential%20sensitivity%20to%20cilengitide%20and%20resistance%20mechanisms.%20We%20tested%20an%20additional%20pan-ITGAV%20inhibitor%20%28GLPG0187%29%20to%20determine%20how%20generalizable%20our%20findings%20on%20cilengitide%20sensitivity%20might%20be%20to%20integrin%20inhibition.%20ITGB4%2C%20ITGA3%2C%20and%20ITGA6%20knockdown%20experiments%20assessed%20the%20importance%20of%20integrin%20monomers%20in%20cell%20attachment%20during%20cilengitide%20treatment.%20Additionally%2C%20we%20explored%20the%20role%20of%20extracellular%20matrix%20%28ECM%29%20proteins%20in%20cilengitide%20response%20by%20performing%20cell%20replating%20experiments%20and%20by%20culturing%20on%20collagen%2C%20fibronectin%2C%20or%20laminin%20coated%20plates.%5CnRESULTS%3A%20We%20discovered%20that%20cell-derived%20ECM%20modulates%20cilengitide%20sensitivity%20and%20exogenous%20fibronectin%20addition%20conferred%20resistance%20to%20all%20sensitive%20TNBC%20cell%20lines%2C%20though%20fibronectin%20expression%20did%20not%20correlate%20with%20sensitivity.%20Instead%2C%20elevated%20overall%20integrin%20protein%20levels%2C%20not%20specific%20integrins%2C%20in%20TNBC%20cells%20positively%20correlated%20with%20resistance.%20This%20suggested%20that%20high%20pan-integrin%20expression%20promotes%20cilengitide%20resistance.%20Thus%2C%20we%20tested%20cilengitide%20in%20six%20luminal%20breast%20cancer%20cell%20lines%20%28which%20have%20low%20integrin%20levels%29%3B%20all%20were%20sensitive.%20Also%2C%20pan-ITGAV%20inhibitor%2C%20GLPG0187%2C%20showed%20the%20same%20sensitivity%20profile%20across%20our%20TNBC%20cell%20lines%2C%20suggesting%20our%20findings%20apply%20to%20other%20integrin%20inhibitors.%5CnCONCLUSIONS%3A%20Integrin%20inhibitors%20are%20appealing%20candidates%20to%20pursue%20as%20anti-cancer%20drugs%20because%20they%20are%20generally%20well-tolerated%2C%20but%20their%20efficacy%20is%20mixed%2C%20possibly%20due%20to%20the%20absence%20of%20predictive%20markers.%20Cilengitide%20induces%20death%20in%20breast%20cancer%20cells%20with%20low%20integrin%20abundance%2C%20where%20complementary%20ECM%20promotes%20survival.%20Thus%2C%20integrin%20inhibition%20in%20breast%20cancer%20warrants%20further%20study.%22%2C%22date%22%3A%222024-12-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13058-024-01942-2%22%2C%22ISSN%22%3A%221465-542X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-06T15%3A12%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22ULE9PA2Y%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Letai%20and%20de%20The%22%2C%22parsedDate%22%3A%222024-12-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELetai%2C%20A.%2C%20%26amp%3B%20de%20The%2C%20H.%20%282024%29.%20Conventional%20chemotherapy%3A%20millions%20of%20cures%2C%20unresolved%20therapeutic%20index.%20%3Ci%3ENature%20Reviews.%20Cancer%3C%5C%2Fi%3E.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41568-024-00778-4%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41568-024-00778-4%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Conventional%20chemotherapy%3A%20millions%20of%20cures%2C%20unresolved%20therapeutic%20index%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Letai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugues%22%2C%22lastName%22%3A%22de%20The%22%7D%5D%2C%22abstractNote%22%3A%22In%20recent%20decades%2C%20millions%20of%20patients%20with%20cancer%20have%20been%20cured%20by%20chemotherapy%20alone.%20By%20%27cure%27%2C%20we%20mean%20that%20patients%20with%20cancers%20that%20would%20be%20fatal%20if%20left%20untreated%20receive%20a%20time-limited%20course%20of%20chemotherapy%20and%20their%20cancer%20disappears%2C%20never%20to%20return.%20In%20an%20era%20when%20hundreds%20of%20thousands%20of%20cancer%20genomes%20have%20been%20sequenced%2C%20a%20remarkable%20fact%20persists%3A%20in%20most%20patients%20who%20have%20been%20cured%2C%20we%20still%20do%20not%20fully%20understand%20the%20mechanisms%20underlying%20the%20therapeutic%20index%20by%20which%20the%20tumour%20cells%20are%20killed%2C%20but%20normal%20cells%20are%20somehow%20spared.%20In%20contrast%2C%20in%20more%20recent%20years%2C%20patients%20with%20cancer%20have%20benefited%20from%20targeted%20therapies%20that%20usually%20do%20not%20cure%20but%20whose%20mechanisms%20of%20therapeutic%20index%20are%2C%20at%20least%20superficially%2C%20understood.%20In%20this%20Perspective%2C%20we%20will%20explore%20the%20various%20and%20sometimes%20contradictory%20models%20that%20have%20attempted%20to%20explain%20why%20chemotherapy%20can%20cure%20some%20patients%20with%20cancer%2C%20and%20what%20gaps%20in%20our%20understanding%20of%20the%20therapeutic%20index%20of%20chemotherapy%20remain%20to%20be%20filled.%20We%20will%20summarize%20principles%20which%20have%20benefited%20curative%20conventional%20chemotherapy%20regimens%20in%20the%20past%2C%20principles%20which%20might%20be%20deployed%20in%20constructing%20combinations%20that%20include%20modern%20targeted%20therapies.%22%2C%22date%22%3A%222024-12-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41568-024-00778-4%22%2C%22ISSN%22%3A%221474-1768%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-06T15%3A14%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22K3DA49MG%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Yu%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EYu%2C%20W.-W.%2C%20Barrett%2C%20J.%20N.%20P.%2C%20Tong%2C%20J.%2C%20Lin%2C%20M.-J.%2C%20Marohn%2C%20M.%2C%20Devlin%2C%20J.%20C.%2C%20Herrera%2C%20A.%2C%20Remark%2C%20J.%2C%20Levine%2C%20J.%2C%20Liu%2C%20P.-K.%2C%20Fang%2C%20V.%2C%20Zellmer%2C%20A.%20M.%2C%20Oldridge%2C%20D.%20A.%2C%20Wherry%2C%20E.%20J.%2C%20Lin%2C%20J.-R.%2C%20Chen%2C%20J.-Y.%2C%20Sorger%2C%20P.%2C%20Santagata%2C%20S.%2C%20Krueger%2C%20J.%20G.%2C%20%26%23x2026%3B%20Lu%2C%20C.%20P.%20%282024%29.%20Skin%20immune-mesenchymal%20interplay%20within%20tertiary%20lymphoid%20structures%20promotes%20autoimmunepathogenesis%20in%20hidradenitis%20suppurativa.%20%3Ci%3EImmunity%3C%5C%2Fi%3E%2C%20%3Ci%3E57%3C%5C%2Fi%3E%2812%29%2C%202827-2842.e5.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.immuni.2024.11.010%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.immuni.2024.11.010%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Skin%20immune-mesenchymal%20interplay%20within%20tertiary%20lymphoid%20structures%20promotes%20autoimmunepathogenesis%20in%20hidradenitis%20suppurativa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Wen%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joy%20N.%20P.%22%2C%22lastName%22%3A%22Barrett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Tong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng-Ju%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meaghan%22%2C%22lastName%22%3A%22Marohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20C.%22%2C%22lastName%22%3A%22Devlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alberto%22%2C%22lastName%22%3A%22Herrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliana%22%2C%22lastName%22%3A%22Remark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamie%22%2C%22lastName%22%3A%22Levine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pei-Kang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victoria%22%2C%22lastName%22%3A%22Fang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abigail%20M.%22%2C%22lastName%22%3A%22Zellmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derek%20A.%22%2C%22lastName%22%3A%22Oldridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20John%22%2C%22lastName%22%3A%22Wherry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20G.%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%20V.%22%2C%22lastName%22%3A%22Ruggles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chang%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergei%20B.%22%2C%22lastName%22%3A%22Koralov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernest%20S.%22%2C%22lastName%22%3A%22Chiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20P.%22%2C%22lastName%22%3A%22Lu%22%7D%5D%2C%22abstractNote%22%3A%22Hidradenitis%20suppurativa%20%28HS%29%20is%20a%20chronic%2C%20debilitating%20inflammatory%20skin%20disease%20characterized%20by%20keratinized%20epithelial%20tunnels%20that%20grow%20deeply%20into%20the%20dermis.%20Here%2C%20we%20examined%20the%20immune%20microenvironment%20within%20human%20HS%20lesions.%20Multi-omics%20profiling%20and%20multiplexed%20imaging%20identified%20tertiary%20lymphoid%20structures%20%28TLSs%29%20near%20HS%20tunnels.%20These%20TLSs%20were%20enriched%20with%20proliferative%20T%5Cu00a0cells%2C%20including%20follicular%20helper%20%28Tfh%29%2C%20regulatory%20%28Treg%29%2C%20and%20pathogenic%20T%5Cu00a0cells%20%28IL17A%2B%20and%20IFNG%2B%29%2C%20alongside%20extensive%20clonal%20expansion%20of%20plasma%20cells%20producing%20antibodies%20reactive%20to%20keratinocytes.%20HS%20fibroblasts%20express%20CXCL13%20or%20CCL19%20in%20response%20to%20immune%20cytokines.%20Using%20a%20microfluidic%20system%20to%20mimic%20TLS%20on%20a%20chip%2C%20we%20found%20that%20HS%20fibroblasts%20critically%20orchestrated%20lymphocyte%20aggregation%20via%20tumor%20necrosis%20factor%20alpha%20%28TNF-%5Cu03b1%29-CXCL13%20and%20TNF-%5Cu03b1-CCL19%20feedback%20loops%20with%20B%20and%20T%5Cu00a0cells%2C%20respectively%3B%20early%20TNF-%5Cu03b1%20blockade%20suppressed%20aggregate%20initiation.%20Our%20findings%20provide%20insights%20into%20TLS%20formation%20in%20the%20skin%2C%20suggest%20therapeutic%20avenues%20for%20HS%2C%20and%20reveal%20mechanisms%20that%20may%20apply%20to%20other%20autoimmune%20settings%2C%20including%20Crohn%27s%20disease.%22%2C%22date%22%3A%222024-12-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.immuni.2024.11.010%22%2C%22ISSN%22%3A%221097-4180%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-15T16%3A04%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22VWZ4SC8R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Launonen%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELaunonen%2C%20I.-M.%2C%20Niemiec%2C%20I.%2C%20Hincapi%26%23xE9%3B-Otero%2C%20M.%2C%20Erkan%2C%20E.%20P.%2C%20Junquera%2C%20A.%2C%20Afenteva%2C%20D.%2C%20Falco%2C%20M.%20M.%2C%20Liang%2C%20Z.%2C%20Salko%2C%20M.%2C%20Chamchougia%2C%20F.%2C%20Szabo%2C%20A.%2C%20Perez-Villatoro%2C%20F.%2C%20Li%2C%20Y.%2C%20Micoli%2C%20G.%2C%20Nagaraj%2C%20A.%2C%20Haltia%2C%20U.-M.%2C%20Kahelin%2C%20E.%2C%20Oikkonen%2C%20J.%2C%20Hynninen%2C%20J.%2C%20%26%23x2026%3B%20F%26%23xE4%3Brkkil%26%23xE4%3B%2C%20A.%20%282024%29.%20Chemotherapy%20induces%20myeloid-driven%20spatially%20confined%20T%26%23xA0%3Bcell%20exhaustion%20in%20ovarian%20cancer.%20%3Ci%3ECancer%20Cell%3C%5C%2Fi%3E%2C%20%3Ci%3E42%3C%5C%2Fi%3E%2812%29%2C%202045-2063.e10.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ccell.2024.11.005%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ccell.2024.11.005%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chemotherapy%20induces%20myeloid-driven%20spatially%20confined%20T%5Cu00a0cell%20exhaustion%20in%20ovarian%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inga-Maria%22%2C%22lastName%22%3A%22Launonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iga%22%2C%22lastName%22%3A%22Niemiec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%22%2C%22lastName%22%3A%22Hincapi%5Cu00e9-Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erdogan%20Pekcan%22%2C%22lastName%22%3A%22Erkan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ada%22%2C%22lastName%22%3A%22Junquera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daria%22%2C%22lastName%22%3A%22Afenteva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matias%20M.%22%2C%22lastName%22%3A%22Falco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhihan%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matilda%22%2C%22lastName%22%3A%22Salko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Foteini%22%2C%22lastName%22%3A%22Chamchougia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Szabo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Perez-Villatoro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22Micoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Nagaraj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulla-Maija%22%2C%22lastName%22%3A%22Haltia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Essi%22%2C%22lastName%22%3A%22Kahelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaana%22%2C%22lastName%22%3A%22Oikkonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johanna%22%2C%22lastName%22%3A%22Hynninen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anni%22%2C%22lastName%22%3A%22Virtanen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sampsa%22%2C%22lastName%22%3A%22Hautaniemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22V%5Cu00e4h%5Cu00e4rautio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anniina%22%2C%22lastName%22%3A%22F%5Cu00e4rkkil%5Cu00e4%22%7D%5D%2C%22abstractNote%22%3A%22Anti-tumor%20immunity%20is%20crucial%20for%20high-grade%20serous%20ovarian%20cancer%20%28HGSC%29%20prognosis%2C%20yet%20its%20adaptation%20upon%20standard%20chemotherapy%20remains%20poorly%20understood.%20Here%2C%20we%20conduct%20spatial%20and%20molecular%20characterization%20of%20117%20HGSC%20samples%20collected%20before%20and%20after%20chemotherapy.%20Our%20single-cell%20and%20spatial%20analyses%20reveal%20increasingly%20versatile%20immune%20cell%20states%20forming%20spatiotemporally%20dynamic%20microcommunities.%20We%20describe%20Myelonets%2C%20networks%20of%20interconnected%20myeloid%20cells%20that%20contribute%20to%20CD8%2B%20T%5Cu00a0cell%20exhaustion%20post-chemotherapy%20and%20show%20that%20M1%5C%2FM2%20polarization%20at%20the%20tumor-stroma%20interface%20is%20associated%20with%20CD8%2B%20T%5Cu00a0cell%20exhaustion%20and%20exclusion%2C%20correlating%20with%20poor%20chemoresponse.%20Single-cell%20and%20spatial%20transcriptomics%20reveal%20prominent%20myeloid-T%20cell%20interactions%20via%20NECTIN2-TIGIT%20induced%20by%20chemotherapy.%20Targeting%20these%20interactions%20using%20a%20functional%20patient-derived%20immuno-oncology%20platform%20demonstrates%20that%20high%20NECTIN2-TIGIT%20signaling%20in%20matched%20tumors%20predicts%20responses%20to%20immune%20checkpoint%20blockade.%20Our%20discovery%20of%20clinically%20relevant%20myeloid-driven%20spatial%20T%5Cu00a0cell%20exhaustion%20unlocks%20immunotherapeutic%20strategies%20to%20unleash%20CD8%2B%20T%5Cu00a0cell-mediated%20anti-tumor%20immunity%20in%20HGSC.%22%2C%22date%22%3A%222024-12-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2024.11.005%22%2C%22ISSN%22%3A%221878-3686%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-02-28T15%3A49%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22U6N5QSRP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Loi%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELoi%2C%20P.%2C%20Schade%2C%20A.%20E.%2C%20Rodriguez%2C%20C.%20L.%2C%20Krishnan%2C%20A.%2C%20Perurena%2C%20N.%2C%20Nguyen%2C%20V.%20T.%20M.%2C%20Xu%2C%20Y.%2C%20Watanabe%2C%20M.%2C%20Davis%2C%20R.%20A.%2C%20Gardner%2C%20A.%2C%20Pilla%2C%20N.%20F.%2C%20Mattioli%2C%20K.%2C%20Popow%2C%20O.%2C%20Gunduz%2C%20N.%2C%20Lannagan%2C%20T.%20R.%20M.%2C%20Fitzgerald%2C%20S.%2C%20Sicinska%2C%20E.%20T.%2C%20Lin%2C%20J.-R.%2C%20Tan%2C%20W.%2C%20%26%23x2026%3B%20Cichowski%2C%20K.%20%282024%29.%20Epigenetic%20and%20Oncogenic%20Inhibitors%20Cooperatively%20Drive%20Differentiation%20and%20Kill%20KRAS-Mutant%20Colorectal%20Cancers.%20%3Ci%3ECancer%20Discovery%3C%5C%2Fi%3E%2C%20%3Ci%3E14%3C%5C%2Fi%3E%2812%29%2C%202430%26%23x2013%3B2449.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2159-8290.CD-23-0866%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2159-8290.CD-23-0866%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Epigenetic%20and%20Oncogenic%20Inhibitors%20Cooperatively%20Drive%20Differentiation%20and%20Kill%20KRAS-Mutant%20Colorectal%20Cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Loi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20E.%22%2C%22lastName%22%3A%22Schade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20L.%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjana%22%2C%22lastName%22%3A%22Krishnan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naiara%22%2C%22lastName%22%3A%22Perurena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20T.%20M.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Watanabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20A.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alycia%22%2C%22lastName%22%3A%22Gardner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20F.%22%2C%22lastName%22%3A%22Pilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaia%22%2C%22lastName%22%3A%22Mattioli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olesja%22%2C%22lastName%22%3A%22Popow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nuray%22%2C%22lastName%22%3A%22Gunduz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamsin%20R.%20M.%22%2C%22lastName%22%3A%22Lannagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%22%2C%22lastName%22%3A%22Fitzgerald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ewa%20T.%22%2C%22lastName%22%3A%22Sicinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20K.%22%2C%22lastName%22%3A%22Brais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20M.%22%2C%22lastName%22%3A%22Haigis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marios%22%2C%22lastName%22%3A%22Giannakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimmie%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristian%22%2C%22lastName%22%3A%22Helin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Owen%20J.%22%2C%22lastName%22%3A%22Sansom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Cichowski%22%7D%5D%2C%22abstractNote%22%3A%22Combined%20EZH2%20and%20RAS%20pathway%20inhibitors%20kill%20KRAS-mutant%20colorectal%20cancer%20cells%20and%20promote%20durable%20tumor%20regression%20in%20vivo.%20These%20agents%20function%20by%20cooperatively%20suppressing%20the%20WNT%20pathway%2C%20driving%20differentiation%2C%20and%20epigenetically%20reprogramming%20cells%20to%20permit%20the%20induction%20of%20apoptotic%20signals%2C%20which%20then%20kill%20these%20more%20differentiated%20tumor%20cells.%22%2C%22date%22%3A%222024-12-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-23-0866%22%2C%22ISSN%22%3A%222159-8290%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-12-04T17%3A39%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22TU5GP63R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tobochnik%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ETobochnik%2C%20S.%2C%20Regan%2C%20M.%20S.%2C%20Dorotan%2C%20M.%20K.%20C.%2C%20Reich%2C%20D.%2C%20Lapinskas%2C%20E.%2C%20Hossain%2C%20M.%20A.%2C%20Stopka%2C%20S.%2C%20Meredith%2C%20D.%20M.%2C%20Santagata%2C%20S.%2C%20Murphy%2C%20M.%20M.%2C%20Arnaout%2C%20O.%2C%20Bi%2C%20W.%20L.%2C%20Chiocca%2C%20E.%20A.%2C%20Golby%2C%20A.%20J.%2C%20Mooney%2C%20M.%20A.%2C%20Smith%2C%20T.%20R.%2C%20Ligon%2C%20K.%20L.%2C%20Wen%2C%20P.%20Y.%2C%20Agar%2C%20N.%20Y.%20R.%2C%20%26amp%3B%20Lee%2C%20J.%20W.%20%282024%29.%20Pilot%20Trial%20of%20Perampanel%20on%20Peritumoral%20Hyperexcitability%20in%20Newly%20Diagnosed%20High-grade%20Glioma.%20%3Ci%3EClinical%20Cancer%20Research%3A%20An%20Official%20Journal%20of%20the%20American%20Association%20for%20Cancer%20Research%3C%5C%2Fi%3E%2C%20%3Ci%3E30%3C%5C%2Fi%3E%2823%29%2C%205365%26%23x2013%3B5373.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-24-1849%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-24-1849%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pilot%20Trial%20of%20Perampanel%20on%20Peritumoral%20Hyperexcitability%20in%20Newly%20Diagnosed%20High-grade%20Glioma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Tobochnik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20K.%20C.%22%2C%22lastName%22%3A%22Dorotan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dustine%22%2C%22lastName%22%3A%22Reich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Lapinskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Amin%22%2C%22lastName%22%3A%22Hossain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Meredith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20M.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Arnaout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20J.%22%2C%22lastName%22%3A%22Golby%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Mooney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong%20Woo%22%2C%22lastName%22%3A%22Lee%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Glutamatergic%20neuron-glioma%20synaptogenesis%20and%20peritumoral%20hyperexcitability%20promote%20glioma%20growth%20in%20a%20positive%20feedback%20loop.%20The%20objective%20of%20this%20study%20was%20to%20evaluate%20the%20feasibility%20and%20estimated%20effect%20sizes%20of%20the%20targeted%20AMPA%20receptor%20antagonist%20perampanel%20on%20peritumoral%20hyperexcitability.%5CnEXPERIMENTAL%20DESIGN%3A%20An%20open-label%20trial%20was%20performed%20comparing%20perampanel%20with%20standard%20of%20care%20%28SOC%29%20in%20patients%20undergoing%20resection%20of%20newly%20diagnosed%20radiologic%20high-grade%20glioma.%20Perampanel%20was%20administered%20as%20a%20preoperative%20loading%20dose%20followed%20by%20maintenance%20therapy%20until%20progressive%20disease%20or%20up%20to%2012%20months.%20SOC%20treatment%20involved%20levetiracetam%20for%207%20days%20or%20as%20clinically%20indicated.%20The%20primary%20outcome%20of%20hyperexcitability%20was%20defined%20by%20intraoperative%20electrocorticography%20high-frequency%20oscillation%20%28HFO%29%20rates.%20Seizure%20freedom%20and%20overall%20survival%20were%20estimated%20by%20the%20Kaplan-Meier%20method.%20Tissue%20concentrations%20of%20perampanel%2C%20levetiracetam%2C%20and%20correlative%20biomarkers%20were%20measured%20by%20mass%20spectrometry.%5CnRESULTS%3A%20HFO%20rates%20were%20similar%20between%20patients%20treated%20with%20perampanel%20and%20levetiracetam.%20The%20trial%20was%20terminated%20early%20after%20a%20planned%20interim%20analysis%2C%20and%20outcomes%20assessed%20in%2011%20patients%20%28seven%20perampanel%20treated%3B%20four%20treated%20with%20SOC%29.%20Over%20a%20median%20281%20days%20of%20postenrollment%20follow-up%2C%2027%25%20of%20patients%20had%20seizures%2C%20including%2014%25%20maintained%20on%20perampanel%20and%2050%25%20treated%20with%20SOC.%20Overall%20survival%20in%20perampanel-treated%20patients%20was%20similar%20to%20that%20in%20a%20glioblastoma%20reference%20cohort.%20Glutamate%20concentrations%20in%20surface%20biopsies%20were%20positively%20correlated%20with%20HFO%20rates%20in%20adjacent%20electrode%20contacts%20and%20were%20not%20significantly%20associated%20with%20treatment%20assignment%20or%20drug%20concentrations.%5CnCONCLUSIONS%3A%20Glioma%20peritumoral%20glutamate%20concentrations%20correlated%20with%20high-gamma%20oscillation%20rates.%20Targeting%20glutamatergic%20activity%20with%20perampanel%20achieved%20similar%20electrocorticographic%20hyperexcitability%20levels%20as%20in%20levetiracetam-treated%20patients.%22%2C%22date%22%3A%222024-12-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1158%5C%2F1078-0432.CCR-24-1849%22%2C%22ISSN%22%3A%221557-3265%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-12-04T17%3A40%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22CFKPMF4J%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Baker%20et%20al.%22%2C%22parsedDate%22%3A%222024-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBaker%2C%20G.%20J.%2C%20Novikov%2C%20E.%2C%20Zhao%2C%20Z.%2C%20Vallius%2C%20T.%2C%20Davis%2C%20J.%20A.%2C%20Lin%2C%20J.-R.%2C%20Muhlich%2C%20J.%20L.%2C%20Mittendorf%2C%20E.%20A.%2C%20Santagata%2C%20S.%2C%20Guerriero%2C%20J.%20L.%2C%20%26amp%3B%20Sorger%2C%20P.%20K.%20%282024%29.%20Quality%20control%20for%20single-cell%20analysis%20of%20high-plex%20tissue%20profiles%20using%20CyLinter.%20%3Ci%3ENature%20Methods%3C%5C%2Fi%3E%2C%20%3Ci%3E21%3C%5C%2Fi%3E%2812%29%2C%202248%26%23x2013%3B2259.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41592-024-02328-0%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41592-024-02328-0%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Quality%20control%20for%20single-cell%20analysis%20of%20high-plex%20tissue%20profiles%20using%20CyLinter%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Novikov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziyuan%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janae%20A.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Tumors%20are%20complex%20assemblies%20of%20cellular%20and%20acellular%20structures%20patterned%20on%20spatial%20scales%20from%20microns%20to%20centimeters.%20Study%20of%20these%20assemblies%20has%20advanced%20dramatically%20with%20the%20introduction%20of%20high-plex%20spatial%20profiling.%20Image-based%20profiling%20methods%20reveal%20the%20intensities%20and%20spatial%20distributions%20of%2020-100%20proteins%20at%20subcellular%20resolution%20in%20103-107%20cells%20per%20specimen.%20Despite%20extensive%20work%20on%20methods%20for%20extracting%20single-cell%20data%20from%20these%20images%2C%20all%20tissue%20images%20contain%20artifacts%20such%20as%20folds%2C%20debris%2C%20antibody%20aggregates%2C%20optical%20aberrations%20and%20image%20processing%20errors%20that%20arise%20from%20imperfections%20in%20specimen%20preparation%2C%20data%20acquisition%2C%20image%20assembly%20and%20feature%20extraction.%20Here%20we%20show%20that%20these%20artifacts%20dramatically%20impact%20single-cell%20data%20analysis%2C%20obscuring%20meaningful%20biological%20interpretation.%20We%20describe%20an%20interactive%20quality%20control%20software%20tool%2C%20CyLinter%2C%20that%20identifies%20and%20removes%20data%20associated%20with%20imaging%20artifacts.%20CyLinter%20greatly%20improves%20single-cell%20analysis%2C%20especially%20for%20archival%20specimens%20sectioned%20many%20years%20before%20data%20collection%2C%20such%20as%20those%20from%20clinical%20trials.%22%2C%22date%22%3A%222024-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-024-02328-0%22%2C%22ISSN%22%3A%221548-7105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-01-21T19%3A50%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22E89QCNID%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Shimada%20et%20al.%22%2C%22parsedDate%22%3A%222024-11-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EShimada%2C%20K.%2C%20Michaud%2C%20D.%20E.%2C%20Cui%2C%20Y.%20X.%2C%20Zheng%2C%20K.%2C%20Goldberg%2C%20J.%2C%20Ju%2C%20Z.%2C%20Schnitt%2C%20S.%20J.%2C%20Pastorello%2C%20R.%2C%20Kania%2C%20L.%20D.%2C%20Hoffer%2C%20J.%2C%20Muhlich%2C%20J.%20L.%2C%20Hyun%2C%20N.%2C%20Krueger%2C%20R.%2C%20Gottlieb%2C%20A.%2C%20Nelson%2C%20A.%2C%20Wanderley%2C%20C.%20W.%2C%20Antonellis%2C%20G.%2C%20McAllister%2C%20S.%20S.%2C%20Tolaney%2C%20S.%20M.%2C%20%26%23x2026%3B%20Guerriero%2C%20J.%20L.%20%282024%29.%20%3Ci%3EAn%20estrogen%20receptor%20signaling%20transcriptional%20program%20linked%20to%20immune%20evasion%20in%20human%20hormone%20receptor-positive%20breast%20cancer%3C%5C%2Fi%3E%20%5BPreprint%5D.%20bioRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.11.23.619172%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.11.23.619172%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22An%20estrogen%20receptor%20signaling%20transcriptional%20program%20linked%20to%20immune%20evasion%20in%20human%20hormone%20receptor-positive%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenichi%22%2C%22lastName%22%3A%22Shimada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20E.%22%2C%22lastName%22%3A%22Michaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%20Xiaoyong%22%2C%22lastName%22%3A%22Cui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Goldberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhenlin%22%2C%22lastName%22%3A%22Ju%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stuart%20J.%22%2C%22lastName%22%3A%22Schnitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ricardo%22%2C%22lastName%22%3A%22Pastorello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%20D.%22%2C%22lastName%22%3A%22Kania%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hoffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhan%22%2C%22lastName%22%3A%22Hyun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Krueger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Gottlieb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Nelson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20W.%22%2C%22lastName%22%3A%22Wanderley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriella%22%2C%22lastName%22%3A%22Antonellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20S.%22%2C%22lastName%22%3A%22McAllister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrienne%20G.%22%2C%22lastName%22%3A%22Waks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rinath%22%2C%22lastName%22%3A%22Jeselsohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Agudo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20L.%22%2C%22lastName%22%3A%22Guerriero%22%7D%5D%2C%22abstractNote%22%3A%22T%20cells%20are%20generally%20sparse%20in%20hormone%20receptor-positive%20%28HR%2B%29%20breast%20cancer%2C%20potentially%20due%20to%20limited%20antigen%20presentation%2C%20but%20the%20driving%20mechanisms%20of%20low%20T%20cell%20abundance%20remains%20unclear.%20Therefore%2C%20we%20defined%20and%20investigated%20programs%20%28%27gene%20modules%27%29%2C%20related%20to%20estrogen%20receptor%20signaling%20%28ERS%29%20and%20immune%20signaling%20using%20bulk%20and%20single-cell%20transcriptome%20and%20multiplexed%20immunofluorescence%20of%20breast%20cancer%20tissues%20from%20multiple%20clinical%20sources%20and%20human%20cell%20lines.%20The%20ERS%20gene%20module%2C%20dominantly%20expressed%20in%20cancer%20cells%2C%20was%20negatively%20associated%20with%20immune-related%20gene%20modules%20TNF%5Cu03b1%5C%2FNF-%5Cu03baB%20signaling%20and%20type-I%20interferon%20%28IFN-I%29%20response%2C%20which%20were%20expressed%20in%20distinct%20stromal%20and%20immune%20cell%20types%2C%20but%20also%2C%20in%20part%2C%20expressed%20and%20preserved%20as%20a%20cancer%20cell-intrinsic%20mechanisms.%20Spatial%20analysis%20revealed%20that%20ERS%20strongly%20correlated%20with%20reduced%20T%20cell%20infiltration%2C%20potentially%20due%20to%20its%20association%20with%20suppression%20of%20TNF%5Cu03b1%5C%2FNF-%5Cu03baB-induced%20angiogenesis%20and%20IFN-I-induced%20HLA%20expression%20in%20macrophages.%20Preoperative%20endocrine%20therapy%20in%20ER%2B%5C%2FHER2-breast%20cancer%20patients%20produced%20better%20responses%20in%20ERS-high%20patients%2C%20with%20TNF%5Cu03b1%5C%2FNF-%5Cu03baB%20expression%20associated%20with%20reduced%20ERS.%20Targeting%20these%20pathways%20may%20enhance%20T%20cell%20infiltration%20in%20HR%2B%20breast%20cancer%20patients.%5CnSTATEMENT%20OF%20SIGNIFICANCE%3A%20This%20study%20elucidates%20the%20immunosuppressive%20role%20of%20ER%20signaling%20in%20breast%20cancer%2C%20highlighting%20a%20complex%20interplay%20between%20cancer%2C%20stromal%2C%20and%20immune%20cells%20and%20reveals%20potential%20approaches%20to%20enhance%20immunogenicity%20in%20HR%2B%20breast%20cancer.%20These%20findings%20offer%20crucial%20insights%20into%20immune%20evasion%20in%20breast%20cancer%20and%20identify%20strategies%20to%20enhance%20T%20cell%20abundance.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-11-25%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.11.23.619172%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T22%3A48%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22QJY6AUSU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rand%20et%20al.%22%2C%22parsedDate%22%3A%222024-11-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERand%2C%20E.%20A.%2C%20Owen%2C%20S.%20V.%2C%20Quinones-Olvera%2C%20N.%2C%20Jean%2C%20K.%20D.%20C.%2C%20Hernandez-Perez%2C%20C.%2C%20%26amp%3B%20Baym%2C%20M.%20%282024%29.%20%3Ci%3EPhage%20DisCo%3A%20targeted%20discovery%20of%20bacteriophages%20by%20co-culture%3C%5C%2Fi%3E%20%5BPreprint%5D.%20bioRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.11.22.624878%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.11.22.624878%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Phage%20DisCo%3A%20targeted%20discovery%20of%20bacteriophages%20by%20co-culture%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%20A.%22%2C%22lastName%22%3A%22Rand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Quinones-Olvera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kesther%20D.%20C.%22%2C%22lastName%22%3A%22Jean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%22%2C%22lastName%22%3A%22Hernandez-Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Phages%20interact%20with%20many%20components%20of%20bacterial%20physiology%20from%20the%20surface%20to%20the%20cytoplasm.%20Although%20there%20are%20methods%20to%20determine%20the%20receptors%20and%20intracellular%20systems%20a%20specified%20phage%20interacts%20with%20retroactively%2C%20finding%20a%20phage%20that%20interacts%20with%20a%20chosen%20piece%20of%20bacterial%20physiology%5Cn%20%20%20%20%20%20%20%20%20%20%20%20a%20priori%5Cn%20%20%20%20%20%20%20%20%20%20%20%20is%20very%20challenging.%20Variation%20in%20phage%20plaque%20morphology%20does%20not%20to%20reliably%20distinguish%20distinct%20phages%20and%20therefore%20many%20potentially%20redundant%20phages%20may%20need%20to%20be%20isolated%2C%20purified%2C%20and%20individually%20characterized%20to%20find%20phages%20of%20interest.%20Here%2C%20we%20present%20a%20method%20in%20which%20multiple%20bacterial%20strains%20are%20co-cultured%20on%20the%20same%20screening%20plate%20to%20add%20an%20extra%20dimension%20to%20plaque%20morphology%20data.%20In%20this%20method%2C%20Phage%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Dis%5Cn%20%20%20%20%20%20%20%20%20%20%20%20covery%20by%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Co%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-culture%20%28Phage%20DisCo%29%2C%20strains%20are%20isogenic%20except%20for%20fluorescent%20tags%20and%20one%20perturbation%20expected%20to%20impact%20phage%20infection.%20Differential%20plaquing%20on%20the%20strains%20is%20easily%20detectable%20by%20fluorescent%20signal%20and%20implies%20that%20the%20perturbation%20made%20to%20the%20surviving%20strain%20in%20a%20plaque%20prevents%20phage%20infection.%20We%20validate%20the%20phage%20DisCo%20method%20by%20showing%20that%20characterized%20phages%20have%20the%20expected%20plaque%20morphology%20on%20Phage%20DisCo%20plates%20and%20demonstrate%20the%20power%20of%20Phage%20DisCo%20for%20multiple%20targeted%20discovery%20applications%2C%20from%20receptors%20to%20phage%20defense%20systems.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-11-22%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.11.22.624878%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.biorxiv.org%5C%2Fcontent%5C%2F10.1101%5C%2F2024.11.22.624878v1%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A48%3A35Z%22%7D%7D%2C%7B%22key%22%3A%2237L7TMD8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Vaelli%20et%20al.%22%2C%22parsedDate%22%3A%222024-11-18%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVaelli%2C%20P.%2C%20Fujita%2C%20A.%2C%20Jo%2C%20S.%2C%20Zhang%2C%20H.-X.%20B.%2C%20Osorno%2C%20T.%2C%20Ma%2C%20X.%2C%20%26amp%3B%20Bean%2C%20B.%20P.%20%282024%29.%20State-Dependent%20Inhibition%20of%20Nav1.8%20Sodium%20Channels%20by%20VX-150%20and%20VX-548.%20%3Ci%3EMolecular%20Pharmacology%3C%5C%2Fi%3E%2C%20%3Ci%3E106%3C%5C%2Fi%3E%286%29%2C%20298%26%23x2013%3B308.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1124%5C%2Fmolpharm.124.000944%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1124%5C%2Fmolpharm.124.000944%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22State-Dependent%20Inhibition%20of%20Nav1.8%20Sodium%20Channels%20by%20VX-150%20and%20VX-548%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patric%22%2C%22lastName%22%3A%22Vaelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akie%22%2C%22lastName%22%3A%22Fujita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sooyeon%22%2C%22lastName%22%3A%22Jo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Han-Xiong%20Bear%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tom%5Cu00e1s%22%2C%22lastName%22%3A%22Osorno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20P.%22%2C%22lastName%22%3A%22Bean%22%7D%5D%2C%22abstractNote%22%3A%22Nav1.8%20sodium%20channels%20%28Nav1.8%29%20are%20an%20attractive%20therapeutic%20target%20for%20pain%20because%20they%20are%20prominent%20in%20primary%20pain-sensing%20neurons%20with%20little%20expression%20in%20most%20other%20kinds%20of%20neurons.%20Recently%2C%20two%20Nav1.8-targeted%20compounds%2C%20VX-150%20and%20VX-548%2C%20have%20shown%20efficacy%20in%20clinical%20trials%20for%20reducing%20pain.%20We%20examined%20the%20characteristics%20of%20Nav1.8%20inhibition%20by%20these%20compounds.%20The%20active%20metabolite%20form%20of%20VX-150%20%28VX-150m%29%20inhibited%20human%20Nav1.8%20channels%20with%20an%20IC50%20of%2015%20nM.%20VX-548%20%28suzetrigine%29%20was%20even%20more%20potent%20%28IC50%200.27%20nM%29.%20Both%20VX-150m%20and%20VX-548%20had%20the%20unusual%20property%20of%20%5C%22reverse%20use-dependence%2C%5C%22%20whereby%20inhibition%20could%20be%20relieved%20by%20repetitive%20depolarizations%2C%20a%20property%20seen%20before%20with%20another%20Nav1.8%20inhibitor%2C%20A-887826.%20The%20relief%20of%20VX-548%20inhibition%20by%20large%20depolarizations%20occurred%20with%20a%20time%20constant%20of%20%5Cu223c40%20milliseconds%20that%20was%20not%20concentration-dependent.%20Reinhibition%20at%20negative%20voltages%20occurred%20with%20a%20rate%20that%20was%20nearly%20proportional%20to%20drug%20concentration%2C%20consistent%20with%20the%20idea%20that%20relief%20of%20inhibition%20reflects%20dissociation%20of%20drug%20from%20the%20channel%20and%20reinhibition%20reflects%20rebinding.%20The%20relief%20of%20inhibition%20by%20depolarization%20suggests%20a%20remarkably%20strong%20and%20unusual%20state-dependence%20for%20both%20VX-150m%20and%20VX-548%2C%20with%20very%20weak%20binding%20to%20channels%20with%20fully%20activated%20voltage%20sensors%20despite%20very%20tight%20binding%20to%20channels%20with%20voltage%20sensors%20in%20the%20resting%20state.%20SIGNIFICANCE%20STATEMENT%3A%20The%20Nav1.8%20sodium%20channel%20%28Nav1.8%29%20is%20a%20current%20target%20for%20new%20drugs%20for%20pain.%20This%20work%20describes%20the%20potency%2C%20selectivity%2C%20and%20state-dependent%20characteristics%20of%20inhibition%20of%20Nav1.8%20channels%20by%20VX-150%20and%20VX-548%2C%20compounds%20that%20have%20recently%20shown%20efficacy%20for%20relief%20of%20pain%20in%20clinical%20trials%20but%20whose%20mechanism%20of%20interaction%20with%20channels%20has%20not%20been%20described.%20The%20results%20show%20that%20the%20compounds%20share%20an%20unusual%20property%20whereby%20inhibition%20is%20relieved%20by%20depolarization%2C%20demonstrating%20a%20state-dependence%20different%20from%20most%20sodium%20channel%20inhibitors.%22%2C%22date%22%3A%222024-11-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1124%5C%2Fmolpharm.124.000944%22%2C%22ISSN%22%3A%221521-0111%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-30T14%3A11%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22C82DPHGV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Souque%20et%20al.%22%2C%22parsedDate%22%3A%222024-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESouque%2C%20C.%2C%20Gonz%26%23xE1%3Blez%20Ojeda%2C%20I.%2C%20%26amp%3B%20Baym%2C%20M.%20%282024%29.%20From%20Petri%20Dishes%20to%20Patients%20to%20Populations%3A%20Scales%20and%20Evolutionary%20Mechanisms%20Driving%20Antibiotic%20Resistance.%20%3Ci%3EAnnual%20Review%20of%20Microbiology%3C%5C%2Fi%3E%2C%20%3Ci%3E78%3C%5C%2Fi%3E%281%29%2C%20361%26%23x2013%3B382.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1146%5C%2Fannurev-micro-041522-102707%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1146%5C%2Fannurev-micro-041522-102707%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20Petri%20Dishes%20to%20Patients%20to%20Populations%3A%20Scales%20and%20Evolutionary%20Mechanisms%20Driving%20Antibiotic%20Resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9lia%22%2C%22lastName%22%3A%22Souque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Indra%22%2C%22lastName%22%3A%22Gonz%5Cu00e1lez%20Ojeda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Tackling%20the%20challenge%20created%20by%20antibiotic%20resistance%20requires%20understanding%20the%20mechanisms%20behind%20its%20evolution.%20Like%20any%20evolutionary%20process%2C%20the%20evolution%20of%20antimicrobial%20resistance%20%28AMR%29%20is%20driven%20by%20the%20underlying%20variation%20in%20a%20bacterial%20population%20and%20the%20selective%20pressures%20acting%20upon%20it.%20Importantly%2C%20both%20selection%20and%20variation%20will%20depend%20on%20the%20scale%20at%20which%20resistance%20evolution%20is%20considered%20%28from%20evolution%20within%20a%20single%20patient%20to%20the%20host%20population%20level%29.%20While%20laboratory%20experiments%20have%20generated%20fundamental%20insights%20into%20the%20mechanisms%20underlying%20antibiotic%20resistance%20evolution%2C%20the%20technological%20advances%20in%20whole%20genome%20sequencing%20now%20allow%20us%20to%20probe%20antibiotic%20resistance%20evolution%20beyond%20the%20lab%20and%20directly%20record%20it%20in%20individual%20patients%20and%20host%20populations.%20Here%20we%20review%20the%20evolutionary%20forces%20driving%20antibiotic%20resistance%20at%20each%20of%20these%20scales%2C%20highlight%20gaps%20in%20our%20current%20understanding%20of%20AMR%20evolution%2C%20and%20discuss%20future%20steps%20toward%20evolution-guided%20interventions.%22%2C%22date%22%3A%222024-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1146%5C%2Fannurev-micro-041522-102707%22%2C%22ISSN%22%3A%221545-3251%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A48%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22VSPLVMKA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Schade%20et%20al.%22%2C%22parsedDate%22%3A%222024-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESchade%2C%20A.%20E.%2C%20Perurena%2C%20N.%2C%20Yang%2C%20Y.%2C%20Rodriguez%2C%20C.%20L.%2C%20Krishnan%2C%20A.%2C%20Gardner%2C%20A.%2C%20Loi%2C%20P.%2C%20Xu%2C%20Y.%2C%20Nguyen%2C%20V.%20T.%20M.%2C%20Mastellone%2C%20G.%20M.%2C%20Pilla%2C%20N.%20F.%2C%20Watanabe%2C%20M.%2C%20Ota%2C%20K.%2C%20Davis%2C%20R.%20A.%2C%20Mattioli%2C%20K.%2C%20Xiang%2C%20D.%2C%20Zoeller%2C%20J.%20J.%2C%20Lin%2C%20J.-R.%2C%20Morganti%2C%20S.%2C%20%26%23x2026%3B%20Cichowski%2C%20K.%20%282024%29.%20AKT%20and%20EZH2%20inhibitors%20kill%20TNBCs%20by%20hijacking%20mechanisms%20of%20involution.%20%3Ci%3ENature%3C%5C%2Fi%3E%2C%20%3Ci%3E635%3C%5C%2Fi%3E%288039%29%2C%20755%26%23x2013%3B763.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41586-024-08031-6%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41586-024-08031-6%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22AKT%20and%20EZH2%20inhibitors%20kill%20TNBCs%20by%20hijacking%20mechanisms%20of%20involution%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20E.%22%2C%22lastName%22%3A%22Schade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naiara%22%2C%22lastName%22%3A%22Perurena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoona%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carrie%20L.%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anjana%22%2C%22lastName%22%3A%22Krishnan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alycia%22%2C%22lastName%22%3A%22Gardner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Loi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilin%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20T.%20M.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20M.%22%2C%22lastName%22%3A%22Mastellone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20F.%22%2C%22lastName%22%3A%22Pilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Watanabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keiichi%22%2C%22lastName%22%3A%22Ota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20A.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaia%22%2C%22lastName%22%3A%22Mattioli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dongxi%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20J.%22%2C%22lastName%22%3A%22Zoeller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Morganti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20C.%22%2C%22lastName%22%3A%22Garrido-Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhe%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Barbie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristian%22%2C%22lastName%22%3A%22Helin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20R.%20V.%22%2C%22lastName%22%3A%22Knott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Cichowski%22%7D%5D%2C%22abstractNote%22%3A%22Triple-negative%20breast%20cancer%20%28TNBC%29%20is%20the%20most%20aggressive%20breast%20cancer%20subtype%20and%20has%20the%20highest%20rate%20of%20recurrence1.%20The%20predominant%20standard%20of%20care%20for%20advanced%20TNBC%20is%20systemic%20chemotherapy%20with%20or%20without%20immunotherapy%3B%20however%2C%20responses%20are%20typically%20short%20lived1%2C2.%20Thus%2C%20there%20is%20an%20urgent%20need%20to%20develop%20more%20effective%20treatments.%20Components%20of%20the%20PI3K%20pathway%20represent%20plausible%20therapeutic%20targets%3B%20more%20than%2070%25%20of%20TNBCs%20have%20alterations%20in%20PIK3CA%2C%20AKT1%20or%20PTEN3-6.%20However%2C%20in%20contrast%20to%20hormone-receptor-positive%20tumours%2C%20it%20is%20still%20unclear%20whether%20or%20how%20triple-negative%20disease%20will%20respond%20to%20PI3K%20pathway%20inhibitors7.%20Here%20we%20describe%20a%20promising%20AKT-inhibitor-based%20therapeutic%20combination%20for%20TNBC.%20Specifically%2C%20we%20show%20that%20AKT%20inhibitors%20synergize%20with%20agents%20that%20suppress%20the%20histone%20methyltransferase%20EZH2%20and%20promote%20robust%20tumour%20regression%20in%20multiple%20TNBC%20models%20in%20vivo.%20AKT%20and%20EZH2%20inhibitors%20exert%20these%20effects%20by%20first%20cooperatively%20driving%20basal-like%20TNBC%20cells%20into%20a%20more%20differentiated%2C%20luminal-like%20state%2C%20which%20cannot%20be%20effectively%20induced%20by%20either%20agent%20alone.%20Once%5Cu00a0TNBCs%20are%20differentiated%2C%20these%20agents%20kill%20them%20by%20hijacking%20signals%20that%20normally%20drive%20mammary%20gland%20involution.%20Using%20a%20machine%20learning%20approach%2C%20we%20developed%20a%20classifier%20that%20can%20be%20used%20to%20predict%20sensitivity.%20Together%2C%20these%20findings%20identify%20a%20promising%20therapeutic%20strategy%20for%20this%20highly%20aggressive%20tumour%20type%20and%20illustrate%20how%20deregulated%20epigenetic%20enzymes%20can%20insulate%20tumours%20from%20oncogenic%20vulnerabilities.%20These%20studies%20also%20reveal%20how%20developmental%20tissue-specific%20cell%20death%20pathways%20may%20be%20co-opted%20for%20therapeutic%20benefit.%22%2C%22date%22%3A%222024-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-024-08031-6%22%2C%22ISSN%22%3A%221476-4687%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-30T14%3A04%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22I6B3VFS9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lu%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELu%2C%20D.%2C%20Faizi%2C%20M.%2C%20Drown%2C%20B.%2C%20Simerzin%2C%20A.%2C%20Fran%26%23xE7%3Bois%2C%20J.%2C%20Bradshaw%2C%20G.%2C%20Kelleher%2C%20N.%2C%20Jambhekar%2C%20A.%2C%20Gunawardena%2C%20J.%2C%20%26amp%3B%20Lahav%2C%20G.%20%282024%29.%20Temporal%20regulation%20of%20gene%20expression%20through%20integration%20of%20p53%20dynamics%20and%20modifications.%20%3Ci%3EScience%20Advances%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E%2843%29%2C%20eadp2229.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.adp2229%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.adp2229%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Temporal%20regulation%20of%20gene%20expression%20through%20integration%20of%20p53%20dynamics%20and%20modifications%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marjan%22%2C%22lastName%22%3A%22Faizi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryon%22%2C%22lastName%22%3A%22Drown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alina%22%2C%22lastName%22%3A%22Simerzin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Fran%5Cu00e7ois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%22%2C%22lastName%22%3A%22Kelleher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashwini%22%2C%22lastName%22%3A%22Jambhekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Gunawardena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Galit%22%2C%22lastName%22%3A%22Lahav%22%7D%5D%2C%22abstractNote%22%3A%22The%20master%20regulator%20of%20the%20DNA%20damage%20response%2C%20the%20transcription%20factor%20p53%2C%20orchestrates%20multiple%20downstream%20responses%20and%20coordinates%20repair%20processes.%20In%20response%20to%20double-strand%20DNA%20breaks%2C%20p53%20exhibits%20pulses%20of%20expression%2C%20but%20how%20it%20achieves%20temporal%20coordination%20of%20downstream%20responses%20remains%20unclear.%20Here%2C%20we%20show%20that%20p53%27s%20posttranslational%20modification%20state%20is%20altered%20between%20its%20first%20and%20second%20pulses%20of%20expression.%20We%20show%20that%20acetylations%20at%20two%20sites%2C%20K373%20and%20K382%2C%20were%20reduced%20in%20the%20second%20pulse%2C%20and%20these%20acetylations%20differentially%20affected%20p53%20target%20genes%2C%20resulting%20in%20changes%20in%20gene%20expression%20programs%20over%20time.%20This%20interplay%20between%20dynamics%20and%20modification%20may%20offer%20a%20strategy%20for%20cellular%20hubs%20like%20p53%20to%20temporally%20organize%20multiple%20processes%20in%20individual%20cells.%22%2C%22date%22%3A%222024-10-25%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.adp2229%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-10-28T15%3A22%3A10Z%22%7D%7D%2C%7B%22key%22%3A%223K4AQJ79%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ji%20et%20al.%22%2C%22parsedDate%22%3A%222024-10-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJi%2C%20W.%2C%20Du%2C%20G.%2C%20Jiang%2C%20J.%2C%20Lu%2C%20W.%2C%20Mills%2C%20C.%20E.%2C%20Yuan%2C%20L.%2C%20Jiang%2C%20F.%2C%20He%2C%20Z.%2C%20Bradshaw%2C%20G.%20A.%2C%20Chung%2C%20M.%2C%20Jiang%2C%20Z.%2C%20Byun%2C%20W.%20S.%2C%20Hinshaw%2C%20S.%20M.%2C%20Zhang%2C%20T.%2C%20%26amp%3B%20Gray%2C%20N.%20S.%20%282024%29.%20Discovery%20of%20bivalent%20small%20molecule%20degraders%20of%20cyclin-dependent%20kinase%207%20%28CDK7%29.%20%3Ci%3EEuropean%20Journal%20of%20Medicinal%20Chemistry%3C%5C%2Fi%3E%2C%20%3Ci%3E276%3C%5C%2Fi%3E%2C%20116613.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejmech.2024.116613%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejmech.2024.116613%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discovery%20of%20bivalent%20small%20molecule%20degraders%20of%20cyclin-dependent%20kinase%207%20%28CDK7%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenzhi%22%2C%22lastName%22%3A%22Ji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guangyan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenchao%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linjie%22%2C%22lastName%22%3A%22Yuan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fen%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhixiang%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zixuan%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Woong%20Sub%22%2C%22lastName%22%3A%22Byun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20M.%22%2C%22lastName%22%3A%22Hinshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinghu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathanael%20S.%22%2C%22lastName%22%3A%22Gray%22%7D%5D%2C%22abstractNote%22%3A%22Cyclin-dependent%20kinase%207%2C%20along%20with%20cyclin%20H%20and%20MAT1%2C%20forms%20the%20CDK-activating%20complex%20%28CAK%29%2C%20which%20directs%20cell%20cycle%20progression%20via%20T-loop%20phosphorylation%20of%20cell%20cycle%20CDKs.%20Pharmacological%20inhibition%20of%20CDK7%20leads%20to%20selective%20anti-cancer%20effects%20in%20cellular%20and%20in%20vivo%20models%2C%20motivating%20several%20ongoing%20clinical%20investigations%20of%20this%20target.%20Current%20CDK7%20inhibitors%20are%20either%20reversible%20or%20covalent%20inhibitors%20of%20its%20catalytic%20activity.%20We%20hypothesized%20that%20small%20molecule%20targeted%20protein%20degradation%20%28TPD%29%20might%20result%20in%20differentiated%20pharmacology%20due%20to%20the%20loss%20of%20scaffolding%20functions.%20Here%2C%20we%20report%20the%20design%20and%20characterization%20of%20a%20potent%20CDK7%20degrader%20that%20is%20comprised%20of%20an%20ATP-competitive%20CDK7%20binder%20linked%20to%20a%20CRL2VHL%20recruiter.%20JWZ-5-13%20effectively%20degrades%20CDK7%20in%20multiple%20cancer%20cells%20and%20leads%20to%20a%20potent%20inhibition%20of%20cell%20proliferation.%20Additionally%2C%20compound%20JWZ-5-13%20displayed%20bioavailability%20in%20a%20pharmacokinetic%20study%20conducted%20in%20mice.%20Therefore%2C%20JWZ-5-13%20is%20a%20useful%20chemical%20probe%20to%20investigate%20the%20pharmacological%20consequences%20of%20CDK7%20degradation.%22%2C%22date%22%3A%222024-10-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ejmech.2024.116613%22%2C%22ISSN%22%3A%221768-3254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222024-11-04T19%3A54%3A24Z%22%7D%7D%2C%7B%22key%22%3A%229LABQV53%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Wala%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWala%2C%20J.%2C%20de%20Bruijn%2C%20I.%2C%20Coy%2C%20S.%2C%20Gagn%26%23xE9%3B%2C%20A.%2C%20Chan%2C%20S.%2C%20Chen%2C%20Y.-A.%2C%20Hoffer%2C%20J.%2C%20Muhlich%2C%20J.%2C%20Schultz%2C%20N.%2C%20Santagata%2C%20S.%2C%20%26amp%3B%20Sorger%2C%20P.%20K.%20%282024%29.%20%3Ci%3EIntegrating%20spatial%20profiles%20and%20cancer%20genomics%20to%20identify%20immune-infiltrated%20mismatch%20repair%20proficient%20colorectal%20cancers%3C%5C%2Fi%3E%20%5BPreprint%5D.%20bioRxiv.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.09.24.614701%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2024.09.24.614701%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Integrating%20spatial%20profiles%20and%20cancer%20genomics%20to%20identify%20immune-infiltrated%20mismatch%20repair%20proficient%20colorectal%20cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremiah%22%2C%22lastName%22%3A%22Wala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ino%22%2C%22lastName%22%3A%22de%20Bruijn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22Gagn%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Hoffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Predicting%20the%20progression%20of%20solid%20cancers%20based%20solely%20on%20genetics%20is%20challenging%20due%20to%20the%20influence%20of%20the%20tumor%20microenvironment%20%28TME%29.%20For%20colorectal%20cancer%20%28CRC%29%2C%20tumors%20deficient%20in%20mismatch%20repair%20%28dMMR%29%20are%20more%20immune%20infiltrated%20than%20mismatch%20repair%20proficient%20%28pMMR%29%20tumors%20and%20have%20better%20prognosis%20following%20resection.%20Here%20we%20quantify%20features%20of%20the%20CRC%20TME%20by%20combining%20spatial%20profiling%20with%20genetic%20analysis%20and%20release%20our%20findings%20via%20a%20spatially%20enhanced%20version%20of%20cBioPortal%20that%20facilitates%20multi-modal%20data%20exploration%20and%20analysis.%20We%20find%20that%20%5Cu223c20%25%20of%20pMMR%20tumors%20exhibit%20similar%20levels%20of%20T%20cell%20infiltration%20as%20dMMR%20tumors%20and%20that%20this%20is%20associated%20with%20better%20survival%20but%20not%20any%20specific%20somatic%20mutation.%20These%20T%20cell-infiltrated%20pMMR%20%28tipMMR%29%20tumors%20contain%20abundant%20cells%20expressing%20PD1%20and%20PDL1%20as%20well%20as%20T%20regulatory%20cells%2C%20consistent%20with%20a%20suppressed%20immune%20response.%20Thus%2C%20like%20dMMR%20CRC%2C%20tipMMR%20CRC%20may%20benefit%20from%20immune%20checkpoint%20inhibitor%20therapy.%5CnSIGNIFICANCE%3A%20pMMR%20tumors%20with%20high%20T%20cell%20infiltration%20and%20active%20immunosuppression%20are%20identifiable%20with%20a%20mid-plex%20imaging%20assay%20whose%20clinical%20deployment%20might%20double%20the%20number%20of%20treatment-na%5Cu00efve%20CRCs%20eligible%20for%20ICIs.%20Moreover%2C%20the%20low%20tumor%20mutational%20burden%20in%20tipMMR%20CRC%20shows%20that%20MMR%20status%20is%20not%20the%20only%20factor%20promoting%20immune%20infiltration.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222024-09-26%22%2C%22DOI%22%3A%2210.1101%5C%2F2024.09.24.614701%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T22%3A47%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22BKCZQFCY%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Minichetti%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMinichetti%2C%20D.%20G.%2C%20Boyd%2C%20A.%2C%20Lemire%2C%20E.%2C%20Hacker%2C%20J.%2C%20Haber%2C%20A.%20L.%2C%20Roditi%2C%20R.%20E.%2C%20Albers%2C%20M.%20W.%2C%20Lee%2C%20S.%2C%20Buchheit%2C%20K.%20M.%2C%20Laidlaw%2C%20T.%20M.%2C%20%26amp%3B%20Bankova%2C%20L.%20G.%20%282024%29.%20Determinants%20of%20Persistence%20and%20Recovery%20of%20Chronic%20COVID19%20Chemosensory%20Dysfunction.%20%3Ci%3EThe%20Journal%20of%20Allergy%20and%20Clinical%20Immunology%3C%5C%2Fi%3E%2C%20S0091-6749%2824%2900913-8.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaci.2024.08.027%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaci.2024.08.027%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Determinants%20of%20Persistence%20and%20Recovery%20of%20Chronic%20COVID19%20Chemosensory%20Dysfunction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dante%20G.%22%2C%22lastName%22%3A%22Minichetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amelia%22%2C%22lastName%22%3A%22Boyd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evan%22%2C%22lastName%22%3A%22Lemire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Hacker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20L.%22%2C%22lastName%22%3A%22Haber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20E.%22%2C%22lastName%22%3A%22Roditi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stella%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20M.%22%2C%22lastName%22%3A%22Buchheit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanya%20M.%22%2C%22lastName%22%3A%22Laidlaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lora%20G.%22%2C%22lastName%22%3A%22Bankova%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%202-4%25%20of%20patients%2C%20COVID19%20chemosensory%20dysfunction%20%28CSD%29%20persists%20beyond%20six%20months%2C%20accounting%20for%20up%20to%204%20million%20people%20in%20the%20US.%20The%20predictors%20of%20persistence%20and%20recovery%20require%20further%20exploration.%5CnOBJECTIVE%3A%20To%20define%20the%20predictors%20of%20recovery%20and%20assess%20the%20quality%20of%20CSD%20in%20registry%20subjects%20with%20self-reported%20persistent%20smell%20and%20taste%20dysfunction%20after%20COVID19.%5CnMETHODS%3A%20COVID19%20CSD%20participants%20%28n%3D408%29%20from%20the%20four%20major%20waves%20of%20the%20pandemic%20completed%20questionnaires%20at%20four%20time%20points%20between%202021%20and%202023%2C%20assessing%20demographics%2C%20sinonasal%20symptoms%20and%20self-assessed%20recovery.%20Objective%20measurements%20of%20smell%20%28UPSIT%29%20and%20taste%20%28BWETT%29%20were%20performed%20on%20a%20sub-cohort%20%28n%3D108%29.%5CnRESULTS%3A%20In%20this%20chronic%20CSD%20cohort%2C%20the%20average%20symptom%20duration%20was%2024%5Cu00b15%20months%20but%2070%25%20those%20who%20contracted%20COVID19%20in%202020%20have%20ongoing%20dysfunction.%20Phantosmia%20and%20dysgeusia%20were%20most%20prevalent%20in%20the%20early%20waves%20of%20COVID19%2C%20while%20most%20participants%20reported%20disrupted%20ability%20to%20distinguish%20scents%20and%20flavors%20and%20undulating%20chemosensory%20function.%20Subjects%20reported%20low%20incidence%20of%20subjective%20sinonasal%20symptoms%20but%20high%20prevalence%20of%20sleep%20and%20mood%20disturbance.%20Cigarette%20phantom%20smells%20were%20predictive%20of%20persistence%20of%20CSD.%20Conversely%2C%20self-reported%20environmental%20allergies%20were%20predictive%20of%20recovery%20and%20dust%20mite%20allergies%2C%20specifically%2C%20were%20negative%20predictors%20of%20cigarette%20phantom%20smells.%20Finally%2C%20no%20treatment%20resolved%20CSD%2C%20but%20nasal%20steroids%20were%20reported%20effective%20by%20recovered%20CSD%20subjects.%20Objective%20measures%20of%20both%20smell%20and%20taste%20were%20significantly%20reduced%20in%20chronic%20CSD%20compared%20to%20controls.%5CnCONCLUSIONS%3A%20Chronic%20COVID19%20CSD%20is%20a%20syndrome%20resistant%20to%20standard%20anti-inflammatory%20therapy.%20Pre-existing%20environmental%20allergies%20and%20hypertension%20predict%20recovery%2C%20while%20cigarette%20smoke%20phantosmia%20predicts%20persistence.%22%2C%22date%22%3A%222024-09-11%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaci.2024.08.027%22%2C%22ISSN%22%3A%221097-6825%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-05-05T19%3A50%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22K8L2ZTL7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Conger%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EConger%2C%20K.%20O.%2C%20Chidley%2C%20C.%2C%20Ozgurses%2C%20M.%20E.%2C%20Zhao%2C%20H.%2C%20Kim%2C%20Y.%2C%20Semina%2C%20S.%20E.%2C%20Burns%2C%20P.%2C%20Rawat%2C%20V.%2C%20Lietuvninkas%2C%20L.%2C%20Sheldon%2C%20R.%2C%20Ben-Sahra%2C%20I.%2C%20Frasor%2C%20J.%2C%20Sorger%2C%20P.%20K.%2C%20DeNicola%2C%20G.%20M.%2C%20%26amp%3B%20Coloff%2C%20J.%20L.%20%282024%29.%20ASCT2%20is%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells.%20%3Ci%3ECell%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E43%3C%5C%2Fi%3E%288%29%2C%20114552.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.celrep.2024.114552%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.celrep.2024.114552%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ASCT2%20is%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%20O.%22%2C%22lastName%22%3A%22Conger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mete%20Emir%22%2C%22lastName%22%3A%22Ozgurses%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huiping%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yumi%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svetlana%20E.%22%2C%22lastName%22%3A%22Semina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippa%22%2C%22lastName%22%3A%22Burns%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vipin%22%2C%22lastName%22%3A%22Rawat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lina%22%2C%22lastName%22%3A%22Lietuvninkas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Sheldon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Issam%22%2C%22lastName%22%3A%22Ben-Sahra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonna%22%2C%22lastName%22%3A%22Frasor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gina%20M.%22%2C%22lastName%22%3A%22DeNicola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20L.%22%2C%22lastName%22%3A%22Coloff%22%7D%5D%2C%22abstractNote%22%3A%22The%20non-essential%20amino%20acid%20serine%20is%20a%20critical%20nutrient%20for%20cancer%20cells%20due%20to%20its%20diverse%20biosynthetic%20functions.%20While%20some%20tumors%20can%20synthesize%20serine%20de%20novo%2C%20others%20are%20auxotrophic%20and%20therefore%20reliant%20on%20serine%20uptake.%20Importantly%2C%20despite%20several%20transporters%20being%20known%20to%20be%20capable%20of%20transporting%20serine%2C%20the%20transporters%20that%20mediate%20serine%20uptake%20in%20cancer%20cells%20are%20not%20known.%20Here%2C%20we%20characterize%20the%20amino%20acid%20transporter%20ASCT2%20%28SLC1A5%29%20as%20a%20major%20contributor%20to%20serine%20uptake%20in%20cancer%20cells.%20ASCT2%20is%20well%20known%20as%20a%20glutamine%20transporter%20in%20cancer%2C%20and%20our%20work%20demonstrates%20that%20serine%20and%20glutamine%20compete%20for%20uptake%20through%20ASCT2.%20We%20further%20show%20that%20ASCT2-mediated%20serine%20uptake%20is%20essential%20for%20purine%20nucleotide%20biosynthesis%20and%20that%20estrogen%20receptor%20%5Cu03b1%20%28ER%5Cu03b1%29%20promotes%20serine%20uptake%20by%20directly%20activating%20SLC1A5%20transcription.%20Collectively%2C%20our%20work%20defines%20an%20additional%20important%20role%20for%20ASCT2%20as%20a%20serine%20transporter%20in%20cancer%20and%20evaluates%20ASCT2%20as%20a%20potential%20therapeutic%20target.%22%2C%22date%22%3A%222024-08-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2024.114552%22%2C%22ISSN%22%3A%222211-1247%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-04-07T22%3A43%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22Z8DVFU7U%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A9036456%2C%22username%22%3A%22jtefft%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Fjtefft%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ghosh%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGhosh%2C%20H.%20S.%2C%20Patel%2C%20R.%20V.%2C%20Woodward%2C%20E.%2C%20Greenwald%2C%20N.%20F.%2C%20Bhave%2C%20V.%20M.%2C%20Maury%2C%20E.%20A.%2C%20Cello%2C%20G.%2C%20Hoffman%2C%20S.%20E.%2C%20Li%2C%20Y.%2C%20Gupta%2C%20H.%2C%20Youssef%2C%20G.%2C%20Spurr%2C%20L.%20F.%2C%20Vogelzang%2C%20J.%2C%20Touat%2C%20M.%2C%20Dubois%2C%20F.%2C%20Cherniack%2C%20A.%20D.%2C%20Guo%2C%20X.%2C%20Tavakol%2C%20S.%2C%20Cioffi%2C%20G.%2C%20%26%23x2026%3B%20Bi%2C%20W.%20L.%20%282024%29.%20Contemporary%20Prognostic%20Signatures%20and%20Refined%20Risk%20Stratification%20of%20Gliomas%3A%20An%20Analysis%20of%204%2C400%20Tumors.%20%3Ci%3ENeuro-Oncology%3C%5C%2Fi%3E%2C%20noae164.%20%3Ca%20class%3D%27zp-DOIURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fneuonc%5C%2Fnoae164%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fneuonc%5C%2Fnoae164%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Contemporary%20Prognostic%20Signatures%20and%20Refined%20Risk%20Stratification%20of%20Gliomas%3A%20An%20Analysis%20of%204%2C400%20Tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hia%20S.%22%2C%22lastName%22%3A%22Ghosh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruchit%20V.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%22%2C%22lastName%22%3A%22Woodward%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noah%20F.%22%2C%22lastName%22%3A%22Greenwald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varun%20M.%22%2C%22lastName%22%3A%22Bhave%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20A.%22%2C%22lastName%22%3A%22Maury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%22%2C%22lastName%22%3A%22Cello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%20E.%22%2C%22lastName%22%3A%22Hoffman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hersh%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilbert%22%2C%22lastName%22%3A%22Youssef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liam%20F.%22%2C%22lastName%22%3A%22Spurr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jayne%22%2C%22lastName%22%3A%22Vogelzang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Dubois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Cherniack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaopeng%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherwin%22%2C%22lastName%22%3A%22Tavakol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gino%22%2C%22lastName%22%3A%22Cioffi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20I.%22%2C%22lastName%22%3A%22Lindeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azra%20H.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Meredith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jill%20S.%22%2C%22lastName%22%3A%22Barnholtz-Sloan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20With%20the%20significant%20shift%20in%20the%20classification%2C%20risk%20stratification%2C%20and%20standards%20of%20care%20for%20gliomas%2C%20we%20sought%20to%20understand%20how%20the%20overall%20survival%20of%20patients%20with%20these%20tumors%20is%20impacted%20by%20molecular%20features%2C%20clinical%20metrics%2C%20and%20treatment%20received.%5CnMETHODS%3A%20We%20assembled%20a%20cohort%20of%20patients%20with%20a%20histopathologically%20diagnosed%20glioma%20from%20The%20Cancer%20Genome%20Atlas%2C%20Project%20Genomics%20Evidence%20Neoplasia%20Information%20Exchange%2C%20and%20Dana-Farber%20Cancer%20Institute%5C%2FBrigham%20and%20Women%27s%20Hospital.%20This%20incorporated%20retrospective%20clinical%2C%20histological%2C%20and%20molecular%20data%20alongside%20prospective%20assessment%20of%20patient%20survival.%5CnRESULTS%3A%204%2C400%20gliomas%20were%20identified%3A%202%2C195%20glioblastoma%2C%201%2C198%20IDH1%5C%2F2-mutant%20astrocytoma%2C%20531%20oligodendroglioma%2C%20271%20other%20IDH1%5C%2F2-wildtype%20glioma%2C%20and%20205%20pediatric-type%20glioma.%20Molecular%20classification%20updated%2027.2%25%20of%20gliomas%20from%20their%20original%20histopathologic%20diagnosis.%20Examining%20the%20distribution%20of%20molecular%20alterations%20across%20glioma%20subtypes%20revealed%20mutually%20exclusive%20alterations%20within%20tumorigenic%20pathways.%20Non-TCGA%20patients%20had%20significantly%20improved%20overall%20survival%20compared%20to%20TCGA%20patients%2C%20with%2026.7%25%2C%2055.6%25%2C%20and%20127.8%25%20longer%20survival%20for%20glioblastoma%2C%20IDH1%5C%2F2-mutant%20astrocytoma%2C%20and%20oligodendroglioma%20respectively%20%28all%20p%3C0.01%29.%20Several%20prognostic%20features%20were%20characterized%2C%20including%20NF1%20alteration%20and%2021q%20loss%20in%20glioblastoma%2C%20and%20EGFR%20amplification%20and%2022q%20loss%20in%20IDH1%5C%2F2-mutant%20astrocytoma.%20Leveraging%20the%20size%20of%20this%20cohort%2C%20nomograms%20were%20generated%20to%20assess%20the%20probability%20of%20overall%20survival%20based%20on%20patient%20age%2C%20the%20molecular%20features%20of%20a%20tumor%2C%20and%20the%20treatment%20received.%5CnCONCLUSIONS%3A%20By%20applying%20modern%20molecular%20criteria%2C%20we%20characterize%20the%20genomic%20diversity%20across%20glioma%20subtypes%2C%20identify%20clinically%20applicable%20prognostic%20features%2C%20and%20provide%20a%20contemporary%20update%20on%20patient%20survival%20to%20serve%20as%20a%20reference%20for%20ongoing%20investigations.%22%2C%22date%22%3A%222024-08-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnoae164%22%2C%22ISSN%22%3A%221523-5866%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-02-28T15%3A45%3A53Z%22%7D%7D%5D%7D
Oskolas, H., Nogueira, F. C. N., Domont, G. B., Yu, K.-H., Semenov, Y. R., Sorger, P., Steinfelder, E., Corps, L., Schulz, L., Wieslander, E., Fenyö, D., Kárpáti, S., Holló, P., Kemény, L. V., Döme, B., Megyesfalvi, Z., Pawłowski, K., Nishimura, T., Kwon, H., … Gil, J. (2025). Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center. Journal of Proteomics, 316, 105442. https://doi.org/10.1016/j.jprot.2025.105442
Jobin, B., Zigrand, C., Frasnelli, J., Boller, B., & Albers, M. W. (2025). Lower Odor Identification in Subjective Cognitive Decline: A Meta-analysis. MedRxiv: The Preprint Server for Health Sciences, 2025.04.15.25325887. https://doi.org/10.1101/2025.04.15.25325887
Khoury, R., Longobardi, G., Barnatan, T. T., Venkert, D., García Alvarado, A., Yona, A., Green Buzhor, M., Shahar, S., Wang, Q., Acúrcio, R. C., Guedes, R. C., Florindo, H. F., Zhao, J. J., & Satchi-Fainaro, R. (2025). Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy. Journal of Controlled Release: Official Journal of the Controlled Release Society, 383, 113812. https://doi.org/10.1016/j.jconrel.2025.113812
Gui, F., Jiang, B., Jiang, J., He, Z., Tsujino, T., Takai, T., Arai, S., Pana, C., Köllermann, J., Bradshaw, G. A., Eisert, R., Kalocsay, M., Fassl, A., Balk, S. P., Kibel, A. S., & Jia, L. (2025). Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science Advances, 11(17), eadu0847. https://doi.org/10.1126/sciadv.adu0847
Gevertz, J. L., Greene, J. M., Prosperi, S., Comandante-Lou, N., & Sontag, E. D. (2025). Understanding therapeutic tolerance through a mathematical model of drug-induced resistance. NPJ Systems Biology and Applications, 11(1), 30. https://doi.org/10.1038/s41540-025-00511-3
Ma, X. C., & Clardy, J. (2025). Spontaneous Generation of an Endogenous RORγt Agonist. Journal of the American Chemical Society, 147(14), 11688–11692. https://doi.org/10.1021/jacs.5c02724
Kelley, L. P., Hu, S.-H., Boswell, S. A., Sorger, P. K., Ringel, A. E., & Haigis, M. C. (2025). Integrated analysis of transcriptional and metabolic responses to mitochondrial stress. Cell Reports Methods, 101027. https://doi.org/10.1016/j.crmeth.2025.101027
de Bruijn, I., Nikolov, M., Lau, C., Clayton, A., Gibbs, D. L., Mitraka, E., Pozhidayeva, D., Lash, A., Sumer, S. O., Altreuter, J., Anton, K., DeFelice, M., Li, X., Lisman, A., Longabaugh, W. J. R., Muhlich, J., Santagata, S., Nandakumar, S., Sorger, P. K., … Eddy, J. A. (2025). Sharing data from the Human Tumor Atlas Network through standards, infrastructure and community engagement. Nature Methods, 22(4), 664–671. https://doi.org/10.1038/s41592-025-02643-0
Břinda, K., Lima, L., Pignotti, S., Quinones-Olvera, N., Salikhov, K., Chikhi, R., Kucherov, G., Iqbal, Z., & Baym, M. (2025). Efficient and robust search of microbial genomes via phylogenetic compression. Nature Methods, 22(4), 692–697. https://doi.org/10.1038/s41592-025-02625-2
Mukhija, S., Sunog, M., Magdamo, C., & Albers, M. W. (2025). Impact of Severe COVID-19 on Accelerating Dementia Onset: Clinical and Epidemiological Insights. medRxiv. https://doi.org/10.1101/2025.03.26.25324688
Jobin, B., Magdamo, C., Delphus, D., Runde, A., Reineke, S., Soto, A. A., Ergun, B., Mukhija, S., Albers, A. D., & Albers, M. W. (2025). The AROMHA brain health test is a remote olfactory assessment to screen for cognitive impairment. Scientific Reports, 15(1), 9290. https://doi.org/10.1038/s41598-025-92826-8
Mon-Wei Yu, S., Choi, J. Y., Kady, J., De Cos, M., Wong, J. S., King, E., Younis, N., Al Rahy, N., Al Chaar, S., Djebli, H., Eskandari, S., Samuel, S., Merhej, T., Sukumar, N., Lin, J.-R., Chen, J.-Y., Xu, Y., Santagata, S., Weins, A., … Azzi, J. (2025). Transplantation of human kidney organoids elicited a robust allogeneic response in a humanized mouse model. Kidney International, S0085-2538(25)00255-8. https://doi.org/10.1016/j.kint.2025.02.027
Zhou, F. Y., Marin, Z., Yapp, C., Zou, Q., Nanes, B. A., Daetwyler, S., Jamieson, A., Islam, M. T., Jenkins, E., Gihana, G. M., Lin, J., Borges, H. M., Chang, B.-J., Weems, A., Morrison, S. J., Sorger, P. K., Fiolka, R. P., Dean, K. M., & Danuser, G. (2025). Universal consensus 3D segmentation of cells from 2D segmented stacks [Preprint]. bioRxiv. https://doi.org/10.1101/2024.05.03.592249
Vidović, D., Shamsaei, B., Schürer, S. C., Kogan, P., Chojnacki, S., Kouril, M., Medvedovic, M., Niu, W., Azeloglu, E. U., Birtwistle, M. R., Chen, Y., Chen, T., Hansen, J., Hu, B., Iyengar, R., Jayaraman, G., Li, H., Liu, T., Sobie, E. A., … MacCoss, M. J. (2025). Comprehensive proteomics metadata and integrative web portals facilitate sharing and integration of LINCS multiomics data. Molecular & Cellular Proteomics: MCP, 100947. https://doi.org/10.1016/j.mcpro.2025.100947
Deng, X., Bradshaw, G., Kalocsay, M., & Mitchison, T. (2025). Tubulin Regulates the Stability and Localization of STMN2 by Binding Preferentially to Its Soluble Form [Preprint]. bioRxiv. https://doi.org/10.1101/2025.02.27.640326
Fang, R., Vallius, T., Zhang, A., Van Cura, D., Alicandri, F., Fischer, G., Draper, E., Xu, S., Pelletier, R., Wang, J., Mandinova, A., Katsyv, I., Sorger, P. K., Murphy, G. F., & Lian, C. G. (2025). PRAME expression in melanoma is negatively regulated by TET2-mediated DNA hydroxymethylation. Laboratory Investigation; a Journal of Technical Methods and Pathology, 104123. https://doi.org/10.1016/j.labinv.2025.104123
He, X., Wang, Q., Cheng, X., Wang, W., Li, Y., Nan, Y., Wu, J., Xiu, B., Jiang, T., Bergholz, J. S., Gu, H., Chen, F., Fan, G., Sun, L., Xie, S., Zou, J., Lin, S., Wei, Y., Lee, J., … Zhao, J. J. (2025). Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response. Cell, S0092-8674(25)00145-X. https://doi.org/10.1016/j.cell.2025.01.043
Cortés-Ríos, J., Rodriguez-Fernandez, M., Sorger, P. K., & Fröhlich, F. (2025). Dynamic Modeling of Cell Cycle Arrest Through Integrated Single-Cell and Mathematical Modelling Approaches [Preprint]. bioRxiv. https://doi.org/10.1101/2025.02.20.639240
Mears, K. S., Rossine, F. W., Quinones-Olvera, N., Souque, C., & Baym, M. (2025). RNA-guided nucleases enable a gene drive of insertion sequences in plasmids [Preprint]. https://doi.org/10.1101/2025.02.20.638934
Rossine, F., Sanchez, C., Eaton, D., Paulsson, J., & Baym, M. (2025). Intracellular competition shapes plasmid population dynamics [Preprint]. bioRxiv. https://doi.org/10.1101/2025.02.19.639193
Rendo, V., Lee, E. Q., Bossi, C., Khuu, N., Rudek, M. A., Pal, S., Azazmeh, N., Rashid, R., Lin, J.-R., Cusick, M., Reynolds, A. R. N., Fassinou, A. C. R., Ayoub, G., Malinowski, S., Lapinskas, E., Pisano, W., Jeang, J., Stopka, S. A., Regan, M. S., … Beroukhim, R. (2025). A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma. Science Translational Medicine, 17(786), eadn6274. https://doi.org/10.1126/scitranslmed.adn6274
Prabhakaran, S., Yapp, C., Baker, G. J., Beyer, J., Chang, Y. H., Creason, A. L., Krueger, R., Muhlich, J., Patterson, N. H., Sidak, K., Sudar, D., Taylor, A. J., Ternes, L., Troidl, J., Yubin, X., Sokolov, A., & Tyson, D. R. (2025). Addressing persistent challenges in digital image analysis of cancer tissue: resources developed from a hackathon. Molecular Oncology. https://doi.org/10.1002/1878-0261.13783
Sun, Y., Maggs, L., Panda, A., Wright, S. J., Cicerchia, A. M., Jenney, A., Perricone, M. D., Mills, C. E., Cattaneo, G., Ventin, M., Chen, F., Rasmussen, M. Q., Miranda, A., Revach, O.-Y., Fang, J., Fu, A., Bowling, P. J., Sharova, T., Lawless, A., … Jenkins, R. W. (2025). TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids. Cancer Immunology Research, 13(2), 210–228. https://doi.org/10.1158/2326-6066.CIR-23-1011
Spellberg, B., Gilbert, D. N., Baym, M., Bearman, G., Boyles, T., Casadevall, A., Forrest, G. N., Freling, S., Ghanem, B., Hamilton, F., Luna, B., Moore, J., Musher, D. M., Nielsen, T. B., Nori, P., Phillips, M. C., Pirofski, L.-A., Shorr, A. F., Tong, S. Y. C., … McDonald, E. G. (2025). Sustainable solutions to the continuous threat of antimicrobial resistance. Health Affairs Scholar, 3(2), qxaf012. https://doi.org/10.1093/haschl/qxaf012
Lee, E. Q., Alexander, B. M., Romo, C. G., Supko, J. G., Agar, N. Y. R., Talebi, Z., Ahluwalia, M. S., Desai, A. S., Dietrich, J., Kaley, T. J., Peereboom, D. M., Gantchev, J., Baquer, G., Santagata, S., Takebe, N., Desideri, S., Fisher, J. D., Sims, M., Ye, X., … Wen, P. Y. (2025). Phase I study of adavosertib with radiation therapy and temozolomide in newly diagnosed glioblastoma and intratumoral drug levels in recurrent glioblastoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-24-2311
Kaul, A., Souque, C., Holland, M., & Baym, M. (2025). Genomic resistance in historical clinical isolates increased in frequency and mobility after the age of antibiotics. bioRxiv. https://doi.org/10.1101/2025.01.16.633422
Stojanovic, L., Abbotts, R., Tripathi, K., Coon, C. M., Rajendran, S., Abbasi Farid, E., Hostetter, G., Guarnieri, J. W., Wallace, D. C., Liu, S., Wan, J., Calendo, G., Marker, R., Gohari, Z., Inayatullah, M. M. A., Tiwari, V. K., Kader, T., Santagata, S., Drapkin, R., … Rassool, F. V. (2025). ZNFX1 functions as a master regulator of epigenetically induced pathogen mimicry and inflammasome signaling in cancer. Cancer Research. https://doi.org/10.1158/0008-5472.CAN-24-1286
MacDonald, J. A., Bradshaw, G. A., Jochems, F., Bernards, R., & Letai, A. (2025). Apoptotic priming in senescence predicts specific senolysis by quantitative analysis of mitochondrial dependencies. Cell Death and Differentiation. https://doi.org/10.1038/s41418-024-01431-1
Morth, E., Sidak, K., Maliga, Z., Moller, T., Gehlenborg, N., Sorger, P., Pfister, H., Beyer, J., & Kruger, R. (2025). Cell2Cell: Explorative Cell Interaction Analysis in Multi-Volumetric Tissue Data. IEEE Transactions on Visualization and Computer Graphics, 31(1), 569–579. https://doi.org/10.1109/TVCG.2024.3456406
Oka, T., Hasegawa, T., Lee, T., Oliver-Garcia, V. S., Mortaja, M., Azin, M., Horiba, S., Smith, S. S., Khattab, S., Trerice, K. E., Chen, S. T., Semenov, Y. R., & Demehri, S. (2025). Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis. JID Innovations: Skin Science from Molecules to Population Health, 5(1), 100324. https://doi.org/10.1016/j.xjidi.2024.100324
Mollaoglu, G., Tepper, A., Falcomatà, C., Potak, H. T., Pia, L., Amabile, A., Mateus-Tique, J., Rabinovich, N., Park, M. D., LaMarche, N. M., Brody, R., Browning, L., Lin, J.-R., Zamarin, D., Sorger, P. K., Santagata, S., Merad, M., Baccarini, A., & Brown, B. D. (2024). Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell, 187(26), 7492-7510.e22. https://doi.org/10.1016/j.cell.2024.10.006
Kader, T., Lin, J.-R., Hug, C. B., Coy, S., Chen, Y.-A., de Bruijn, I., Shih, N., Jung, E., Pelletier, R. J., Lopez Leon, M., Mingo, G., Omran, D. K., Lee, J. S., Yapp, C., Satravada, B. A., Kundra, R., Xu, Y., Chan, S., Tefft, J. B., … Santagata, S. (2024). Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma. Cancer Discovery. https://doi.org/10.1158/2159-8290.CD-24-1366
Girnius, N., Henstridge, A. Z., Marks, B., Yu, J. K., Gray, G. K., Sander, C., Zervantonakis, I. K., & Luna, A. (2024). Cilengitide sensitivity is predicted by overall integrin expression in breast cancer. Breast Cancer Research: BCR, 26(1), 187. https://doi.org/10.1186/s13058-024-01942-2
Letai, A., & de The, H. (2024). Conventional chemotherapy: millions of cures, unresolved therapeutic index. Nature Reviews. Cancer. https://doi.org/10.1038/s41568-024-00778-4
Yu, W.-W., Barrett, J. N. P., Tong, J., Lin, M.-J., Marohn, M., Devlin, J. C., Herrera, A., Remark, J., Levine, J., Liu, P.-K., Fang, V., Zellmer, A. M., Oldridge, D. A., Wherry, E. J., Lin, J.-R., Chen, J.-Y., Sorger, P., Santagata, S., Krueger, J. G., … Lu, C. P. (2024). Skin immune-mesenchymal interplay within tertiary lymphoid structures promotes autoimmunepathogenesis in hidradenitis suppurativa. Immunity, 57(12), 2827-2842.e5. https://doi.org/10.1016/j.immuni.2024.11.010
Launonen, I.-M., Niemiec, I., Hincapié-Otero, M., Erkan, E. P., Junquera, A., Afenteva, D., Falco, M. M., Liang, Z., Salko, M., Chamchougia, F., Szabo, A., Perez-Villatoro, F., Li, Y., Micoli, G., Nagaraj, A., Haltia, U.-M., Kahelin, E., Oikkonen, J., Hynninen, J., … Färkkilä, A. (2024). Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer. Cancer Cell, 42(12), 2045-2063.e10. https://doi.org/10.1016/j.ccell.2024.11.005
Loi, P., Schade, A. E., Rodriguez, C. L., Krishnan, A., Perurena, N., Nguyen, V. T. M., Xu, Y., Watanabe, M., Davis, R. A., Gardner, A., Pilla, N. F., Mattioli, K., Popow, O., Gunduz, N., Lannagan, T. R. M., Fitzgerald, S., Sicinska, E. T., Lin, J.-R., Tan, W., … Cichowski, K. (2024). Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers. Cancer Discovery, 14(12), 2430–2449. https://doi.org/10.1158/2159-8290.CD-23-0866
Tobochnik, S., Regan, M. S., Dorotan, M. K. C., Reich, D., Lapinskas, E., Hossain, M. A., Stopka, S., Meredith, D. M., Santagata, S., Murphy, M. M., Arnaout, O., Bi, W. L., Chiocca, E. A., Golby, A. J., Mooney, M. A., Smith, T. R., Ligon, K. L., Wen, P. Y., Agar, N. Y. R., & Lee, J. W. (2024). Pilot Trial of Perampanel on Peritumoral Hyperexcitability in Newly Diagnosed High-grade Glioma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 30(23), 5365–5373. https://doi.org/10.1158/1078-0432.CCR-24-1849
Baker, G. J., Novikov, E., Zhao, Z., Vallius, T., Davis, J. A., Lin, J.-R., Muhlich, J. L., Mittendorf, E. A., Santagata, S., Guerriero, J. L., & Sorger, P. K. (2024). Quality control for single-cell analysis of high-plex tissue profiles using CyLinter. Nature Methods, 21(12), 2248–2259. https://doi.org/10.1038/s41592-024-02328-0
Shimada, K., Michaud, D. E., Cui, Y. X., Zheng, K., Goldberg, J., Ju, Z., Schnitt, S. J., Pastorello, R., Kania, L. D., Hoffer, J., Muhlich, J. L., Hyun, N., Krueger, R., Gottlieb, A., Nelson, A., Wanderley, C. W., Antonellis, G., McAllister, S. S., Tolaney, S. M., … Guerriero, J. L. (2024). An estrogen receptor signaling transcriptional program linked to immune evasion in human hormone receptor-positive breast cancer [Preprint]. bioRxiv. https://doi.org/10.1101/2024.11.23.619172
Rand, E. A., Owen, S. V., Quinones-Olvera, N., Jean, K. D. C., Hernandez-Perez, C., & Baym, M. (2024). Phage DisCo: targeted discovery of bacteriophages by co-culture [Preprint]. bioRxiv. https://doi.org/10.1101/2024.11.22.624878
Vaelli, P., Fujita, A., Jo, S., Zhang, H.-X. B., Osorno, T., Ma, X., & Bean, B. P. (2024). State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-548. Molecular Pharmacology, 106(6), 298–308. https://doi.org/10.1124/molpharm.124.000944
Souque, C., González Ojeda, I., & Baym, M. (2024). From Petri Dishes to Patients to Populations: Scales and Evolutionary Mechanisms Driving Antibiotic Resistance. Annual Review of Microbiology, 78(1), 361–382. https://doi.org/10.1146/annurev-micro-041522-102707
Schade, A. E., Perurena, N., Yang, Y., Rodriguez, C. L., Krishnan, A., Gardner, A., Loi, P., Xu, Y., Nguyen, V. T. M., Mastellone, G. M., Pilla, N. F., Watanabe, M., Ota, K., Davis, R. A., Mattioli, K., Xiang, D., Zoeller, J. J., Lin, J.-R., Morganti, S., … Cichowski, K. (2024). AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution. Nature, 635(8039), 755–763. https://doi.org/10.1038/s41586-024-08031-6
Lu, D., Faizi, M., Drown, B., Simerzin, A., François, J., Bradshaw, G., Kelleher, N., Jambhekar, A., Gunawardena, J., & Lahav, G. (2024). Temporal regulation of gene expression through integration of p53 dynamics and modifications. Science Advances, 10(43), eadp2229. https://doi.org/10.1126/sciadv.adp2229
Ji, W., Du, G., Jiang, J., Lu, W., Mills, C. E., Yuan, L., Jiang, F., He, Z., Bradshaw, G. A., Chung, M., Jiang, Z., Byun, W. S., Hinshaw, S. M., Zhang, T., & Gray, N. S. (2024). Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7). European Journal of Medicinal Chemistry, 276, 116613. https://doi.org/10.1016/j.ejmech.2024.116613
Wala, J., de Bruijn, I., Coy, S., Gagné, A., Chan, S., Chen, Y.-A., Hoffer, J., Muhlich, J., Schultz, N., Santagata, S., & Sorger, P. K. (2024). Integrating spatial profiles and cancer genomics to identify immune-infiltrated mismatch repair proficient colorectal cancers [Preprint]. bioRxiv. https://doi.org/10.1101/2024.09.24.614701
Minichetti, D. G., Boyd, A., Lemire, E., Hacker, J., Haber, A. L., Roditi, R. E., Albers, M. W., Lee, S., Buchheit, K. M., Laidlaw, T. M., & Bankova, L. G. (2024). Determinants of Persistence and Recovery of Chronic COVID19 Chemosensory Dysfunction. The Journal of Allergy and Clinical Immunology, S0091-6749(24)00913-8. https://doi.org/10.1016/j.jaci.2024.08.027
Conger, K. O., Chidley, C., Ozgurses, M. E., Zhao, H., Kim, Y., Semina, S. E., Burns, P., Rawat, V., Lietuvninkas, L., Sheldon, R., Ben-Sahra, I., Frasor, J., Sorger, P. K., DeNicola, G. M., & Coloff, J. L. (2024). ASCT2 is a major contributor to serine uptake in cancer cells. Cell Reports, 43(8), 114552. https://doi.org/10.1016/j.celrep.2024.114552
Ghosh, H. S., Patel, R. V., Woodward, E., Greenwald, N. F., Bhave, V. M., Maury, E. A., Cello, G., Hoffman, S. E., Li, Y., Gupta, H., Youssef, G., Spurr, L. F., Vogelzang, J., Touat, M., Dubois, F., Cherniack, A. D., Guo, X., Tavakol, S., Cioffi, G., … Bi, W. L. (2024). Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors. Neuro-Oncology, noae164. https://doi.org/10.1093/neuonc/noae164